Cailun Road Shanghai Shi, 201203 China2Y-Chem provides custom synthesis and analytical chemistry services

Building 12, No. 67 Libing Road, Zhangjiang Hi-Tech Park,Pudong Shanghai 201203 China2Y-Chem provides custom synthesis and analytical chemistry services

Jiangsu Wuzhong Life Science Park 1338 Wuzhong Blvd., Wuzhong District Suzhou, Jiangsu 215104, China3D BioOptima provides services in bioanalysis, HTS ADME, in-vitro ADME, in-vivo ADME, ADME-assisted lead optimization, along with PK, PK/PD and TK studies.

Jiangsu Wuzhong Life Science Park 1338 Wuzhong Blvd., Wuzhong District Suzhou, Jiangsu, 215104 China3D BioOptima provides services in bioanalysis, HTS ADME, in-vitro ADME, in-vivo ADME, ADME-assisted lead optimization, along with PK, PK/PD and TK studies.

Room C334, No. 128, Xiangyin Road Shanghai, Yangpu 200433 China3Way Pharm offers intermediate and API manufacturing services.

Shanghai, Shanghai China3Way Pharm offers intermediate and API manufacturing services.

201 Nigxia Road, 18 D Shanghai, 200063 ChinaABACHEM specializes in contract manufacturing of API, intermediates, and fine chemicals.

Shanghai, Shanghai ChinaABACHEM specializes in contract manufacturing of API, intermediates, and fine chemicals.

Suzhou Industrial Park, 218 Lake St. Garden Biological Nano, Bldg #C10 SuZhou ChinaAbgent provides custom peptide synthesis (including long and difficult peptides), custom antibody development and other related services:antibody validation,flow cytomery, idiotypic antibodies, recombinant antibodies.

Shanghai, Shanghai ChinaAbmart provides monoclonal antibody development services.

2nd Floor, Building No. 1, 333 Guiping Road, Juke Bio-tech park, 200233, Shanghai, ChinaAbmart provides monoclonal antibody development services.

1st Building Landian Road no. 1199 Shanghai, Pudong New District, 201318 ChinaAbovchem was founded by MedChem and CMC veterans to serve the Drug Discovery community. We are a part of BirdoTech Pharma Group and the platform of Catalog Reagent and Compound Management. We have ~160,000 building blocks in our catalog and offer a wide range of chemistry services from Discovery to CMC research and manufacturing. We strive to become your trusted chemistry partner. Our US office is located in sunny San Diego and we warehouse over 45k different research chemicals ready for next day delivery. The AbovChem vision is to help our clients realize maximum value, through our world-class innovation-driven drug discovery and manufacturing service platform. Our mission is to help you identify your next clinical candidates as soon as possible.

222 Guangdan Road, No. 21, Pudong New Area, Shanghai, Shanghai, 201318 ChinaAccela ChemBio have both sales offices and warehouses in San Diego, CA (USA) and Shanghai (China). Besides 120,000+ catalog products on our website www.accelachem.com, we'll also be pleased to research your new compounds. Now we’re committed to offer integrated CDMO service from gram to ton scales of advanced intermediates, and raw materials for GMP-like production. Our 3 R&D centers are located in Shanghai (China) and Jinan(China); and one manufacture base in Jiangxi(China). Welcome to see more lab and plant information on web www.accelachem.cn. Our mission is to provide high-quality, innovative products and technical services to our valuable customers.

Fl 7, Building 5, No. 333 Guiping Road, Shanghai, PRC Shanghai, Shanghai, 200233 ChinaA service provider based in Shanghai with branches in Beijing, Guangzhou, Chengdu, Wuhan and Hong Kong, providing Services based on the listed platforms: 10X genomics, SomaLogic (SomaScan), Akoya Bioscience, ISOplex, BioSkryb, Sengenics (KREX). We provide services to academic institute, Hospital institution, as well as Biopharma (Biotech).

Fl 7, Building 5, No. 333 Guiping Road, Shanghai, PRC Fl 7, Building 5, No. 333 Guiping Road, Shanghai, PRC Shanghai, Shanghai, 200233 ChinaA service provider based in Shanghai with branches in Beijing, Guangzhou, Chengdu, Wuhan and Hong Kong, providing Services based on the listed platforms: 10X genomics, SomaLogic (SomaScan), Akoya Bioscience, ISOplex, BioSkryb, Sengenics (KREX). We provide services to academic institute, Hospital institution, as well as Biopharma (Biotech).

Fl 7, Building 7, No. 333 Guiping Road, Shanghai, PRC shanghai, shanghai, 200233 ChinaA service provider based in Shanghai with branches in Beijing, Guangzhou, Chengdu, Wuhan and Hong Kong, providing Services based on the listed platforms: 10X genomics, SomaLogic (SomaScan), Akoya Bioscience, ISOplex, BioSkryb, Sengenics (KREX). We provide services to academic institute, Hospital institution, as well as Biopharma (Biotech).

Room 505, Floor 5, No. 8, Jiafeng Rd, Free Trade Zone Shanghai, Shanghai, 200131 ChinaAccurant Biotech is an innovative contract research organization (CRO) specializing in providing analytical science expertise for the clinical and pre-clinical development of new biological drugs. With a strong presence across North America and strategic partnerships with over 250 clients worldwide, including leading pharmaceutical and biotechnology companies, Accurant Biotech plays a pivotal role in advancing the development of novel therapies, contributing to multiple Biologics License Application (BLA) submissions, and supporting hundreds of clinical studies at various stages.

218 Xinghu Street No. 218,xinghu Street Suzhou Shi, Jiangsu ChinaAdagene Inc. (Nasdaq: ADAG) is a platform-driven, clinical-stage biotechnology company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Adagene combines computational biology and artificial intelligence to design novel antibodies that address globally unmet patient needs. The company has forged strategic collaborations with reputable global partners that leverage its SAFEbody® precision masking technology in multiple approaches at the vanguard of science. Powered by its proprietary Dynamic Precision Library (DPL) platform, composed of NEObody™, SAFEbody, and POWERbody™ technologies, Adagene’s highly differentiated pipeline features novel immunotherapy programs. The company’s SAFEbody technology is designed to address safety and tolerability challenges associated with many antibody therapeutics by using precision masking technology to shield the binding domain of the biologic therapy. Through activation in the tumor microenvironment, this allows for tumor-specific targeting of antibodies in tumor microenvironment, while minimizing on-target off-tumor toxicity in healthy tissues. Adagene’s lead clinical program, ADG126 (muzastotug), is a masked, anti-CTLA-4 SAFEbody that targets a unique epitope of CTLA-4 in regulatory T cells (Tregs) in the tumor microenvironment. ADG126 is currently in phase 1b/2 clinical studies in combination with anti-PD-1 therapy, particularly focused on Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC). Validated by ongoing clinical research, the SAFEbody platform can be applied to a wide variety of antibody-based therapeutic modalities, including Fc empowered antibodies, antibody-drug conjugates, and bi/multi-specific T-cell engagers. For more information, please visit: https://investor.adagene.com.

4F, Building C14, No. 218 Xinghu Street, Suzhou Industrial Park, Suzhou, Jiangsu Province, 215123 ChinaAdagene Inc. (Nasdaq: ADAG) is a platform-driven, clinical-stage biotechnology company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Adagene combines computational biology and artificial intelligence to design novel antibodies that address globally unmet patient needs. The company has forged strategic collaborations with reputable global partners that leverage its SAFEbody® precision masking technology in multiple approaches at the vanguard of science. Powered by its proprietary Dynamic Precision Library (DPL) platform, composed of NEObody™, SAFEbody, and POWERbody™ technologies, Adagene’s highly differentiated pipeline features novel immunotherapy programs. The company’s SAFEbody technology is designed to address safety and tolerability challenges associated with many antibody therapeutics by using precision masking technology to shield the binding domain of the biologic therapy. Through activation in the tumor microenvironment, this allows for tumor-specific targeting of antibodies in tumor microenvironment, while minimizing on-target off-tumor toxicity in healthy tissues. Adagene’s lead clinical program, ADG126 (muzastotug), is a masked, anti-CTLA-4 SAFEbody that targets a unique epitope of CTLA-4 in regulatory T cells (Tregs) in the tumor microenvironment. ADG126 is currently in phase 1b/2 clinical studies in combination with anti-PD-1 therapy, particularly focused on Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC). Validated by ongoing clinical research, the SAFEbody platform can be applied to a wide variety of antibody-based therapeutic modalities, including Fc empowered antibodies, antibody-drug conjugates, and bi/multi-specific T-cell engagers. For more information, please visit: https://investor.adagene.com.

Unit 3526A, Level 35 CITIC Square 1168 West Nanjing Road Shanghai 200041, ChinaAdhesives Research offers custom manufacturing and product management.

Building 1, 207 Huanqiao Road, Pudong New Area Shanghai, 201315, China Shanghai, Shanghai, 201315 ChinaAilux Biologics, a division of XtalPi, is an end-to-end AI-powered biologics discovery and engineering platform. Created at the intersection of artificial intelligence and wet-lab excellence, Ailux is at the forefront of revolutionizing the way biologics are developed, leveraging the power of artificial intelligence to address the most complex challenges facing the industry. Ailux’s technology stack includes: - XtalFold, a state-of-the-art Ab-Ag complex structure prediction algorithm demonstrated superior to Alphafold-Multimer, as evidenced by industry-standard scoring metrics such as DOCKQ and iRMSD. - XenProt, comprehensive suite of AI models that includes generative large language models capable of predicting binding affinity, developability and immunogenicity of biologics. - End-to-end wetlab discovery and characterization services, including single B cell microfluidics, synthetic smart display libraries and hybridoma. Ailux technology has proven effective targeting GPCR's and ion channels, as well as addressing engineering challenges like pH-selectivity, super humanization, and multiparametric developability. Collaborate with Ailux to enable our innovative technologies for your most challenging projects or to elevate the results of more conventional programs.

Xu Shi Jie Suzhou Shi, Jiangsu Sheng, 215164 ChinaA&J Pharmtech specializes in medicine chemistry, process R&D and conjugation chemistry.

538 Xushi Road, Suzhou wuzhong District, Jiangsu Province 215164 ChinaA&J Pharmtech specializes in medicine chemistry, process R&D and conjugation chemistry.

Building 43#, NO.136, Yuhai East Rd., Hangzhou Bay Dist., Ningbo, Zhejiang, 315336 ChinaAlpha Nuclide (Ningbo) Medical Technology Co., Ltd. was established in 2020 and is one of the founding members of the World Astatine Community initiated by the European Cooperation in Science and Technology (serving as China's sole representative). The core technical team consists of returnees from renowned international universities such as Duke University and the University of Missouri. The team specializes in the production and R&D of medical radionuclides and radiopharmaceuticals, leveraging globally advanced Astatine-211 (At-211) technology to provide integrated diagnostic and therapeutic solutions for diseases. The company's R&D headquarters is located in the Hangzhou Bay New Area, Ningbo, Zhejiang Province, and has obtained the Zhejiang Provincial "Radiation Safety License" and "Laboratory Animal Use License." Its East China production base (Zhejiang Alpha Nuclide Medical Technology Co., Ltd.) and North China production base (Hebei Alpha Nuclide Medical Technology Co., Ltd.) were established in 2022 and 2025 in Jiaxing Haiyan and Shijiazhuang Economic Development Zone, respectively. These bases have deployed one 30MeV proton cyclotron and two 30MeV alpha cyclotrons (the only such facilities in China). The East China production base has completed all pre-operational preparations and is set to commence operations by 2026, commercially supplying the alpha radionuclide At-211 and other scarce medical isotopes for research and clinical needs. By 2028, the Alpha Nuclide Group is expected to establish a new landscape driven by multiple domestic and international bases, with coordinated production and full utilization of regional advantages, further strengthening the development of alpha radionuclide pharmaceuticals.

168 Dongping Street Suzhou Industrial Oark Suzhou, Jiangsu, 215123 ChinaAltruist Biologics is a reliable, one-stop CDMO service provider, focusing on the development and commercial manufacturing of antibodies, fusion proteins, ADCs, cell and gene therapies, and other drugs.

Office 908, Platinum Building 233 Taicang Road Huangpu District, Shanghai 200020 ChinaAmiculum is an independent healthcare consulting and communications agency with >300 talented team members in key locations worldwide. For over two decades, we’ve partnered with visionary pharmaceutical companies and external medical experts, building connections across the healthcare community and communicating groundbreaking science. We amplify the scientific advances that transform healthcare. Taking our clients’ science, we create evidence-based narratives that ignite understanding and inspire action across the healthcare community. Because when science speaks clearly, it transforms lives.

01-04/31F King Tower, No.28 Xinjinqiao Road Shanghai, Pudong 201206 ChinaAmino-Chem is a China chemical intermediates manufacturer and supplier.

Shanghai, Shanghai ChinaAmino-Chem is a China chemical intermediates manufacturer and supplier.

818 Xianing Road Shanghai Shi, 201513 ChinaAngel Pharmatech, Ltd. is a R&D based company specializing in providing research chemicals to pharmaceutical companies, universities, biotech companies, healthcare industries, contract research organizations etc. With its own R&D expertise, Angel Pharmatech’s main field covers the development and production of medicinal discovery compounds and pharmaceutical research items. Our mission is to provide high-quality and innovative products to our customers. By offering a broad range of products, custom synthesis and personalized services, we can help scientists speeding up their research in the chemical and pharmaceutical field.

No. 70, Xianing Lane 818, Jinshan Industrial Area, Shanghai, Shanghai, 201516 ChinaAngel Pharmatech, Ltd. is a R&D based company specializing in providing research chemicals to pharmaceutical companies, universities, biotech companies, healthcare industries, contract research organizations etc. With its own R&D expertise, Angel Pharmatech’s main field covers the development and production of medicinal discovery compounds and pharmaceutical research items. Our mission is to provide high-quality and innovative products to our customers. By offering a broad range of products, custom synthesis and personalized services, we can help scientists speeding up their research in the chemical and pharmaceutical field.

Suite 1209-1209, Block B, Zhongshan SOHO Plaza 1065 West Zhongshan Road Changning District, Shanghai, Shanghai, 200051 ChinaAntengene is a leading commercial-stage R&D-driven global biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative first-in-class/best-in-class therapeutics for cancer patients. We are currently seeking global partnerships for our differentiating cancer and autoimmune programs, as well as AnTenGager™, the second-generation T cell platform (2+1 structure with masking technology) we developed. For the AnTenGager™ TCE platform, we are open to partnership opportunities at the program and platform level to develop novel T-cell engagers (TCEs) for autoimmune diseases, etc. For platform collaborations, we welcome partners to bring their own DAA/antibody to integrate into AnTenGager™, or to just nominate targets for us to do (early) development of bi- or trispecific TCE programs. AnTenGager™ TCE platform - “2+1” structure facilitates bivalent binding to the targets, enabling the detection and depletion of cells with low expression of the targets - “Steric hindrance” allows unique TAA-dependent CD3 binding and activation, which mitigates the risk of off-target CRS - Masking is achieved through the low stiffness of the CD3 arm, which is NOT protease-dependent, does NOT rely on the tumor microenvironment (TME) to be effective, and functions effectively in both cancer and non-cancer disease settings - In-house developed proprietary CD3 sequences (diverse affinities) with fast on/fast off kinetics and targeting a unique conformational epitope on CD3 that expressed on T-cells, which mitigates risk of on-target CRS Good PK profile and developability; PCT filed Lead program is ATG-201 (CD19xCD3): specifically designed for autoimmune diseases - Preclinical studies have shown it delivers superior efficacy with a reduced risk of cytokine release syndrome compared to current clinical benchmarks (thanks to the steric hindrance of the CD3 arm in our TCE structure) >> Head-to-head studies against CLN-978 and blinatumomab show that ATG-201 offers comparable or better naïve B cell depletion and reduced cytokine release >> In another in vivo study, a single dose of ATG-201 shows better efficacy compared to CN201 – ATG-201 completely depletes B cells in CD34 humanized mice, with no detectable B cells in blood, bone marrow, or spleen 14 days post-treatment - Good stability at high concentration (125mg/mL) and suitable for potential SC formulation development - NHP pilot tox data expected in Q2 2025; GLP will initiate in Q2 2025; Plan to submit an IND application by Q4 2025 Novel targets for oncology ATG-106 (CDH6 x CD3): ovarian cancer & RCC ATG-110 (LY6G6D x CD3): MSS CRC ATG-107 (FLT3 x CD3): AML ATG-021 (GPRC5D x CD3): MM ATG-102 (LILRB4 x CD3): AML/CMML ATG-112 (ALPPL2 x CD3): Gynecological Tumors & Lung Cancer Undisclosed novel target: HCC

No.A Room 406, Jinhai Road 2588 Shanghai, Pudong District 201209 ChinaApeptide offers advanced building block, peptide synthesis, and custom organic synthesis services.

RM#15 C202.No 300 Chuantu Rd. Shanghai, Pudong 201202 ChinaApichem Chemical Technology offers custom synthesis, contract manufacturing, and process development services.

shangbu Road, Xuhui District ,ShanghaiAPL Instruments offers spectrometer instruments.

Suite 614, Bldg 1, 720 Cailun RoadAQBioPharma offers Heterocycle construction, amination, chiral resolution, halogenation, organic synthesis, and compounds for purchase.

Suite 614, Bldg 1, 720 Cailun Road Zhangjiang Hi-Tech Park, Pudong New Area Shanghai 201203 ChinaAQBioPharma offers Heterocycle construction, amination, chiral resolution, halogenation, organic synthesis, and compounds for purchase.

1st Floor, Building 2, No.1876 Chenqiao Road, Fengxian District, Shanghai, 201400, P.R. China Shanghai, China, Shanghai, 201400 ChinaAsymchem (Stock Code: 002821.SZ / 6821.HK) is a leading global CDMO established in 1995 in North Carolina, U.S., dedicated to delivering integrated, end-to-end solutions across the pharmaceutical value chain. Operating from a global network of R&D and manufacturing facilities in China, the U.S and UK, Asymchem employs more than 9,000 professionals worldwide, with 45% of those dedicated to R&D. Leveraging a robust technical foundation and global infrastructure, Asymchem provides fundamental development and commercial manufacturing services in response to the growing complexity of modern drug development. With decades of innovation and execution, Asymchem has evolved from a small molecule CDMO into a diversified partner supporting a wide range of modalities, including TIDES, biologics, drug products, clinical research, synthetic biology, and technology transfer. Trusted by more than 1,000 clients worldwide, including top 20 pharmaceutical companies and leading biotechs, backed by a proven track record of USFDA and other agency inspections, Asymchem supports over 700 clinical-stage projects and more than 40 commercial production projects for clients around the globe. These projects are underpinned by our strong commitment to cGMP compliance and environmental health and safety (EHS). Asymchem helps accelerate drug development, reduce time to market, and deliver client-centric, cost-effective solutions tailored to the complex challenges of modern pharmaceutical innovation.

Room 206, No. 6, Lane 999, Raike Road, Shanghai Pilot Free Trade Zone, 201208, P.R. China Shanghai, China, Shanghai, 201208 ChinaAsymchem (Stock Code: 002821.SZ / 6821.HK) is a leading global CDMO established in 1995 in North Carolina, U.S., dedicated to delivering integrated, end-to-end solutions across the pharmaceutical value chain. Operating from a global network of R&D and manufacturing facilities in China, the U.S and UK, Asymchem employs more than 9,000 professionals worldwide, with 45% of those dedicated to R&D. Leveraging a robust technical foundation and global infrastructure, Asymchem provides fundamental development and commercial manufacturing services in response to the growing complexity of modern drug development. With decades of innovation and execution, Asymchem has evolved from a small molecule CDMO into a diversified partner supporting a wide range of modalities, including TIDES, biologics, drug products, clinical research, synthetic biology, and technology transfer. Trusted by more than 1,000 clients worldwide, including top 20 pharmaceutical companies and leading biotechs, backed by a proven track record of USFDA and other agency inspections, Asymchem supports over 700 clinical-stage projects and more than 40 commercial production projects for clients around the globe. These projects are underpinned by our strong commitment to cGMP compliance and environmental health and safety (EHS). Asymchem helps accelerate drug development, reduce time to market, and deliver client-centric, cost-effective solutions tailored to the complex challenges of modern pharmaceutical innovation.

Building 8, No. 15, Lane 855, Jinzheng Road, and Building 1, No. 518 Haoye Road, 4th floor, Jinshan Industrial Zone, Shanghai, 201517, P.R. China Shanghai, China, Shanghai, 201517 ChinaAsymchem (Stock Code: 002821.SZ / 6821.HK) is a leading global CDMO established in 1995 in North Carolina, U.S., dedicated to delivering integrated, end-to-end solutions across the pharmaceutical value chain. Operating from a global network of R&D and manufacturing facilities in China, the U.S and UK, Asymchem employs more than 9,000 professionals worldwide, with 45% of those dedicated to R&D. Leveraging a robust technical foundation and global infrastructure, Asymchem provides fundamental development and commercial manufacturing services in response to the growing complexity of modern drug development. With decades of innovation and execution, Asymchem has evolved from a small molecule CDMO into a diversified partner supporting a wide range of modalities, including TIDES, biologics, drug products, clinical research, synthetic biology, and technology transfer. Trusted by more than 1,000 clients worldwide, including top 20 pharmaceutical companies and leading biotechs, backed by a proven track record of USFDA and other agency inspections, Asymchem supports over 700 clinical-stage projects and more than 40 commercial production projects for clients around the globe. These projects are underpinned by our strong commitment to cGMP compliance and environmental health and safety (EHS). Asymchem helps accelerate drug development, reduce time to market, and deliver client-centric, cost-effective solutions tailored to the complex challenges of modern pharmaceutical innovation.

Room 725, No. 88, KeYuan Road Shanghai, 201203 ChinaATDBio founded in 2005 by Prof. Tom Brown, a leading nucleic acid chemist, is now a part of Biotage. We are experts in oligonucleotide synthesis for therapeutic applications: ASOs, siRNA, RNAi, Aptamers, new chemical modalities.

1336 Wuzhong Avenue Suzhou, Jiangsu, 215104 ChinaAtuka provides contract research and consultancy services for the biopharmaceutical industry with world-leading expertise in Parkinson's disease and other neurological conditions. We combine cutting-edge pre-clinical rodent and primate efficacy testing including a comprehensive range of motor and non-motor assays (e.g. cognition and impulse control) with medicinal chemistry services, DMPK and in-vivo imaging in aiding the development of novel therapeutics and diagnostics.

Bdg 2-101, 999 Jiangyue Road Minhang District Shanghai, 201114 ChinaAn Integrated Contract Chemistry Service Organisation Since 2010, Bellen Chemistry has been providing chemistry CRO/CDMO services as an integrated Contract Chemistry Service Organization. With years of accumulated technical advantages and experience in chemical synthesis of small molecule compounds, Bellen has built a one-stop-shop chemistry service platform, supporting big pharmas, biotech innovators and new drug development institutions for their research programs from discovery to commercial stage through comprehensive chemistry solutions. Our R&D, production, sales and operation team are based globally and at present, Bellen has nearly 1,000 employees worldwide, of which our technical team accounts for around 50%. Bellen is committed to continuing investing in innovation and state-of-the-art facilities to enable a one-stop-shop chemistry service platform, adding value to your project from library synthesis to API GMP manufactory. Our Key Services & Capabilities: - Key intermediates & RSMs (non-GMP & GMP) - cGMP APIs - Flow chemistry & Biocatalysis - Process development & optimisation - Process safety assessment - Early phase scale up - Late phase API & intermediates manufacturing - Solid Phase & Recrystallisation platforms (New for 2023) Watch our introductory video here: https://www.youtube.com/watch?v=6EoahD-c6WI

128 Xiangyin Road, 5F Building 12,Yangpu District Shanghai, 200433 ChinaBePharm supplies chemicals, building blocks and pharmaceutical intermediates.

Shanghai, Shanghai, 201203 ChinaBide Pharmatech Ltd. has a research and development center equipped with advanced organic synthesis and analysis of testing equipment and professional chemical storage warehouse. Domestic first-class R & D team has medicinal chemistry industry background and extensive research and development, management experience, the need to constantly update the Product in accordance with the customer. Long-term reserves massive inventory, cash deployment orders directly via Shanghai Pudong warehousing and logistics center logistics center and the United States, providing customers with the most efficient and efficient product purchasing experience.

3rd Floor, Unit 7-2 160 Basheng Road Shanghai, Shanghai , 200213 ChinaAbout Biocast Biocast's vision is to become the standard of 3D disease modeling company, on the pathway leading from disease biology to breakthrough for therapeutics tomorrow. Biocast consists of research team specialized in 3D disease modeling and image-based phenotypic assay. Biocast offers services in drug discovery, complex in vitro models and spatial biology, including: Physiologically accurate and disease-specific in vitro models Phenotypic image-based assay service Validated workflow, robust, reproducible and suitable for automation Downstream single cel analysis at the spatial resolution Integration of phenotypic data, pharmacology and omics data at a large scale

Building #12 Haimen Biotech and Pharmaceutical Park Linjiang New District, Haimen Jiangsu Province, 226100 ChinaBiocytogen provides comprehensive, one-stop solutions for next-generation drug development, supporting the global biomedical community from target identification to IND application. Leveraging proprietary gene-editing technology and the innovative RenMice® platforms, Biocytogen offers fully human antibody discovery, featuring a library of over 400,000 sequences targeting nearly 1,000 antigens for global partnerships. Our technical teams also deliver an extensive portfolio of products and services, including drug-targeted humanized models, comprehensive preclinical pharmacology services, and custom gene-editing solutions. Biocytogen collaborates with all top 10 and 70% of the top 50 pharmaceutical companies, as well as numerous biotech start-ups worldwide, driving innovation in drug discovery and development.

Building 8, 249 Faladi Road China (Shanghai) Pilot Free Trade Zone Pudong District, Shanghai, 201203 ChinaBioDuro, an Advent portfolio company, is a CRDMO with a 30-year proven track record. Headquartered in Irvine, California, BioDuro employs more than 2,000 scientists with deep expertise in small molecules and advanced modalities, including peptides, ADCs, XDCs, and Targeted Protein Degradation (TPD). We serve over 1,500 active customers globally across discovery, development, and manufacturing. We provide fully integrated drug discovery services spanning chemistry, biology, and pharmacokinetics (DMPK), along with comprehensive IND-enabling capabilities, including both drug substance and drug product development. BioDuro’s right-sized organization and flat corporate structure enable rapid decision-making, flexibility, and highly responsive communication. Our scientific teams operate as true extensions of our clients’ organizations, providing high-touch engagement, customized solutions, and proactive problem-solving. This combination of scientific depth, operational agility, and partnership mindset has earned BioDuro long-standing client relationships and industry recognition for delivering results with speed, quality, and trust.

Floor 3, 665 Zhangjiang Road Pilot Free Trade Zone Pudong District, Shanghai, 200131 ChinaBioDuro, an Advent portfolio company, is a CRDMO with a 30-year proven track record. Headquartered in Irvine, California, BioDuro employs more than 2,000 scientists with deep expertise in small molecules and advanced modalities, including peptides, ADCs, XDCs, and Targeted Protein Degradation (TPD). We serve over 1,500 active customers globally across discovery, development, and manufacturing. We provide fully integrated drug discovery services spanning chemistry, biology, and pharmacokinetics (DMPK), along with comprehensive IND-enabling capabilities, including both drug substance and drug product development. BioDuro’s right-sized organization and flat corporate structure enable rapid decision-making, flexibility, and highly responsive communication. Our scientific teams operate as true extensions of our clients’ organizations, providing high-touch engagement, customized solutions, and proactive problem-solving. This combination of scientific depth, operational agility, and partnership mindset has earned BioDuro long-standing client relationships and industry recognition for delivering results with speed, quality, and trust.

Building 1, Lane 917, Halei Road Zhangjiang High Tech Park Pudong District, Shanghai, 201203 ChinaBioDuro, an Advent portfolio company, is a CRDMO with a 30-year proven track record. Headquartered in Irvine, California, BioDuro employs more than 2,000 scientists with deep expertise in small molecules and advanced modalities, including peptides, ADCs, XDCs, and Targeted Protein Degradation (TPD). We serve over 1,500 active customers globally across discovery, development, and manufacturing. We provide fully integrated drug discovery services spanning chemistry, biology, and pharmacokinetics (DMPK), along with comprehensive IND-enabling capabilities, including both drug substance and drug product development. BioDuro’s right-sized organization and flat corporate structure enable rapid decision-making, flexibility, and highly responsive communication. Our scientific teams operate as true extensions of our clients’ organizations, providing high-touch engagement, customized solutions, and proactive problem-solving. This combination of scientific depth, operational agility, and partnership mindset has earned BioDuro long-standing client relationships and industry recognition for delivering results with speed, quality, and trust.

Building 8, 388 Jialilue Road Zhangjiang High Tech Park Pudong District, Shanghai, 201203 ChinaBioDuro, an Advent portfolio company, is a CRDMO with a 30-year proven track record. Headquartered in Irvine, California, BioDuro employs more than 2,000 scientists with deep expertise in small molecules and advanced modalities, including peptides, ADCs, XDCs, and Targeted Protein Degradation (TPD). We serve over 1,500 active customers globally across discovery, development, and manufacturing. We provide fully integrated drug discovery services spanning chemistry, biology, and pharmacokinetics (DMPK), along with comprehensive IND-enabling capabilities, including both drug substance and drug product development. BioDuro’s right-sized organization and flat corporate structure enable rapid decision-making, flexibility, and highly responsive communication. Our scientific teams operate as true extensions of our clients’ organizations, providing high-touch engagement, customized solutions, and proactive problem-solving. This combination of scientific depth, operational agility, and partnership mindset has earned BioDuro long-standing client relationships and industry recognition for delivering results with speed, quality, and trust.

No. 233 North Fu Te Road Waigaoqiao Free Trade Zone Shanghai, Shanghai, 200131 ChinaBioDuro, an Advent portfolio company, is a CRDMO with a 30-year proven track record. Headquartered in Irvine, California, BioDuro employs more than 2,000 scientists with deep expertise in small molecules and advanced modalities, including peptides, ADCs, XDCs, and Targeted Protein Degradation (TPD). We serve over 1,500 active customers globally across discovery, development, and manufacturing. We provide fully integrated drug discovery services spanning chemistry, biology, and pharmacokinetics (DMPK), along with comprehensive IND-enabling capabilities, including both drug substance and drug product development. BioDuro’s right-sized organization and flat corporate structure enable rapid decision-making, flexibility, and highly responsive communication. Our scientific teams operate as true extensions of our clients’ organizations, providing high-touch engagement, customized solutions, and proactive problem-solving. This combination of scientific depth, operational agility, and partnership mindset has earned BioDuro long-standing client relationships and industry recognition for delivering results with speed, quality, and trust.

Building 1 and 2, No. 98 Zhaoxi Road Shaxi Town, Taicang, Jiangsu, China, Jiangsu, 215021 ChinaCDMO for GMP production of antibodies, cell therapies, gene therapies, and cell culture media.

Room 101, 106, 201, 301, 401, Unit 1, No. 1-9 Lane 99, Shenmei Road, Zhoupu Town, Pudong New District, Shanghai, 201318 ChinaBiointron, founded in 2012, is headquartered in Shanghai. We specialize in antibody expression, discovery, and optimization. Our mission is to accelerate the antibody discovery process to provide one-stop antibody discovery services. With fully automated production processes adhering to international standards, we've served 3,000+ pharmaceutical companies across 20 countries. Our expertise includes VHH production, hybridoma sequencing, antibody humanization, affinity maturation, and single B cell screening. Biointron has global commercialization reauthorization for ECACC's CHO-K1 cell line and meets international multicenter requirements, which has also been filed with the U.S. FDA's DMF and several partners’ projects have entered the international multicenter clinical stage. For more information, please visit our official website at www.biointron.com or contact us at info@biointron.com.

Room J5061, floor 1, building 1, 1185 Huyi road Jiading District, Shanghai, 201800 ChinaBiointron, founded in 2012, is headquartered in Shanghai. We specialize in antibody expression, discovery, and optimization. Our mission is to accelerate the antibody discovery process to provide one-stop antibody discovery services. With fully automated production processes adhering to international standards, we've served 3,000+ pharmaceutical companies across 20 countries. Our expertise includes VHH production, hybridoma sequencing, antibody humanization, affinity maturation, and single B cell screening. Biointron has global commercialization reauthorization for ECACC's CHO-K1 cell line and meets international multicenter requirements, which has also been filed with the U.S. FDA's DMF and several partners’ projects have entered the international multicenter clinical stage. For more information, please visit our official website at www.biointron.com or contact us at info@biointron.com.

Building A3, Phase Five, SISPARK No. 328 Xinghu Street, Suzhou Industrial Park Suzhou, Jiangsu Province, 215000 ChinaBioMap is a global pioneer in AI foundation models for life sciences. We are charting the map of life sciences, replacing fragmented, trial-and-error experimentation with systematic, computational, and predictable discovery powered by life science AI foundation models. Our mission is to converge massive biological data with large-scale model technologies, building the essential infrastructure for a new era where discovery is faster, deeper, and far more reliable. As a global pioneer and leader in foundation model-driven R&D, we created BioMap OS—a world-leading life science discovery AI system. Validated across multiple programs with early commercial traction, BioMap OS is powered by xTrimo, our proprietary foundation model family with over 268 billion parameters. xTrimo continuously strengthens BioMap OS in performance, breadth, and applicability, forming its intelligent backbone. Through BioMap OS, we deliver a unified platform that models and predicts complex biological mechanisms, explores uncharted design spaces, boosts discovery efficiency and success rates, and unlocks breakthroughs beyond the reach of traditional methods—systematizing life science innovation at global scale.

Building A3, Phase Five, SISPARK No. 328 Xinghu Street, Suzhou Industrial Park Suzhou Suzhou, Jiangsu Province, 215000 ChinaBioMap is a global pioneer in AI foundation models for life sciences. We are charting the map of life sciences, replacing fragmented, trial-and-error experimentation with systematic, computational, and predictable discovery powered by life science AI foundation models. Our mission is to converge massive biological data with large-scale model technologies, building the essential infrastructure for a new era where discovery is faster, deeper, and far more reliable. As a global pioneer and leader in foundation model-driven R&D, we created BioMap OS—a world-leading life science discovery AI system. Validated across multiple programs with early commercial traction, BioMap OS is powered by xTrimo, our proprietary foundation model family with over 268 billion parameters. xTrimo continuously strengthens BioMap OS in performance, breadth, and applicability, forming its intelligent backbone. Through BioMap OS, we deliver a unified platform that models and predicts complex biological mechanisms, explores uncharted design spaces, boosts discovery efficiency and success rates, and unlocks breakthroughs beyond the reach of traditional methods—systematizing life science innovation at global scale.

1369 Cheng Nan Road Unit #4-3 Jiaxing, Zhejiang, 314001, ChinaBiomatrik offers biodegradable polymers, building blocks, and biotin products and services.

334 Ai Di Sheng Road Shanghai, 201203 ChinaCommitted to building a world leading biology-focused R&D service platform to provide global pharmaceutical companies and biotechs with one-stop R&D solutions, including target validation, molecular biology, protein expression, antibody production, bioanalytics, cell-based assays, in-vitro assays, ADME, in-vivo pharmacology, in-life PK, PCC identification and China/US IND services.

330 Ai Di Sheng Road Floor 2 Shanghai, 201203 ChinaCommitted to building a world leading biology-focused R&D service platform to provide global pharmaceutical companies and biotechs with one-stop R&D solutions, including target validation, molecular biology, protein expression, antibody production, bioanalytics, cell-based assays, in-vitro assays, ADME, in-vivo pharmacology, in-life PK, PCC identification and China/US IND services.

Nantong, Jiangsu ChinaBiomics Biotechnologies offers DNA and RNA synthesis and modification, protein expression and purification, and gene targeting services.

76 Changxing Rd, Economic & Technology Development Area Nantong, 226016 ChinaBiomics Biotechnologies offers DNA and RNA synthesis and modification, protein expression and purification, and gene targeting services.

Room102, 1st. Building No.1199, Landian Road Pudong New District, Shanghai, 201318 ChinaBirdoTech is a state-of-the-art CRO/CDMO. We are committed to providing the highest quality services to drug discovery companies addressing worldwide healthcare needs. The world’s top pharmaceuticals companies and institutes are also our partners. We have been tested to meet time sensitive deadlines supporting critical clinical trials. We leverage our significant scientific foundation to maximize the collaborative value with our partners. With 25,000m2 of R&D laboratory space distributed over 3 sites throughout China, our partners gain the maximum flexibility in leveraging our services in medicinal chemistry SAR development, synthetic route scouting, process optimization, and c-GMP manufacturing to multi-tons scale. Our success comes from our pursuit of ever more stringent scientific demands. Every challenge is an opportunity to show our commitment to our partner's success. BirdoTech’s FTE Solutions - Birdo will deliver the industry's most competitive prices and solution-driven value propositions - Birdo rigorously enforces IP protection for every project, utilizing encrypted data management and a secure depository system - Birdo’s FTE program is highly scalable and can be deployed swiftly. For example, fewer than 30 FTEs can be ready immediately, 30-60 FTEs within 2 weeks, and over 60 FTEs within 4 weeks - Birdo will supply highly qualified chemists and scientists, each with 5 to 10 years of lab experience and holding PhD, MS, or BS degrees, all under the leadership of a seasoned Project Manager with no language barriers. We will provide complete profiles and resumes of the chemists for your review - Leveraging our extensive compound library and expertise in managing over 200,000 building blocks—from structural and fragment-based drug design for various receptor developments—Birdo is dedicated to your success and satisfaction, recognizing that every day matters - Upon request, we will swiftly create a detailed proposal customized to meet your specific business needs

No.1, Middle Wangdong Road, 2nd floor, Building 3, Shanghai, Shanghai, 201601 ChinaBLD Pharm is a globally leading manufacturer and supplier of research chemicals, offering over 1.3 million items in our catalog, with more than 140,000 compounds readily available from stock. Our product portfolio includes: Building Blocks Pharmaceutical Intermediates Inhibitors and Agonists Amino Acids and Peptides XDC Fragments PROTACs Nucleosides & Nucleotides We are ISO-certified and DUNS-registered, and offer a range of value-added services including: Pre-packaged inventories Custom synthesis Scale‑up production

No.1, Middle Wangdong Road, 2nd floor, Building 3, Sijing Town, Songjiang District, Shanghai 201601, shanghai, 201601 ChinaBLD Pharm is a globally leading manufacturer and supplier of research chemicals, offering over 1.3 million items in our catalog, with more than 140,000 compounds readily available from stock. Our product portfolio includes: Building Blocks Pharmaceutical Intermediates Inhibitors and Agonists Amino Acids and Peptides XDC Fragments PROTACs Nucleosides & Nucleotides We are ISO-certified and DUNS-registered, and offer a range of value-added services including: Pre-packaged inventories Custom synthesis Scale‑up production

No.1 Wangdong Middle Road, Songjiang District, Shanghai 201601, China. Shanghai, Shanghai, 201601 ChinaBLD Pharm is a globally leading manufacturer and supplier of research chemicals, offering over 1.3 million items in our catalog, with more than 140,000 compounds readily available from stock. Our product portfolio includes: Building Blocks Pharmaceutical Intermediates Inhibitors and Agonists Amino Acids and Peptides XDC Fragments PROTACs Nucleosides & Nucleotides We are ISO-certified and DUNS-registered, and offer a range of value-added services including: Pre-packaged inventories Custom synthesis Scale‑up production

No.1 Wangdong Middle Road, Building 5, Songjiang District, Shanghai 201601, China. Shanghai, Shanghai, 201601 ChinaBLD Pharm is a globally leading manufacturer and supplier of research chemicals, offering over 1.3 million items in our catalog, with more than 140,000 compounds readily available from stock. Our product portfolio includes: Building Blocks Pharmaceutical Intermediates Inhibitors and Agonists Amino Acids and Peptides XDC Fragments PROTACs Nucleosides & Nucleotides We are ISO-certified and DUNS-registered, and offer a range of value-added services including: Pre-packaged inventories Custom synthesis Scale‑up production

Shanghai, Shanghai ChinaOur mission is to be a trustable partner to our clients by delivering robust bioprocess solutions on time. BIB is dedicated to building up long-term strategic partnerships with the clients. We value the success of our clients as our success, and stand by our clients along with his way to the success. *Strain & Cell Line Development* BIB provides strain and cell line development services with high throughput technologies to support our clients with accurate and high standard of quality. *Microbial Fermentation & Cell Culture Development* Aiming to achieve high cell density, high titer and high product quality, BIB can quickly develop a robust fermentation or cell culture process to support our clients. *Recovery & Purification Development* With broad experience, BIB provides quick primary recovery and purification process development to meet the requirement of our clients. *Analytical Services* Whether you are looking for assay development or assay support for fermentation, cell culture and purification development, you can always count on BIB as your development partner. *Process Characterization* BIB can provide our customer with a deep understanding of the whole bioprocess through PC study to obtain effective and robust process control strategy. *Materials Supply & Technology Support* BIB offers technology solutions and material supplies to support on-time delivery to our client to enhance the living quality of the patients and their families.

Floor 4, No.59 of Lane, 680 Zizhou Road Shanghai, 200333 ChinaBrook Chemical specializes in the sourcing of functional chemicals and various lab instruments from competitive and capable Asian manufacturers, and the business has now also extended to CRO and toll manufacture.

Rm 804, Sino Life Tower,707 Zhangyang road Shanghai, Pudong 200120 ChinaByelen Chemicals is a fine chemicals manufacturer-based company, as well as a custom manufacture-driven company that develops, manufactures and markets a broad range of chemicals to meet customers’ need in the worldwide.

270 Dongan Road, Xuhui District, Shanghai, China Zipcode: 200032The Institutional Tissue Bank (ITB) of Fudan University Shanghai Cancer Center was established in 2006 with the goal of serving as a central repository for human tissue samples for cancer research and possible personalized medicine for the institution. The Institutional Research Board oversees the fulfilling of informed consent of each patient whose samples are collected. The ITB’s collection procedures meet the global quality standards and provide high quality tissue samples. The quality control for morphology, RNA, DNA and protein has been set up to ensure the sample quality. Routine frozen section from tissue aliquot is made for every piece of sample to ensure the component of tumor tissue and the pathological feature is the same as the diagnosed tumor. Agilent 2100 Bioanalyzer was used to provide RNA and DNA quality parameters. The Tissue Bank occupies 500 m2, with sufficient space for sample preparation and storage, data registration, data tracking/access, related equipments and monitor system. Variant samples including blood, tumor tissue, and body fluids are collected and serve as alternative permanent patient tissue records. Annotation of collected samples is captured through linking the medical record and pathological report system to tissue bank software. Frequent tumor types such as lung cancer, breast cancer, gastric cancer, urological tumors, gynecological tumors and esophageal cancers, head & neck cancers, as well as infrequent cancer types such as malignant soft tissue sarcomas, pancreatic cancer, gall bladder cancer, and other rare cancers are all collected and stored. Tumor tissues are stored with matched normal tissues. Serum and plasma are isolated from coagulation plus and coagulation minus blood samples. White blood cells are stored as well. Tissues are stored both in RNALater at -20℃ and -80℃ after snap frozen. Samples have been increased from 4,000 in 2008 to 10,783 in 2009. To the end of September 2010, over 30,000 samples has been processed and stored in our tissue bank. As planned, 50,000 samples will be stored dynamically. Over 50 funded projects have used the samples from our tissue bank. Productive papers have been published in the past years by using the samples. More and more projects will be approved to get research resources from tissue bank in the future. The tissue bank of FUSCC has been designated as the key subject and successful model by Shanghai municipal government.

#166 Meiyue Road, Blk 122, Level 2, Shanghai Pilot Free-Trade Zone Shanghai, Shanghai, 201208 ChinaCarcell is a global biotech company empowering drug delivery through red cell therapeutics and lipid nanoparticles (LNPs). As a fellow biotech company, we understand the intricacies of making and developing a drug. As such, we offer a variety of licensing opportunities, research collaborations and contract services depending on your needs to bring your preclinical pipelines all the way to the finish line. Carcell has a rapidly growing vault of > 1,500 novel and proprietary ionizable lipids. We test the potency and distribution of these lipids in mice and compare them to commercial benchmarks such as ALC-0315, SM-102 and MC3. The top performers are subjected to further scrutiny such as tolerability studies and freedom-to-operate (FTO) analysis. Some of these lipids are available for licensing (with or without co-development). Carcell also has a suite of end-to-end LNP services for your experimental needs. Our LNP services include: 1. Lipid synthesis 2. Lipid screening (pre-curated or customized panels) 3. LNP formulation 4. LNP optimization 5. In vivo testing of LNP 6. Toxicological evaluation of LNP Contact us to find out more!

Building A3, 20 Datong Road, Suzhou New District, Suzhou, China Suzhou, Jiangsu, 215151 ChinaA leading manufacturer of serum-free, chemically defined, and high-performance cell culture media. Our products offer batch-to-batch consistency and GMP-grade quality, supporting both research and large-scale biomanufacturing for antibody drugs, recombinant proteins, virus particles for cell and gene therapies, and vaccines. #CHO, #HEK293, #Sf9, #Vero, #BHK21, # Why Working with CellPlus Bio? - Ultra-High Performance: Empowering customers to increase protein expression titers. - Consistent Quality: Reducing batch-to-batch variability of customer’s products (e.g., recombinant proteins). - Flexible & Customizable Manufacturing: Facilitating the rapid advancement of customer projects: o Adaptable to short-term media demands o Custom formulations to meet specific needs o Flexible packaging options - Expert Technical Support: Responsive and experienced technical assistance whenever you need it. - Cost Efficiency: Competitive pricing through innovations in our internal process optimizations. - Proven Track Records: Since our founding in 2021, CellPlus Bio has gained recognition in the biopharmaceutical and protein services industry, with a proven track record supporting clinical and commercial pipelines for biologics.

3rd Floor, 6th Row, Youyi Shangcheng, Tao Wu Road, Nantong 226006, ChinaChangChem specializes in developing, manufacturing and marketing fine organic compounds and intermediates for the pharmaceutical industry.

Building A2, Lane 2555,Xiupu Road, Pudong New Area, Shanghai, 201315 ChinaChemenu Inc., found in 2011, is a high-end reagent brand of LinkChem. In Chemenu, we're responsible for marketing specialty chemicals of high quality. Our clients include academic, industrial and government research and development laboratories as well as commercial scale businesses in the pharmaceutical and chemical industries. We provide custom synthesis and GMP manufacturing services. As an ISO 9001:2015 certified company, all of our business activities are in strict compliance with the international quality management standard.

Lane 3399, Kangxin Highway,Bldg 5, Shanghai International Medical Zone, Pudong New District, Shanghai, 201321 ChinaChemenu Inc., found in 2011, is a high-end reagent brand of LinkChem. In Chemenu, we're responsible for marketing specialty chemicals of high quality. Our clients include academic, industrial and government research and development laboratories as well as commercial scale businesses in the pharmaceutical and chemical industries. We provide custom synthesis and GMP manufacturing services. As an ISO 9001:2015 certified company, all of our business activities are in strict compliance with the international quality management standard.

Zhangjiang Town No. 3 Building, No. 1999, Zhangheng Road,Pudong New Area, Shanghai, P.R.China. Shanghai, Shanghai, 201210 ChinaFounded in 2006, Shanghai Haoyuan Chemexpress Co., Ltd.（abbreviation：ChemExpress）. ChemExpress focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. Our comprehensive CRO & CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug products. We are a one-stop service platform to support our client’s projects from early drug discovery, process development to commercialization. Over the past 18 years, we have established a state-of-the-art QC/QA system aligning with ICH guidelines for pharmaceutical manufacturing. We provide our clients with high-quality products and CMC services across the entire life-cycle of drug development. Featured ADC services: ChemExpress leads the field for ADC drug development providing one-stop CRO & CDMO services for both small molecule and ADC conjugation. Our facilities include R&D laboratories, kilogram-scale GMP plants and commercial-scale GMP manufacturing plants. This enables us to provide end-to-end project support from discovery to commercialization. We have a substantial inventory of over 80 payloads and 400 linkers, in addition to extensive experience in linker compound synthesis, with over 1000 successful syntheses. This equips us to deliver ADC small molecules in quantities ranging from milligrams to kilograms. To date, we've supported over 800 clients in developing their ADC projects and completed more than 140 ADC projects.

Floor 4 , No.249,Faraday Rd, ZhangjiangHighTech Park, Shanghai, P.R.China,201203 Pudong, shanghai, 201203 ChinaFounded in 2006, Shanghai Haoyuan Chemexpress Co., Ltd.（abbreviation：ChemExpress）. ChemExpress focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. Our comprehensive CRO & CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug products. We are a one-stop service platform to support our client’s projects from early drug discovery, process development to commercialization. Over the past 18 years, we have established a state-of-the-art QC/QA system aligning with ICH guidelines for pharmaceutical manufacturing. We provide our clients with high-quality products and CMC services across the entire life-cycle of drug development. Featured ADC services: ChemExpress leads the field for ADC drug development providing one-stop CRO & CDMO services for both small molecule and ADC conjugation. Our facilities include R&D laboratories, kilogram-scale GMP plants and commercial-scale GMP manufacturing plants. This enables us to provide end-to-end project support from discovery to commercialization. We have a substantial inventory of over 80 payloads and 400 linkers, in addition to extensive experience in linker compound synthesis, with over 1000 successful syntheses. This equips us to deliver ADC small molecules in quantities ranging from milligrams to kilograms. To date, we've supported over 800 clients in developing their ADC projects and completed more than 140 ADC projects.

East Blvd. Zhapu, Economic Development Area, Jiaxing, Zhejiang 314201, ChinaChemPacific provides custom manufacturing, process development, and APIs.

1 East Zhenhai Road Qidong, Jiangsu, 206200 ChinaChemPartner is a global, full-service life science CRO/CDMO with nearly 20 years of biopharmaceutical experience focused on supporting R&D and providing guidance for smaller biotechs and virtual companies. With a team of over 2000 scientists and experienced pharmaceutical executive leadership, ChemPartner is uniquely positioned to not only be a CRO/CDMO, but to be a true pharmaceutical alliance partner. Our integrated CRO services support fee-for-service projects or FTE teams in chemistry, biologics, biology, and DMPK, with many therapeutic sub-specialties (e.g. immunology, oncology, neuroscience, etc). Our CMC teams provide one-stop services for overall process development and IND application support for both small and biologics/large molecule development and manufacturing. ChemPartner serves a diverse global client base and has laboratories, business offices, and representatives in the US, Europe, China, and Japan. ChemPartner is well-positioned to be your partner to support and advance your projects quickly and efficiently with a focus on value and quality.

Block A, 2829 Jinke Road, Zhangjiang Hi-Tech Park, Pudong, Shanghai, 201203 ChinaChemPartner is a global, full-service life science CRO/CDMO with nearly 20 years of biopharmaceutical experience focused on supporting R&D and providing guidance for smaller biotechs and virtual companies. With a team of over 2000 scientists and experienced pharmaceutical executive leadership, ChemPartner is uniquely positioned to not only be a CRO/CDMO, but to be a true pharmaceutical alliance partner. Our integrated CRO services support fee-for-service projects or FTE teams in chemistry, biologics, biology, and DMPK, with many therapeutic sub-specialties (e.g. immunology, oncology, neuroscience, etc). Our CMC teams provide one-stop services for overall process development and IND application support for both small and biologics/large molecule development and manufacturing. ChemPartner serves a diverse global client base and has laboratories, business offices, and representatives in the US, Europe, China, and Japan. ChemPartner is well-positioned to be your partner to support and advance your projects quickly and efficiently with a focus on value and quality.

No.868 Sanlin Road,Room 207 Shanghai, Pudong New Area 201201 ChinaChemsky (Shanghai) International provides API, raw chemicals, intermediates, and fine chemicals.

Silver Centre, 9/F, Unit 902 1388 North Shan Xi Road Shanghai 200060 CHINAChemSun Research provides regulatory strategy, regulatory services, quality assurance, and compliance auditing.

Beijing Representative Office 12F Careri Building, No. 432 West Huai Rd. Shanghai, ChinaChiesi farmaceutici offers drug development, drug discovery, and clinical trials.

Jiaxing, ChinaChimica Laboratories offers custom services and API.

Shanghai, Shanghai ChinaChina Langchem specializes in custom synthesis of organic compounds and supplying of fine chemicals, advanced intermediates, and bulk products.

514 Room,1# Building ,88# Cailun Road, Zhangjiang high tech park Shanghai, 201203 ChinaChina Langchem specializes in custom synthesis of organic compounds and supplying of fine chemicals, advanced intermediates, and bulk products.

Shanghai, Shanghai ChinaChinaPeptides(QYAOBIO) has the capability to synthesize peptides at different purity levels from crude to ≥95%. Various scales from mg to kg to satisfy any aliquoting requirements. In addition, express delivery is available for urgent projects. Higher purity levels require additional production time and cost. We recommend specific purity for different applications. We are able to synthesize peptide of 150 amino acids and above, longer peptides are combined by recombinant peptide technology.

189 Guo Shou Jing Road Zhangjiang High-Tech Park, Pudong Shanghai 201203, ChinaChinese National Center for Drug Screening provides compound screening and natural product services.

Shanghai, Shanghai ChinaChinese National Human Genome Center at Shanghai provides a database for genomic research.

Room 509, Building A1 south, 218 Xinghu Street Suzhou, Jiangsu, 215123 ChinaChiral Quest offers chemistry process development and manufacturing of Intermediates and regulatory starting materials for the biotech and pharma industry. Our capacity starts with low kg quantities and can be scaled-up towards metric ton manufacturing scale. Our expertise is in chiral chemistry via asymmetric hydrogenations, but we can hanlde all kind of chemical reactions; we are able to scale both non-chiral as well as chiral chemistry. We also supply chiral fragments for the genericindustry hence our focus is on cost reduction

268 ChangAn Road Wujiang District Suzhou, Jiangsu, 215200 ChinaChiral Quest offers chemistry process development and manufacturing of Intermediates and regulatory starting materials for the biotech and pharma industry. Our capacity starts with low kg quantities and can be scaled-up towards metric ton manufacturing scale. Our expertise is in chiral chemistry via asymmetric hydrogenations, but we can hanlde all kind of chemical reactions; we are able to scale both non-chiral as well as chiral chemistry. We also supply chiral fragments for the genericindustry hence our focus is on cost reduction

West Tower No. 701, Shangke Road No.88 Shanghai, Shanghai, 201210 ChinaFounded in 2021, Cholesgen (Shanghai) Co. Ltd. is a biopharmaceutical company dedicated to the development of innovative drugs. Focusing on novel disease targets, Cholesgen conducts innovative drug discovery and development for metabolic diseases (hyperlipidemia, obesity, diabetes, atherosclerosis, NASH, etc.) and oncology based on the principles of biochemistry, disease biology, medicinal chemistry and translational medicine.

Shanghai, ChinaCinpathogen provides hematology, clinical chemistry, serology, flow cytometry, histopathology, and genetics.

1223 Lujiazui Ring Road Pudong New District Room 3002-3003, Azia Center Shanghai, Shanghai, 200120 ChinaClarivate is a leading global provider of transformative intelligence, including Cortellis and Decision Resources Group ("DRG"). We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit clarivate.com

Shanghai, ChinaCole-Parmer offers laboratory and industrial fluid handling products, instrumentation, equipment, and supplies.

WeWork Room 201, Block B 135 Yanping Road Shanghai, Jing'an District ChinaCostello Medical is an award winning, independent, global healthcare agency specialising in medical communications, market access and HEOR. Since our founding in 2008, we have grown organically to a team of more than 500 colleagues, supporting over 300 different client organisations globally, from our offices based in the UK, US, Canada, Singapore and China. As an independent agency we are not beholden to external shareholders, allowing us to remain fully client-focused, flexible in how we work, and uncompromising on scientific quality. Together, our global presence, diverse scientific expertise, values driven culture and award winning performance position Costello Medical as a trusted, long term partner for organisations seeking strategic insights coupled with excellent scientific support across the healthcare sector. Our core service offerings are as follows: Medical Communications Our Medical Communications services cover publications, medical affairs, and creative support. We provide publications development, planning and consultancy, enhanced content such as infographics, videos and podcasts, and policy reports. Medical affairs work includes strategy development, omnichannel delivery, scientific exchange, insight gathering through advisory boards, surveys and Delphi panels, and congress engagement such as symposia and scientific coverage. Creative services span graphic, digital and motion design, branding, web and app development, and interactive experiences. We also deliver commercial and marketing support including brand positioning, launch communications, promotional materials, congress resources and disease awareness campaigns. Evidence Development Our Evidence Development services cover literature reviews, statistics and real-world evidence. Literature review expertise includes systematic, pragmatic, rapid and scoping reviews, as well as strategic evidence reviews, competitor intelligence and gap analyses. Statistics support spans analysis plan development, meta-analyses, indirect treatment comparisons, trial and utility analyses, survival modelling and epidemiology, with training and publications support also provided. Real-world evidence services include study design and analysis across databases, registries, electronic health records, observational studies, surveys, qualitative research and expert elicitation, alongside strategic evidence generation planning, data source mapping and dissemination through publications. Value and Access Our Value and Access services cover health economics, health technology assessment and market access. Our health economics services include cost-effectiveness and budget impact models, feasibility assessments, early modelling, technical validation, customer-facing interactive tools, advisory boards and training. HTA support includes strategy development, multi-country HTA submissions, JCA activities, early Scientific Advice, mock stakeholder meetings, payer and clinician advisory boards, training and HEOR publications. We also provide market access strategy and planning, the development of global, regional and local value dossiers, value propositions and messaging, roll-out workshops and objection handlers, as well as local country-specific resources such as AMCP dossiers, interactive tools, brochures, ABN materials and formulary packs. Health Policy & Public Affairs Our Health Policy and Public Affairs services cover the preparation of white papers, position papers, policy briefs, roundtable reports and policy research reports. We also produce best practice, consensus and recommendation articles, expert opinion papers and options appraisals. In addition, we can support multi-stakeholder engagement through Delphi panels, surveys, focus groups, interviews, policy landscape mapping, stakeholder mapping, roundtables and steering committees. Our services also include the creation of advocacy toolkits and policy campaign materials. We also have a dedicated Patient Engagement team who deliver patient engagement activities such as landscape assessments, strategic recommendations, surveys, advisory boards and workshops, as well as the development of patient information, education and support resources and communication of patient commitments. In addition, we collaborate with government bodies and public institutions to deliver policy research, healthcare evaluation projects and strategic initiatives. MedTech and Rare Diseases Expertise In addition to our experience in all major therapeutic areas, we have dedicated MedTech and Rare Diseases teams who work seamlessly across all of our teams with specialist knowledge of the challenges and nuances inherent to MedTech products and rare and ultra-rare diseases.

Shanghai, ChinaCrimson Pharma offers drug formulation, scale up, clinical study management, and regulatory services.

Room 303, Building A6 No. 218 Xinghu Street, Industrial Park Suzhou City, Jiangsu Province, 215000 ChinaCrown Bioscience, a JSR Life Sciences company, is a global contract research organization (CRO) dedicated to accelerating drug discovery and development in oncology and immuno-oncology. We partner with biotech and pharmaceutical companies to provide innovative, tailored solutions spanning preclinical research, translational platforms, and clinical trial support. With the world’s largest commercially available patient-derived xenograft (PDX) collection and approximately 1,000 tumor organoid models powered by Hubrecht Organoid Technology, we offer unparalleled insights across 35 cancer indications. Our expertise spans in vivo, in vitro, ex vivo, and in silico methods, complemented by advanced laboratory services that span the entire drug development continuum. Additionally, our extensive biobank of liquid and human biospecimens, complete with clinical histories, enhances oncology research capabilities. Operating from 11 state-of-the-art facilities across the US, Europe, and APAC, our laboratories meet the highest industry standards, including accreditation by the College of American Pathologists (CAP) and the International Organization for Standardization (ISO). To learn more, visit www.crownbio.com.

3rd Floor, Building 10, Changtai Square Zhangjiang Hi-Tech Park, Pudong New Area Shanghai, 201203 ChinaCrown Bioscience, a JSR Life Sciences company, is a global contract research organization (CRO) dedicated to accelerating drug discovery and development in oncology and immuno-oncology. We partner with biotech and pharmaceutical companies to provide innovative, tailored solutions spanning preclinical research, translational platforms, and clinical trial support. With the world’s largest commercially available patient-derived xenograft (PDX) collection and approximately 1,000 tumor organoid models powered by Hubrecht Organoid Technology, we offer unparalleled insights across 35 cancer indications. Our expertise spans in vivo, in vitro, ex vivo, and in silico methods, complemented by advanced laboratory services that span the entire drug development continuum. Additionally, our extensive biobank of liquid and human biospecimens, complete with clinical histories, enhances oncology research capabilities. Operating from 11 state-of-the-art facilities across the US, Europe, and APAC, our laboratories meet the highest industry standards, including accreditation by the College of American Pathologists (CAP) and the International Organization for Standardization (ISO). To learn more, visit www.crownbio.com.

Science & Technology Innovation Park No.6 Beijing West Road Taicang, Jiangsu Province, 215400 ChinaCrown Bioscience, a JSR Life Sciences company, is a global contract research organization (CRO) dedicated to accelerating drug discovery and development in oncology and immuno-oncology. We partner with biotech and pharmaceutical companies to provide innovative, tailored solutions spanning preclinical research, translational platforms, and clinical trial support. With the world’s largest commercially available patient-derived xenograft (PDX) collection and approximately 1,000 tumor organoid models powered by Hubrecht Organoid Technology, we offer unparalleled insights across 35 cancer indications. Our expertise spans in vivo, in vitro, ex vivo, and in silico methods, complemented by advanced laboratory services that span the entire drug development continuum. Additionally, our extensive biobank of liquid and human biospecimens, complete with clinical histories, enhances oncology research capabilities. Operating from 11 state-of-the-art facilities across the US, Europe, and APAC, our laboratories meet the highest industry standards, including accreditation by the College of American Pathologists (CAP) and the International Organization for Standardization (ISO). To learn more, visit www.crownbio.com.

Science & Technology Innovation Park No.6 Beijing West Road Taicang City, Jiangsu Province, 215400 ChinaCrown Bioscience, a JSR Life Sciences company, is a global contract research organization (CRO) dedicated to accelerating drug discovery and development in oncology and immuno-oncology. We partner with biotech and pharmaceutical companies to provide innovative, tailored solutions spanning preclinical research, translational platforms, and clinical trial support. With the world’s largest commercially available patient-derived xenograft (PDX) collection and approximately 1,000 tumor organoid models powered by Hubrecht Organoid Technology, we offer unparalleled insights across 35 cancer indications. Our expertise spans in vivo, in vitro, ex vivo, and in silico methods, complemented by advanced laboratory services that span the entire drug development continuum. Additionally, our extensive biobank of liquid and human biospecimens, complete with clinical histories, enhances oncology research capabilities. Operating from 11 state-of-the-art facilities across the US, Europe, and APAC, our laboratories meet the highest industry standards, including accreditation by the College of American Pathologists (CAP) and the International Organization for Standardization (ISO). To learn more, visit www.crownbio.com.

255 Jiangyun Road, SIP Floor 4 Suzhou, Jiangsu, 215123 ChinaCrystal NAX (Crystal Nucleic Acid Excellence) is a wholly owned business entity of Crystal Pharmatech. We specialize in providing end-to-end solutions for RNA therapeutics and non-viral delivery. We integrate RNA and DNA synthesis and production, Lipid Nanoaprticles (LNPs) formulation, and comprehensive analytical characterization to deliver the best quality products and services. Core capabilities : - RNA Design & Production: mRNA, saRNA, circRNA, sgRNA and other therapeutic RNA modalities. - LNP Formulation & Delivery Development: Custom xLNP and tLNP formulation, high throughput formulation screening and optimization. - Analytical Characterization: Routine tests and extended characterization of RNA and LNPs. - CMC for IND/IIT packages: Customized process and analytical development package to ensure smooth IND/IIT enabling production and good quality control for various modalities. . - Catalog Products & Reagents: Top quality off-the-shelf catalog products and reagents ready for R&D use. At Crystal NAX, we partner with academic researchers, biotech innovators and global pharmaceutical leaders to transform nucleic acid science into therapies that shape the future of medicine.

68 Chunpu Road, Bldg.3, 1st Floor, Industrial Park, Suzhou, China China/Jiangsu Province/Suzhou City, 215123 ChinaFrom Molecule to Medicine—Your Partner in Small Molecules, Biologics, and Nucleic Acids Crystal Pharmatech, founded in 2010, is a global contract research organization with over 300 employees and four R&D centers in New Jersey (USA), San Francisco (USA), Toronto (Canada), and Suzhou (China). Collectively, these sites provide integrated support for pharmaceutical and biotechnology companies worldwide. Our capabilities span three specialized platforms: in small molecules, we offer API solid-state research and crystallization, preformulation, formulation development, and GMP manufacturing and supply; through Crystal Bio Solutions, we deliver bioanalytical and biomarker testing, biologics CMC analytics, and quantitative clinical pharmacology; and through Crystal NAX, we provide end-to-end solutions for nucleic acid therapeutics. With an average of 20 years of experience, our scientific leadership team has successfully delivered over 100 NCEs and 15 drug products for global pharmaceutical companies. We have served more than 1,000 clients, supporting over 2,000 new chemical entities. Crystal Pharmatech (In Small Molecules) — Global Leader in Solid-State Research, Preformulation & Formulation We offer solid-state research, preformulation, and formulation of small-molecule drugs. We have supported 1,000+ clients and worked on more than 2,000 compounds across developability assessment, solid-form screening, preformulation, formulation development, and clinical trial materials (CTM) through to commercial manufacturing. With four R&D centers in New Jersey, California, Toronto, and Suzhou, and a team of approximately 300 professionals, we combine deep crystal-form expertise with both conventional and enabling technologies—such as amorphous solid dispersion—to unlock bioavailability and manufacturability. Our cGMP facilities operate to FDA, EMA, and NMPA standards, ensuring phase-appropriate quality from early studies through scale-up. Leveraging our unique expertise, we partner with you to design and develop the most suitable crystal form and formulation for downstream development. Our guiding principle—“get the crystal form and formulation right the first time for Phase I”—accelerates IND filing and Phase I entry while minimizing the need for human pharmacokinetic (PK) bridging studies, saving time and reducing costs as programs advance to Phase II and beyond. Crystal Bio Solutions — Your Trusted Partner for Biologics CMC Analytical, Bioanalysis & QCP Crystal Bio Solutions (wholly owned) delivers Quantitative Clinical Pharmacology (QCP), Bioanalytical & Biomarker, and Biologics CMC Analytical services. Modalities include antibodies, bispecifics and multispecifics, proteins, ADCs, cell and gene therapies (CGT), mRNA, LNPs, nucleotides, vaccines, and viruses—providing decision-ready data through sound science and operational excellence. Crystal NAX — Unlocking the Potential of Nucleic Acid Therapeutics Crystal NAX (wholly owned) provides end-to-end support for nucleic acid therapeutics—from early R&D to clinical development—covering xRNA, siRNA, and other oligonucleotides; LNP delivery and formulation; and advanced analytics. Its mission is to accelerate innovation in nucleic acid therapies and help deliver medicines to patients faster. Together, Crystal Pharmatech offers a seamless path from discovery to clinic for small molecules, biologics, and nucleic acids—your partner of choice from molecule to medicine.

B4-101, Biobay, 218 Xinghu Street, Suzhou Industrial Park, Suzhou, 215123 China SuZhou, 215123 ChinaFrom Molecule to Medicine—Your Partner in Small Molecules, Biologics, and Nucleic Acids Crystal Pharmatech, founded in 2010, is a global contract research organization with over 300 employees and four R&D centers in New Jersey (USA), San Francisco (USA), Toronto (Canada), and Suzhou (China). Collectively, these sites provide integrated support for pharmaceutical and biotechnology companies worldwide. Our capabilities span three specialized platforms: in small molecules, we offer API solid-state research and crystallization, preformulation, formulation development, and GMP manufacturing and supply; through Crystal Bio Solutions, we deliver bioanalytical and biomarker testing, biologics CMC analytics, and quantitative clinical pharmacology; and through Crystal NAX, we provide end-to-end solutions for nucleic acid therapeutics. With an average of 20 years of experience, our scientific leadership team has successfully delivered over 100 NCEs and 15 drug products for global pharmaceutical companies. We have served more than 1,000 clients, supporting over 2,000 new chemical entities. Crystal Pharmatech (In Small Molecules) — Global Leader in Solid-State Research, Preformulation & Formulation We offer solid-state research, preformulation, and formulation of small-molecule drugs. We have supported 1,000+ clients and worked on more than 2,000 compounds across developability assessment, solid-form screening, preformulation, formulation development, and clinical trial materials (CTM) through to commercial manufacturing. With four R&D centers in New Jersey, California, Toronto, and Suzhou, and a team of approximately 300 professionals, we combine deep crystal-form expertise with both conventional and enabling technologies—such as amorphous solid dispersion—to unlock bioavailability and manufacturability. Our cGMP facilities operate to FDA, EMA, and NMPA standards, ensuring phase-appropriate quality from early studies through scale-up. Leveraging our unique expertise, we partner with you to design and develop the most suitable crystal form and formulation for downstream development. Our guiding principle—“get the crystal form and formulation right the first time for Phase I”—accelerates IND filing and Phase I entry while minimizing the need for human pharmacokinetic (PK) bridging studies, saving time and reducing costs as programs advance to Phase II and beyond. Crystal Bio Solutions — Your Trusted Partner for Biologics CMC Analytical, Bioanalysis & QCP Crystal Bio Solutions (wholly owned) delivers Quantitative Clinical Pharmacology (QCP), Bioanalytical & Biomarker, and Biologics CMC Analytical services. Modalities include antibodies, bispecifics and multispecifics, proteins, ADCs, cell and gene therapies (CGT), mRNA, LNPs, nucleotides, vaccines, and viruses—providing decision-ready data through sound science and operational excellence. Crystal NAX — Unlocking the Potential of Nucleic Acid Therapeutics Crystal NAX (wholly owned) provides end-to-end support for nucleic acid therapeutics—from early R&D to clinical development—covering xRNA, siRNA, and other oligonucleotides; LNP delivery and formulation; and advanced analytics. Its mission is to accelerate innovation in nucleic acid therapies and help deliver medicines to patients faster. Together, Crystal Pharmatech offers a seamless path from discovery to clinic for small molecules, biologics, and nucleic acids—your partner of choice from molecule to medicine.

8/9F, 288 Jiangyun Road, Suzhou Industrial Park Suzhou, Jiangsu, 215123 ChinaFrom Molecule to Medicine—Your Partner in Small Molecules, Biologics, and Nucleic Acids Crystal Pharmatech, founded in 2010, is a global contract research organization with over 300 employees and four R&D centers in New Jersey (USA), San Francisco (USA), Toronto (Canada), and Suzhou (China). Collectively, these sites provide integrated support for pharmaceutical and biotechnology companies worldwide. Our capabilities span three specialized platforms: in small molecules, we offer API solid-state research and crystallization, preformulation, formulation development, and GMP manufacturing and supply; through Crystal Bio Solutions, we deliver bioanalytical and biomarker testing, biologics CMC analytics, and quantitative clinical pharmacology; and through Crystal NAX, we provide end-to-end solutions for nucleic acid therapeutics. With an average of 20 years of experience, our scientific leadership team has successfully delivered over 100 NCEs and 15 drug products for global pharmaceutical companies. We have served more than 1,000 clients, supporting over 2,000 new chemical entities. Crystal Pharmatech (In Small Molecules) — Global Leader in Solid-State Research, Preformulation & Formulation We offer solid-state research, preformulation, and formulation of small-molecule drugs. We have supported 1,000+ clients and worked on more than 2,000 compounds across developability assessment, solid-form screening, preformulation, formulation development, and clinical trial materials (CTM) through to commercial manufacturing. With four R&D centers in New Jersey, California, Toronto, and Suzhou, and a team of approximately 300 professionals, we combine deep crystal-form expertise with both conventional and enabling technologies—such as amorphous solid dispersion—to unlock bioavailability and manufacturability. Our cGMP facilities operate to FDA, EMA, and NMPA standards, ensuring phase-appropriate quality from early studies through scale-up. Leveraging our unique expertise, we partner with you to design and develop the most suitable crystal form and formulation for downstream development. Our guiding principle—“get the crystal form and formulation right the first time for Phase I”—accelerates IND filing and Phase I entry while minimizing the need for human pharmacokinetic (PK) bridging studies, saving time and reducing costs as programs advance to Phase II and beyond. Crystal Bio Solutions — Your Trusted Partner for Biologics CMC Analytical, Bioanalysis & QCP Crystal Bio Solutions (wholly owned) delivers Quantitative Clinical Pharmacology (QCP), Bioanalytical & Biomarker, and Biologics CMC Analytical services. Modalities include antibodies, bispecifics and multispecifics, proteins, ADCs, cell and gene therapies (CGT), mRNA, LNPs, nucleotides, vaccines, and viruses—providing decision-ready data through sound science and operational excellence. Crystal NAX — Unlocking the Potential of Nucleic Acid Therapeutics Crystal NAX (wholly owned) provides end-to-end support for nucleic acid therapeutics—from early R&D to clinical development—covering xRNA, siRNA, and other oligonucleotides; LNP delivery and formulation; and advanced analytics. Its mission is to accelerate innovation in nucleic acid therapies and help deliver medicines to patients faster. Together, Crystal Pharmatech offers a seamless path from discovery to clinic for small molecules, biologics, and nucleic acids—your partner of choice from molecule to medicine.

1 Building, Lane 1343, Tongpu Rd., Putuo District,Shanghai, ChinaCVC provides pharmaceutical machinery for counting, labeling, packaging and manufacturing.

R301 2A No.699 ChuanHong Rd Shanghai, 201200 ChinaDato Chemicals supplies fine chemicals, API, and other chemicals in addition to offering custom synthesis and manufacturing services.

Shanghai, Shanghai ChinaDato Chemicals supplies fine chemicals, API, and other chemicals in addition to offering custom synthesis and manufacturing services.

100 Jin Yu Lu Building 3,Jinyu Rd 100 Shanghai Shi, 201206 ChinaDC Chemicals is committed to providing global drug research and development as well as medical research clients with a wide range of innovative and comprehensive high-quality small molecule active compounds. We offer over 10,000 specific inhibitors, agonists, and cationic liposomes that act on gene delivery, gene editing, RNA vaccines, epigenetics, PI3K/Akt/mTOR, apoptosis, MAPK, Wnt, and other 20 signaling pathways with more than 1,000 target proteins, covering popular disease research areas such as cancer, neuroscience, and immunology. DC Chemicals has many globally exclusive compounds and a professional team tracking new pharmaceutical and life science research progress, which can provide you with the latest research small molecule compounds to meet your research needs.

Jinxiang Rd 201, Room 610,Building 15 Shanghai , 20015 ChinaDC Chemicals is committed to providing global drug research and development as well as medical research clients with a wide range of innovative and comprehensive high-quality small molecule active compounds. We offer over 10,000 specific inhibitors, agonists, and cationic liposomes that act on gene delivery, gene editing, RNA vaccines, epigenetics, PI3K/Akt/mTOR, apoptosis, MAPK, Wnt, and other 20 signaling pathways with more than 1,000 target proteins, covering popular disease research areas such as cancer, neuroscience, and immunology. DC Chemicals has many globally exclusive compounds and a professional team tracking new pharmaceutical and life science research progress, which can provide you with the latest research small molecule compounds to meet your research needs.

A9 International Innovation Port, No.18 Jinxing Road, Huaqiao Economic Development Zone,Kunshan Suzhou, JIANGSU, 215300 ChinaDeepKinase pioneers in proteomics for drug discovery and development, with two leading products, DoTD and DoTK. DoTD provides mass spectrometry based quantitative proteomics to assist TPD therapeutics; results are featured in numerous IND filings. DoTK offers patented tyrosine phosphoproteomics technology, vital to understand kinase activities and signaling in cancer and immune diseases. DeepKinase is a global front-runner in proteomics analysis, driving novel research, biomarker discovery, and personalized medicine in pharmaceutical industry.

298 Xiangke Road, 3/F Zhangjiang Hi-Tech Park, Pudong Shanghai, Shanghai, 201210 ChinaA next-generation China-based clinical CRO with more than 350 staff who deliver to global quality standards. Led by a select team chosen from leading multinational biopharma firms, we are committed to helping companies leverage the clinical development and regulatory opportunities created by China's radical regulatory liberalization and full ICH membership. We serve leading Western multinationals, innovative Chinese market leaders as well as emerging biotechs from both China and the West. Our serves can be delivered a project basis or as an end-to-end outsourcing partner for all clinical and regulatory needs.

Unit 27J, Cross Region Plaza No. 899 LingLing Rd Shanghai 200030, CHINADojindo Molecular Technologies offers assay kits and reagents for cell analysis, Mitochondrial research, Autophagy, protein analysis, oxidative stress detection, and surface modification studies.

Shanghai, ChinaDragonfly Sciences focuses on the development of biosimilar molecules for monoclonal antibody and soluble receptor drugs.

1299 Ziyue Road Zizhu Science Park Shanghai 200241 ChinaEastbound Pharma provides process development, chemistry, contract manufacturing, and quality systems.

Shanghai, ChinaEnnova MedChem provides custom chemical synthesis and medicinal chemistry R&D.

Shanghai, ChinaEterpharm is a Shanghai based Research company with core capabilites in Chiral Separation and Preparation, Process R&D and Custom Synthesis of APIs & intermediates.

1F, Building 4, No.1151 Lianxi Road Pudong Area, Shanghai, China 201204Eurofins EAG Materials Science, LLC has a long history, dating back to the birth of the company in 1978 in California, as Charles Evans & Associates. Over the years we have expanded from a single location offering SIMS only to having over 200 employees offering over 30 different services via 14 locations in 8 different countries. The original focus of the company was supporting semiconductor manufacturing but now we also work with multiple further industries beyond semiconductors, including: solar/PV, lighting, photonics, energy storage, aerospace & defense, medical devices, raw materials, glass, polymers and plastics and consumer products. EAG's analytical expertise is what enables us to help our clients to meet their goals. Our on-demand analytical testing services can help streamline R&D, solve urgent problems during manufacturing and help resolve materials related issues in the global supply chain, both within and between organizations.

191 Jinyang Road Kunshan, Jiangsu 215331 ChinaFarmtec Research offers custom synthesis, library synthesis, and formulation development services.

Shanghai, Shanghai ChinaFDC Labs offers custom synthesis of novel or known organic compounds, including special chemicals, fine chemicals and building blocks.

Room 111, Building 54-Yi, Handan Road 100 Shanghai 200437 ChinaFDC Labs offers custom synthesis of novel or known organic compounds, including special chemicals, fine chemicals and building blocks.

Room 2401, Sino Life Tower No.707 Zhangyang Rd., Pudong Shanghai 200120, ChinaFlavine specializes in sourcing of Active Pharmaceutical Ingredients and Pharmaceutical Intermediates within human and animal health.

Shanghai, Shanghai, 201203 ChinaFoodchem International Corporation is a worldwide supplier of high quality food additives, feed additives and other ingredients, serving a great variety of customers from over 80 countries.

Luwan, Shanghai, ChinaFountainbridge offers custom synthesis services for pharmaceutical intermediates, labelled compounds, and R&D chemicals

Lane 67 Libing Road Building 13 Shanghai, Shanghai, 201203 ChinaAt Frontage, our business is built on collaboration with a broad spectrum of clients across the pharmaceutical and biopharmaceutical industry—from top global pharma companies to emerging start-ups. We support innovator, generic, and consumer health organizations with IND, NDA, ANDA, and 505(b)(2) submissions, delivering flexible, customized solutions to meet each client’s unique needs. • Laboratory Services: DMPK and CMC services delivered by more than 400 scientists across three facilities in the US and China. Our senior scientists average 10–15 years of experience in complex drug development, many with backgrounds in leading pharmaceutical companies. • Global Bioanalysis and Central Laboratories: A rapidly expanding platform with operations in the US, China, and Europe (Milan), supporting Phase I–IV clinical trials. Services include large molecule bioanalysis (PK/ADA/NAb), safety and specialty testing, advanced biomarker solutions (soluble, tissue, flow cytometry), and genomics, all under a harmonized quality system (CLIA, CAP, ISO, ICH GCP). With a focus on protocol agility, risk-based compliance, and global logistics, Frontage offers both scientific expertise and operational flexibility, enabling sponsors to accelerate development while ensuring data quality and regulatory confidence. • Clinical Services: Phase I–IIa and biometrics capabilities, including a 160-bed clinical unit in Secaucus, NJ, and 18 clinical sites with over 300 beds in China. Our biometrics services support programs from early to late stage. Our commitment to scientific rigor and regulatory compliance ensures the highest quality outcomes. Over the years, we have successfully advanced hundreds of molecules from early development through commercial launch in global markets. With an integrated portfolio of laboratory and clinical services, Frontage provides comprehensive support across the entire product development pipeline.

Huanghai Road, Yangkou Chemical Industry Zone, Rudong City Jiangsu Province Nantong, Jiangsu, 226407 ChinaOne-stop CDMO company certificated by ISO9001：We focus on process development and have ability to do process development from milligram to metric ton scale under ISO and cGMP system. Main products cover pharmaceutical, OLED, Specialty chemicals, Agrochemical and ADC. CAS 796073-69-3; CAS 97739-46-3; CAS 22128-62-7; CAS 123-12-6; CAS 98835-90-6; CAS 28079-04-1; CAS 1000053-23-5; CAS 100129-35-9; CAS 100-15-2; CAS 100327-50-2; CAS 1003-32-3; CAS 100405-37-6; CAS 1004618-85-2; CAS 1005187-65-4; CAS 1006334-34-4; CAS 1008774-87-5; CAS 1008-91-9; CAS 100927-10-4; CAS 100959-19-1; CAS 1010798-64-7; CAS 101093-56-5; CAS 10128-91-3; CAS 10137-67-4; CAS 1013915-06-4; CAS 101410-18-8; CAS 1016258-66-4; CAS 1016258-69-7; CAS 1016769-81-5; CAS 1017356-25-0; CAS 1018332-24-5; CAS 1018446-95-1; CAS 101861-63-6; CAS 1019351-46-2; CAS 10199-61-8; CAS 10201-71-5; CAS 102029-76-5; CAS 102113-98-4; CAS 1022091-49-1; "Since 2009, Fuxin Pharma has grown from a business development startup into a comprehensive CDMO partner. With 2,000+ square meters R&D and 62,000+ square meters manufacturing facilities across multiple locations, we serve the global pharmaceutical, specialty material, and semiconductor industries, etc." 1. Since 2009, Fuxin Pharma has grown from a business development startup 2. into a comprehensive CDMO partner. 3. With 2,000+ square meters R&D and 62,000+ square meters manufacturing facilities 4. across multiple locations, 5. we serve the global pharmaceutical, specialty material, and semiconductor industries for chemical manufacturing and outsourcing.. With different size of multipurpose batch reactors from 100 liters up to 5,000 liters, purification systems, and comprehensive downstream equipment, we bridge the critical transition from the stage from R&D to commercialization. Our ISO and cGMP systems ensure the consistent production and homogeneous quality at every scale." 1. With different size of multipurpose batch reactors from 100 liters up to 5,000 liters, 2. purification systems, and comprehensive downstream equipment, 3. we bridge the critical transition from the stage from R&D to commercialization. 4. Our ISO and cGMP systems ensure the consistent production and homogeneous quality at every scale. Quality is not inspected in, but the result of design, execution, and systems working together. Led by quality professionals with decades cGMP management experience at leading pharmaceutical companies, our QMS ensures every batch meets the highest standards."

Room 330, 3/F, Building 11, No. 68 Huatuo Road, Pudong New District, Shanghai, Shanghai, 201203 ChinaOne-stop CDMO company certificated by ISO9001：We focus on process development and have ability to do process development from milligram to metric ton scale under ISO and cGMP system. Main products cover pharmaceutical, OLED, Specialty chemicals, Agrochemical and ADC. CAS 796073-69-3; CAS 97739-46-3; CAS 22128-62-7; CAS 123-12-6; CAS 98835-90-6; CAS 28079-04-1; CAS 1000053-23-5; CAS 100129-35-9; CAS 100-15-2; CAS 100327-50-2; CAS 1003-32-3; CAS 100405-37-6; CAS 1004618-85-2; CAS 1005187-65-4; CAS 1006334-34-4; CAS 1008774-87-5; CAS 1008-91-9; CAS 100927-10-4; CAS 100959-19-1; CAS 1010798-64-7; CAS 101093-56-5; CAS 10128-91-3; CAS 10137-67-4; CAS 1013915-06-4; CAS 101410-18-8; CAS 1016258-66-4; CAS 1016258-69-7; CAS 1016769-81-5; CAS 1017356-25-0; CAS 1018332-24-5; CAS 1018446-95-1; CAS 101861-63-6; CAS 1019351-46-2; CAS 10199-61-8; CAS 10201-71-5; CAS 102029-76-5; CAS 102113-98-4; CAS 1022091-49-1; "Since 2009, Fuxin Pharma has grown from a business development startup into a comprehensive CDMO partner. With 2,000+ square meters R&D and 62,000+ square meters manufacturing facilities across multiple locations, we serve the global pharmaceutical, specialty material, and semiconductor industries, etc." 1. Since 2009, Fuxin Pharma has grown from a business development startup 2. into a comprehensive CDMO partner. 3. With 2,000+ square meters R&D and 62,000+ square meters manufacturing facilities 4. across multiple locations, 5. we serve the global pharmaceutical, specialty material, and semiconductor industries for chemical manufacturing and outsourcing.. With different size of multipurpose batch reactors from 100 liters up to 5,000 liters, purification systems, and comprehensive downstream equipment, we bridge the critical transition from the stage from R&D to commercialization. Our ISO and cGMP systems ensure the consistent production and homogeneous quality at every scale." 1. With different size of multipurpose batch reactors from 100 liters up to 5,000 liters, 2. purification systems, and comprehensive downstream equipment, 3. we bridge the critical transition from the stage from R&D to commercialization. 4. Our ISO and cGMP systems ensure the consistent production and homogeneous quality at every scale. Quality is not inspected in, but the result of design, execution, and systems working together. Led by quality professionals with decades cGMP management experience at leading pharmaceutical companies, our QMS ensures every batch meets the highest standards."

3rd Floor, No. 39, Xumiao Road, Pudong New Area, Shanghai Shanghai, Shanghai, 201203 ChinaOne-stop CDMO company certificated by ISO9001：We focus on process development and have ability to do process development from milligram to metric ton scale under ISO and cGMP system. Main products cover pharmaceutical, OLED, Specialty chemicals, Agrochemical and ADC. CAS 796073-69-3; CAS 97739-46-3; CAS 22128-62-7; CAS 123-12-6; CAS 98835-90-6; CAS 28079-04-1; CAS 1000053-23-5; CAS 100129-35-9; CAS 100-15-2; CAS 100327-50-2; CAS 1003-32-3; CAS 100405-37-6; CAS 1004618-85-2; CAS 1005187-65-4; CAS 1006334-34-4; CAS 1008774-87-5; CAS 1008-91-9; CAS 100927-10-4; CAS 100959-19-1; CAS 1010798-64-7; CAS 101093-56-5; CAS 10128-91-3; CAS 10137-67-4; CAS 1013915-06-4; CAS 101410-18-8; CAS 1016258-66-4; CAS 1016258-69-7; CAS 1016769-81-5; CAS 1017356-25-0; CAS 1018332-24-5; CAS 1018446-95-1; CAS 101861-63-6; CAS 1019351-46-2; CAS 10199-61-8; CAS 10201-71-5; CAS 102029-76-5; CAS 102113-98-4; CAS 1022091-49-1; "Since 2009, Fuxin Pharma has grown from a business development startup into a comprehensive CDMO partner. With 2,000+ square meters R&D and 62,000+ square meters manufacturing facilities across multiple locations, we serve the global pharmaceutical, specialty material, and semiconductor industries, etc." 1. Since 2009, Fuxin Pharma has grown from a business development startup 2. into a comprehensive CDMO partner. 3. With 2,000+ square meters R&D and 62,000+ square meters manufacturing facilities 4. across multiple locations, 5. we serve the global pharmaceutical, specialty material, and semiconductor industries for chemical manufacturing and outsourcing.. With different size of multipurpose batch reactors from 100 liters up to 5,000 liters, purification systems, and comprehensive downstream equipment, we bridge the critical transition from the stage from R&D to commercialization. Our ISO and cGMP systems ensure the consistent production and homogeneous quality at every scale." 1. With different size of multipurpose batch reactors from 100 liters up to 5,000 liters, 2. purification systems, and comprehensive downstream equipment, 3. we bridge the critical transition from the stage from R&D to commercialization. 4. Our ISO and cGMP systems ensure the consistent production and homogeneous quality at every scale. Quality is not inspected in, but the result of design, execution, and systems working together. Led by quality professionals with decades cGMP management experience at leading pharmaceutical companies, our QMS ensures every batch meets the highest standards."

590 Ruiqing Road, Building 7, 501 Shanghai, Shanghai, 201201 China

上海市浦东新区碧波路690号张江微电子港7号楼3层R301V室 上海, 201203 ChinaBuilding real-world insight-driven INTELLIGENT PLATFORM for precision medicine. Providing ingenious support for drug discovery and development to pharmaceutical and biotechnology companies, and make them more efficient and low-risk.

hanghai Representative Office World Trade Tower Suite 2201 #500 Guangdong Rd., Huangpu 200001 Shanghai, ChinaBEHIND EVERY SOLUTION ARE VALUES THAT HELPED US ARRIVE THERE.

519 Zi Yue Road Shanghai, 200241 ChinaGL Biochem, founded in 1998, is specializing in peptide reagent, peptide products and providing custom peptide/organic synthesis and CRO \CDMO services for pharmaceutical and biotechnology companies and research institutes/universities worldwide. GL Biochem has the world class and most sophisticated equipment such as MS, NMR, FT-IR, UV, Polarimeter, Elemental Analyzer, Karl Fischer Titrator, Amino Acid Analyzer, Ion Chromatography, Gas Chromatography, Multi-channel Peptide Synthesizer, Microwave Peptide Synthesizer just to name a few. We have 5 manufacturing bases globally and 12 offices in all major countries around the world. We presently employ over 1,500 staff. GL Biochem has total of 700,000 squares feet of production space, 100,000 squares feet of R&D center and 20,000 squares feet of cGMP workshop. Over 50% staffs are directly involved in peptide synthesis. We continuously improve production quality and capability, and at the same time emphasize on technology advancement. Peptide reagents and building blocks  Peptide coupling reagents: BOP reagent, HBTU, HOBt, TBTU  Fmoc-amino acids, Boc-Amino Acids, Z-Amino Acids  Protecting reagents: Fmoc-Cl, Fmoc-OSu  Linkers for solid-phase synthesis: HMP linker, DHP linker, Rink amide linker  Unusual amino acids: Homo-tyrosine, DL-m-tyrosine, Nal, Pal, 4-Cl-Phe-OH  Generic Peptide: Octreotide... Custom services  Custom Organic Synthesis  Custom Peptide Synthesis  Custom antibody service  Contract Research/Manufacture  Full-Time Employee

519 Ziyue Road Shanghai ChinaGL Biochem, founded in 1998, is specializing in peptide reagent, peptide products and providing custom peptide/organic synthesis and CRO \CDMO services for pharmaceutical and biotechnology companies and research institutes/universities worldwide. GL Biochem has the world class and most sophisticated equipment such as MS, NMR, FT-IR, UV, Polarimeter, Elemental Analyzer, Karl Fischer Titrator, Amino Acid Analyzer, Ion Chromatography, Gas Chromatography, Multi-channel Peptide Synthesizer, Microwave Peptide Synthesizer just to name a few. We have 5 manufacturing bases globally and 12 offices in all major countries around the world. We presently employ over 1,500 staff. GL Biochem has total of 700,000 squares feet of production space, 100,000 squares feet of R&D center and 20,000 squares feet of cGMP workshop. Over 50% staffs are directly involved in peptide synthesis. We continuously improve production quality and capability, and at the same time emphasize on technology advancement. Peptide reagents and building blocks  Peptide coupling reagents: BOP reagent, HBTU, HOBt, TBTU  Fmoc-amino acids, Boc-Amino Acids, Z-Amino Acids  Protecting reagents: Fmoc-Cl, Fmoc-OSu  Linkers for solid-phase synthesis: HMP linker, DHP linker, Rink amide linker  Unusual amino acids: Homo-tyrosine, DL-m-tyrosine, Nal, Pal, 4-Cl-Phe-OH  Generic Peptide: Octreotide... Custom services  Custom Organic Synthesis  Custom Peptide Synthesis  Custom antibody service  Contract Research/Manufacture  Full-Time Employee

Suzhou, ChinaGranlen offers custom synthesis services for intermediates, scaffolds, building blocks, reference compounds, metabolites, impurities, immunogens, bio-reagents and radiolabeling method development.

Room 611, Zhongchang Jincheng Building, No.1399 Haining Rd., Shanghai 200070, ChinaHamari Chemicals is specialized in the manufacture of APIs and pharmaceutical intermediates, food additives, amino acid derivatives, nutritional ingredients, peptide, cosmetic substances, dietary supplements

Suzhou, Jiangsu ChinaHande Sciences offers custom synthesis services.

35 Tongyuan Road Suzhou, 215006 ChinaHande Sciences offers custom synthesis services.

NO 37, East Fazhan Road, Sanzao Industrial Zone, Nanhui District. ShanghaiHanhong Group offers amino acids, intermediates, nucleosides, and saccharides for purchase in addition to analysis services.

590 Ruiqing Road Zhangjiang Hi-Tech Park East Shanghai, Shanghai, 201201 ChinaHD Biosciences Co., Ltd. a WuXi AppTec company, is a biology-focused preclinical drug discovery platform based in Shanghai China, with operation facilities in San Diego, California and Cranbury, New Jersey, USA. The company offers comprehensive services around target validation, plate-based pharmacology, hit identification and lead discovery, therapeutic antibody discovery, PK/PD and bioanalysis, in vivo pharmacology, as well as other research and development services. The company currently collaborates with global pharmaceutical and biotechnology companies, and has established strategic partnership with many key R&D advancements in clients’ portfolio. The company’s strong scientific expertise, high-quality and consistent deliveries, which constantly meet or exceed the client expectations, have fortified its global leadership as a comprehensive and reliable preclinical drug discovery platform.

#720 Cailun Road Building#1 Room 218 Shanghai, China 201203The Health & Gene Biotech Co., LTD (HG), situated in Shanghai, is a research-based rapid-growing biotech company. On the basis of state-of-the art technologies, we provide molecular biology services and products (e.g., plasmid DNAs), gene transfer services and products, including high-efficient transfection reagents and viral particles, and super-pure cytokines and growth factors of mouse, rat, and human origins. Our mission is to accelerate gene-based biomedical research and drug development by supporting researchers worldwide both in academic and pharmaceutical sectors.

Room 203, Building 8, 500 CaoBao Road Shanghai, ChinaHongene Biotechnology offers manufacturing services and ribonucleoside, deoxyribonucleoside, modified nucleoside and nucleotide products.

Shanghai, ChinaHutchison MediPharma is a biotechnology company in China.

780 Cailun Road Suite 805 Pudong, Shanghai 201203 P.R. ChinaHUYA Bioscience International offers a database of lead, preclinical and clinical drug candidates for co-development of their therapeutic novel drugs.

FL3 NO100 YUEYANG ROAD TAICANG, SUZHOU, 215488 ChinaHySigen Biosciences is a prominent global biotechnology enterprise that integrates R&D, services, and products, specializing in gene editing in gene edited cell lines. HySigen Biosciences embodies a pioneering force in the field of life sciences. Leveraging its profound technological expertise, HySigen Biosciences is devoted to providing exceptional gene editing services to a broad clientele. Our valued customers range across basic research, drug development and translational medicine.

Hzymes Building, No.3006, Huancheng West Road, Fengxian District, Shanghai , Shanghai, 201400 ChinaHzymes Biotech provides: 1. Enzymes and mastermix for PCR/qPCR/RT-qPCR 2. One-Stop solution from enzyme raw Materials, and Cap Analogs, and substrates, QC kits to mRNA CRO service 3. Tool enzymes and QC kit for CGT therapy and ADC drug. 4. Recombinant protein customized service 5. Enzymes and bulk reagents for Clinical chemistry

No.398 Xinlai Road, Jiading District Shanghai, 201815 ChinaImmunocan was founded in 2020 and specializes in using gene editing technology to replace immunoglobulin variable region genes in various animals, resulting in genetically engineered animals capable of producing fully human antibodies and other innovative modalities. The company is committed to offering cutting-edge antibody discovery platforms to worldwide drug research partners, with the goal of developing safer and more effective treatments for human diseases.

Jiangpu Road 75, Shengpu Town Suzhou Industrial Park Jiangsu, China 215126

Shanghai, Shanghai ChinaInhibitor Mall produces and sells more than 1800 inhibitors. With LC-MS, NMR, HPLC, we control the quality to meet your demand.

701-3, Want Want Building No 211, Shimen 1st Road, Jing’an Shanghai, 200041 ChinaInizio is a scaled commercialization platform that unlocks, activates and optimizes value for pharma and biopharma companies at every pivotal moment in the journey from discovery to post-launch . By harnessing our connected platform, we bridge best-in-class scientific expertise, market intelligence, data and analytics, technology, communications and creative execution to help clients make the right strategic choices and maximize the value of their healthcare innovations . Our integrated capabilities span evidence generation, medical communications & publications, market access, HEOR and RWE, data and decision optimization, marketing, PR and communications, medical and promotional engagement, patient engagement, training and events, and management consulting . We orchestrate cross-functional expertise to secure regulatory approval, deliver best-in-class launches, reach the right stakeholders through omnichannel engagement, and drive sustained brand growth throughout the commercialization lifecycle. Purpose-built to navigate complexity and minimize friction, Inizio provides an unrivalled connected offering across all therapeutic areas and geographies – transforming science into value, accelerating access, and ultimately helping more patients receive the medicines they need, faster.

No. 175, Meisheng Road, Pudong New Area shanghai, shanghai, 200120 ChinaOur company was found in 2018, the medical intelligent automation solution provider. We focus on the pharmaceuticals and bioscience industrial, provide intelligent automation solution to help our partner solve the bottleneck of scale, quality consistency and cost effectiveness. We are working with famous CRO, CDMO company and biology laboratory, provide the smart-automation systems, biological culture device, smart-management, Biological detection device, GMP production systems, Desktop bio-devices and general consumables.

Building 11th ,Dongjing Park, No.8 Dongfu Rd, suzhou suzhou, jiangsu, 215000 ChinaOur company was found in 2018, the medical intelligent automation solution provider. We focus on the pharmaceuticals and bioscience industrial, provide intelligent automation solution to help our partner solve the bottleneck of scale, quality consistency and cost effectiveness. We are working with famous CRO, CDMO company and biology laboratory, provide the smart-automation systems, biological culture device, smart-management, Biological detection device, GMP production systems, Desktop bio-devices and general consumables.

Shanghai, Shanghai ChinaIBCB is a Shanghai-based research institute focused on biochemistry and cell biology research.

Room 101, Building 1, No. 79, Lane 85, Cai Lun Road, Pudong New District, Shanghai, China Shanghai, Shanghai, 201203 ChinaINVIVO BIOTECHNOLOGY Founded in 2020 and headquartered in the core area of Zhangjiang Science City, Shanghai, InVivo operates SPF-grade laboratory animal facilities compliant with international pharmaceutical industry standards. Our founding team brings over 20 years of preclinical animal platform management experience from multinational pharmaceutical companies. Through continuous iteration, InVivo has established a globally aligned, pharmaceutical-grade experimental animal platform, delivering professional, comprehensive, and efficient services to biotech and pharmaceutical partners with top-tier facilities and stringent quality management. InVivo holds full domestic and international accreditations for animal research, including the Laboratory Animal Use License and AAALAC International certification. We provide non-clinical pharmacology & efficacy studies (CRO) and translational medicine research services, covering therapeutic areas such as: Autoimmune & Inflammatory Diseases；Ophthalmology；Neurology；Metabolic & Kidney Diseases

上海市浦东新区蔡伦路85弄79号1幢101室 上海, 上海, 201203 ChinaINVIVO BIOTECHNOLOGY Founded in 2020 and headquartered in the core area of Zhangjiang Science City, Shanghai, InVivo operates SPF-grade laboratory animal facilities compliant with international pharmaceutical industry standards. Our founding team brings over 20 years of preclinical animal platform management experience from multinational pharmaceutical companies. Through continuous iteration, InVivo has established a globally aligned, pharmaceutical-grade experimental animal platform, delivering professional, comprehensive, and efficient services to biotech and pharmaceutical partners with top-tier facilities and stringent quality management. InVivo holds full domestic and international accreditations for animal research, including the Laboratory Animal Use License and AAALAC International certification. We provide non-clinical pharmacology & efficacy studies (CRO) and translational medicine research services, covering therapeutic areas such as: Autoimmune & Inflammatory Diseases；Ophthalmology；Neurology；Metabolic & Kidney Diseases

Block A 1088 Shunyang Zhihui Valley Kunshan, Jiangsu, 215332 ChinaiPhase Pharma Service (IPHASE) is a “specialized, novel, and innovative” high-tech enterprise integrating research, development, production, sales, and technical services of innovative biological reagents. Leveraging extensive knowledge and passion for scientific research, our scientific team is committed to supplying quality innovative biological reagents to scientists worldwide and assisting researchers throughout their scientific endeavor to help achieve their research objectives. Pursuing the R&D ideal of “innovative reagents, researching the future”, IPHASE established multiple R&D facility, sales center, warehouse and distribution partners in China, United States, Europe and East Asian countries – covering more than 12,000 square feet.

268# Jungong road,Pudong, Shanghai, ChinaJamson PharmaChem offers API, intermediates, fine chemicals, and custom synthesis services.

7 / F, Building 1, 188 Fuchunjiang Road, High-tech Zone, Suzhou City, Jiangsu Province, 215153 ChinaJiangsu Avatarget Biotechnology Co., Ltd. (Avatarget) is an innovative technology company dedicated to providing solutions for human organ chip products and solutions.The company is committed to the research and development of organ chips, intelligent equipment, and biological reagent products and services, building a complete industrial chain ecosystem for organ chips. It innovatively breaks through the limitations of traditional animal models and 2D cell models, solving the problem of differences in species, achieving 3D dynamic culture of organ models, and constructing a highly realistic human microenvironment to improve the accuracy of experimental data. It provides precise and efficient products and solutions for users in fields such as tumor precision diagnosis, disease modeling, drug screening, drug evaluation, cosmetic evaluation, regenerative medicine research, and aerospace medicine. Avatarget has gathered a group of top experts and engineers from various fields such as bioengineering, microfluidic technology, material science, clinical medicine, automation, and artificial intelligence, with strong and sustainable innovation capabilities. Avatarget has provided products and services to many well-known hospitals, pharmaceutical companies, CRO companies, cosmetic companies, CDCs, testing and inspection institutions, and university research institutes both domestically and internationally, helping to promote the development of the entire life science field. Avatarget provides a variety of services or tests based on fully humanized 3D organ or organ-on-a-chip models, our models as follows(Physiological & Disease model) : •Vascular Barrier/New Blood Vessels & Tumor/Fibroblast/Vascular Co-culture, Tumor/Vascular/Immune Co-culture, Atherosclerosis • Blood-Brain Barrier (BBB) & Brain Tumor/Vascular Co-culture • Cardiac & Heart Disease (Heart Failure, Arrhythmias, Cardiac Hypertrophy, Long-QT) • Liver & Fatty Liver, Liver Injury • Intestine & Intestinal Inflammation, IBD, Intestinal Microbiota • Lung & Pulmonary Fibrosis, Pneumonia, Lung Virus Infection • Skin & Skin Inflammation, Scars, Melanoma • Kidney & Chronic Kidney Disease, Acute Kidney Injury • Retina Basic Detection Indicators: Cell viability, characteristic protein expression (immunofluorescence), cytokine secretion (ELISA, multi-factors), gene sequencing, etc. Characteristic Detection Indicators: Customized according to organ chip model.

Room 432-1, Building 1, No. 1 Jinhe Road Qinshan Street, Haiyan County, Jiaxing, ZHEJIANG, 314300 ChinaHuahe Pharma is a China-based radiopharmaceutical CRO & CDMO integrating radioisotope supply, radiolabeling R&D, preclinical imaging, and GMP manufacturing support under one roof. We are the licensed isotope agent of Qinshan Nuclear Power Plant, providing a stable supply of high-purity medical isotopes including Lu-177 (n.c.a.), C-14 labeled compounds, and Mo-99/Tc-99m generators (expected Q2 2026). Radiolabeling & Preclinical Capabilities ● Custom Radiolabeling & Synthesis: Development of Lu-177, I-131, and C-14 radiolabeled small molecules, peptides and biomolecules for biodistribution, PK/PD, and target-binding studies. ● Animal Facility & Imaging Platforms: In-house PET/CT and SPECT/CT systems for mouse and rat studies including biodistribution and dosimetry assessments. ● Dosimetry & Data Analysis: Standardized ROI segmentation and decay-corrected activity calculations using validated software. ● Clinical Translation: In collaboration with the Institute of Radiation Medicine, Fudan University, we can support investigator-initiated trials (IITs) within 6–8 months after tracer PCC confirmation. CDMO & GMP Manufacturing Services ● Process Development & Scale-up: Optimization of radiolabeling and purification processes for clinical and commercial use. ● GMP Production & Aseptic Filling: Qualified hot cells and Class A + C clean rooms for radiopharmaceutical manufacturing and sterile filling. ● Quality Control & Release Testing: Comprehensive QC including radionuclidic purity, radiochemical purity, endotoxin and sterility testing per USP and EP standards. By combining isotope supply, radiolabeling expertise, and end-to-end CRO/CDMO capabilities, Huahe Pharma provides cost-efficient and regulatory-compliant solutions for radiopharmaceutical development from bench to bedside.

Minhang District, Shanghai, ChinaJ&M Chemstock offers custom synthesis of reference compounds, building blocks, and complex compounds in addition to offering process R&D and manufacturing expertise.

No.1 Zhaoxi Roa Taicang BioMedical Industrial Park Taicang, Suzhou, 215421 ChinaFounded in 1995, JOINN Laboratories (China) Co., Ltd. (JOINN Laboratories, Stock Code: 603127.SSE/6127.HK) is dedicated to providing drug R&D CRO outsourcing services. Headquartered in Beijing, JOINN has subsidiaries in Beijing, Suzhou, Shanghai, Chongqing, Wuzhou and Guangzhou in China, and Richmond (CA) and Worcester (MA) in the United States, with over 2000 professionals. JOINN has built a thorough quality management system complying with international standards: CNAS/ILAC-MRA certification, NMPA, US FDA, OECD, Japan PMDA and Korean MFDS GLP certification and international AAALAC accreditation. JOINN provides customized services to the sponsor’s specific needs for non-clinical safety assessments, clinical trials, registrations, and pharmacovigilance, covering the entire spectrum from development to final drug registration. JOINN also provides services in animal feed and veterinary medicine evaluation, pesticide evaluation, medical device evaluations, and more.

Shanghai, Shanghai ChinaJPY Ion-Tech through its subsidiary, Shanghai JPY Ion-Tech Co., Ltd. (SHJPY), specializes in Gamma irradiation sterilization service.

421Hong Cao Rd., Building 63, 2nd floor, Shanghai, China 200233KangChen Bio-tech provides microarray and sequencing services.

Shanghai, Shanghai ChinaKangChen Bio-tech provides microarray and sequencing services.

Xinghua Street Suzhou Shi, Jiangsu Sheng ChinaKCI Biotech (SUZHOU) Inc. (KCI) and Jiangsu KMQ biotech Inc. (KMQ) which is a wholly-owned subsidiary of KCI are preclinical Contract Research Organization (CRO) providing specialty preclinical pharmacology services in cardiovascular diseases, immune diseases, inflammatory diseases, metabolic diseases, urinary diseases, neuron diseases and oncology by using small (mice, rats, etc.) and large (non human primates, dogs, rabbits, guinea pig etc.) animal disease models. The core competency of KCI&KMQ stems from our pioneering work and expertise in developing and running specialized animal disease models to test drug candidates and medical devices for their pharmacological effects and biocompatible. We also conduct adjacency studies in PK/PD, preliminary toxicology, medical image, translational medicine and pathology. KCI locates in Suzhou industry park. We have 7200sq.ft. of SPF animal facility for about 7000 mice and 5000 rats studies at same time; 5400sq.ft. of experimental laboratories for pathology, cell biology, molecular biology, formulation and other functional laboratories. KMQ, our large animal facility locates in Haimen (Linjiang), is about 30,000sq.ft. for about 500 guinea pigs, 300 rabbits, 200 dogs, 200 monkeys studies at same time; 18000sq.ft. of experimental laboratories for image facility including MRI, CT, X-ray, B-Ultrasound, operation rooms, cell biology, molecular biology, formulation and other functional laboratories.

B8-301, Xinghu Street SIP, Suzhou, 215123 ChinaLevena Biopharma, a US-based ADC specialty services company, was founded in 2013 upon licensing of proprietary, site-specific conjugation chemistries (C-Lock and K-Lock) from Concortis Biosystems (a Sorrento Tx company). Complemented by a growing portfolio of proprietary and non-proprietary Linkers and Payloads, we offer fully integrated CRDMO capabilities, world-class technical expertise and state-of-the-art lab facilities at our headquarters in San Diego, CA. For clients seeking to construct therapeutic or diagnostic conjugates utilizing antigen-targeting biomolecule(s) of their choosing, we welcome discussing our IP and expertise to assist you. Levena was spun off from Sorrento in 2016 to independently serve the biopharma community. Since then, our collaborative partnerships have resulted in 28 successful IND registration packages. Levena also offers leading-edge cGMP ADC manufacturing at our facilities in Nanjing (Ph1, 2) and Suzhou (Ph3+, >200g, Safebridge 6).

Room A3-502, No. 328 of Xinghu Street Suzhou Industrial Park Suzhou, Jiangsu, 215123 ChinaLevostar Biotech: Innovative solutions for innovative therapies Levostar is a technology-driven enterprise focused on innovative technologies for Advanced Therapy Medicinal Products by leveraging synthetic biology, next-generation sequencing, gene editing, and other technologies. We aim to offer leading-edge solutions for antibodies, cell and gene therapies, and RNA drugs. We are a global company with a presence in China and the US.

A3-502, No. 238 Xinghu Street Suzhou Industrial Park Suzhou, Jiangsu, 215123 ChinaLevostar Biotech: Innovative solutions for innovative therapies Levostar is a technology-driven enterprise focused on innovative technologies for Advanced Therapy Medicinal Products by leveraging synthetic biology, next-generation sequencing, gene editing, and other technologies. We aim to offer leading-edge solutions for antibodies, cell and gene therapies, and RNA drugs. We are a global company with a presence in China and the US.

Rm919,9th Floor, CIMIC Tower,800 Shangcheng Road,Pudong new area, Shanghai China 200120Lianhe Chemical Technology offers API, intermediates, and manufacturing services.

Room 63, 38F Park Place, 1601 West Nanjing Road, Jingan District Shanghai, 200040 ChinaLinical is a public, mid-sized Contract Research Organization headquartered in Japan with a significant presence across all major markets including North America, Europe, and Asia-Pacific. Linical provides the full spectrum of drug development services from early stage to large-scale, multinational studies. Our areas of focus include Phase I-IV studies in oncology, neurology & psychiatry, immunology & vaccine, and endocrinology & metabolic diseases.

Room 63, 38F Park Place, 1601 West Nanjing Road, Jingan District Shanghai, 200040 JapanLinical is a public, mid-sized Contract Research Organization headquartered in Japan with a significant presence across all major markets including North America, Europe, and Asia-Pacific. Linical provides the full spectrum of drug development services from early stage to large-scale, multinational studies. Our areas of focus include Phase I-IV studies in oncology, neurology & psychiatry, immunology & vaccine, and endocrinology & metabolic diseases.

1199 Lan Dian Lu 3rd Floor Shanghai Shi China

178号 Ban Xia Lu Ste. 1-402 Shanghai Shi China

168 Banxia Road, Ste. 1-402 Pudong, Shanghai, 201318 China

Building No.5, Lane 67, Libing Road, Zhangjiang High-Tech Park Pudong, Shanghai, 200000 ChinaMedicilon is a leading integrated CRO/CDMO providing one-stop drug discovery and preclinical development services to global pharmaceutical, biotechnology, and academic partners. From hit identification and lead optimization to IND-enabling studies, we accelerate the development of innovative therapeutics through a fully integrated platform encompassing medicinal chemistry, biology, DMPK, pharmacology, toxicology, CMC, API process development, formulation, and bioanalytical services. Our flexible collaboration models, including fee-for-service (FFS), dedicated FTE teams, and fully integrated discovery programs which allow us to support projects of any size and stage. Backed by GLP- and GMP-compliant facilities, AAALAC-accredited animal research capabilities, and extensive regulatory experience, Medicilon delivers high-quality, reliable data that supports global IND submissions. By combining scientific expertise, operational efficiency, and seamless cross-functional collaboration, we help clients shorten development timelines and bring promising therapies to patients faster.

585 Chuanda Rd. Pudong, Shanghai, 201299 ChinaMedicilon is a leading integrated CRO/CDMO providing one-stop drug discovery and preclinical development services to global pharmaceutical, biotechnology, and academic partners. From hit identification and lead optimization to IND-enabling studies, we accelerate the development of innovative therapeutics through a fully integrated platform encompassing medicinal chemistry, biology, DMPK, pharmacology, toxicology, CMC, API process development, formulation, and bioanalytical services. Our flexible collaboration models, including fee-for-service (FFS), dedicated FTE teams, and fully integrated discovery programs which allow us to support projects of any size and stage. Backed by GLP- and GMP-compliant facilities, AAALAC-accredited animal research capabilities, and extensive regulatory experience, Medicilon delivers high-quality, reliable data that supports global IND submissions. By combining scientific expertise, operational efficiency, and seamless cross-functional collaboration, we help clients shorten development timelines and bring promising therapies to patients faster.

No.2300 Xuanhuang Road Pudong, Shanghai, 201300 ChinaMedicilon is a leading integrated CRO/CDMO providing one-stop drug discovery and preclinical development services to global pharmaceutical, biotechnology, and academic partners. From hit identification and lead optimization to IND-enabling studies, we accelerate the development of innovative therapeutics through a fully integrated platform encompassing medicinal chemistry, biology, DMPK, pharmacology, toxicology, CMC, API process development, formulation, and bioanalytical services. Our flexible collaboration models, including fee-for-service (FFS), dedicated FTE teams, and fully integrated discovery programs which allow us to support projects of any size and stage. Backed by GLP- and GMP-compliant facilities, AAALAC-accredited animal research capabilities, and extensive regulatory experience, Medicilon delivers high-quality, reliable data that supports global IND submissions. By combining scientific expertise, operational efficiency, and seamless cross-functional collaboration, we help clients shorten development timelines and bring promising therapies to patients faster.

Building No.5, Lane 67, Libing Road Pudong, Shanghai, 201210 ChinaMedicilon is a leading integrated CRO/CDMO providing one-stop drug discovery and preclinical development services to global pharmaceutical, biotechnology, and academic partners. From hit identification and lead optimization to IND-enabling studies, we accelerate the development of innovative therapeutics through a fully integrated platform encompassing medicinal chemistry, biology, DMPK, pharmacology, toxicology, CMC, API process development, formulation, and bioanalytical services. Our flexible collaboration models, including fee-for-service (FFS), dedicated FTE teams, and fully integrated discovery programs which allow us to support projects of any size and stage. Backed by GLP- and GMP-compliant facilities, AAALAC-accredited animal research capabilities, and extensive regulatory experience, Medicilon delivers high-quality, reliable data that supports global IND submissions. By combining scientific expertise, operational efficiency, and seamless cross-functional collaboration, we help clients shorten development timelines and bring promising therapies to patients faster.

67 Libing Road, Bldg.5, Shanghai 201203, ChinaMedicilon is a leading integrated CRO/CDMO providing one-stop drug discovery and preclinical development services to global pharmaceutical, biotechnology, and academic partners. From hit identification and lead optimization to IND-enabling studies, we accelerate the development of innovative therapeutics through a fully integrated platform encompassing medicinal chemistry, biology, DMPK, pharmacology, toxicology, CMC, API process development, formulation, and bioanalytical services. Our flexible collaboration models, including fee-for-service (FFS), dedicated FTE teams, and fully integrated discovery programs which allow us to support projects of any size and stage. Backed by GLP- and GMP-compliant facilities, AAALAC-accredited animal research capabilities, and extensive regulatory experience, Medicilon delivers high-quality, reliable data that supports global IND submissions. By combining scientific expertise, operational efficiency, and seamless cross-functional collaboration, we help clients shorten development timelines and bring promising therapies to patients faster.

KaiLong Nanhui Business Park, Shanghai Pudong, Shanghai, 200000 ChinaMedicilon is a leading integrated CRO/CDMO providing one-stop drug discovery and preclinical development services to global pharmaceutical, biotechnology, and academic partners. From hit identification and lead optimization to IND-enabling studies, we accelerate the development of innovative therapeutics through a fully integrated platform encompassing medicinal chemistry, biology, DMPK, pharmacology, toxicology, CMC, API process development, formulation, and bioanalytical services. Our flexible collaboration models, including fee-for-service (FFS), dedicated FTE teams, and fully integrated discovery programs which allow us to support projects of any size and stage. Backed by GLP- and GMP-compliant facilities, AAALAC-accredited animal research capabilities, and extensive regulatory experience, Medicilon delivers high-quality, reliable data that supports global IND submissions. By combining scientific expertise, operational efficiency, and seamless cross-functional collaboration, we help clients shorten development timelines and bring promising therapies to patients faster.

585 Chuanda Road Shanghai Shi ChinaMedicilon is a leading integrated CRO/CDMO providing one-stop drug discovery and preclinical development services to global pharmaceutical, biotechnology, and academic partners. From hit identification and lead optimization to IND-enabling studies, we accelerate the development of innovative therapeutics through a fully integrated platform encompassing medicinal chemistry, biology, DMPK, pharmacology, toxicology, CMC, API process development, formulation, and bioanalytical services. Our flexible collaboration models, including fee-for-service (FFS), dedicated FTE teams, and fully integrated discovery programs which allow us to support projects of any size and stage. Backed by GLP- and GMP-compliant facilities, AAALAC-accredited animal research capabilities, and extensive regulatory experience, Medicilon delivers high-quality, reliable data that supports global IND submissions. By combining scientific expertise, operational efficiency, and seamless cross-functional collaboration, we help clients shorten development timelines and bring promising therapies to patients faster.

218 Xinghu St. C9-501 Suzhou, Jiangsu, 215126 ChinaMedinoah is a global Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), established in 2008. We specialize in providing comprehensive and flexible solutions across the entire spectrum of small molecule drug discovery, development, and manufacturing. A key area of our expertise lies in the synthesis, scale-up, and GMP production of protein degraders and molecular glues. Our core services include medicinal chemistry FTE/FFS, catalog compounds, building blocks, route scouting, process optimization, and rapid scale-up in both non-GMP and GMP environments. We are also well-equipped to handle PPQ and PV for RSMs and APIs. Our analytical and regulatory capabilities include genotoxic impurity assessment and control, analytical method development and validation, stability studies, and filing preparation and review. At Medinoah, our culture of scientific innovation is driven by state-of-the-art infrastructure, enabling us to deliver integrated solutions tailored to the needs of our partners in drug discovery and development.

218 Xinghu St, Building B5-901 Suzhou Industrial Park Suzhou, JiangSu, 215123 ChinaMEDx, a leader of complete solution providers in companion diagnostics (CDx), offers comprehensive translational medicine support in the development of new drugs and CDx assays in oncology, and it provides clinical testing for precision medicine as well. It owns 20+ molecular diagnostic testing kits, approved by Notified Body (CE-IVD) and China NMPA, which are now available for global market. Those kits are all used to predict cancer treatment responses in both solid tumors and hematological malignancies. We believe MEDx is your ideal partner to meet your needs and help guide personalized treatment of patients.

Suite 901, B5 Building, 218 Xinghu St Suzhou Industrial Park Suzhou, JiangSu, 215123 ChinaMEDx, a leader of complete solution providers in companion diagnostics (CDx), offers comprehensive translational medicine support in the development of new drugs and CDx assays in oncology, and it provides clinical testing for precision medicine as well. It owns 20+ molecular diagnostic testing kits, approved by Notified Body (CE-IVD) and China NMPA, which are now available for global market. Those kits are all used to predict cancer treatment responses in both solid tumors and hematological malignancies. We believe MEDx is your ideal partner to meet your needs and help guide personalized treatment of patients.

2nd Floor, Block B, E-Tong World South District, No. 685, Huaxu Road, Xujing Town, Qingpu District, Shanghai, Shanghai, 201702 ChinaMEDx, a leader of complete solution providers in companion diagnostics (CDx), offers comprehensive translational medicine support in the development of new drugs and CDx assays in oncology, and it provides clinical testing for precision medicine as well. It owns 20+ molecular diagnostic testing kits, approved by Notified Body (CE-IVD) and China NMPA, which are now available for global market. Those kits are all used to predict cancer treatment responses in both solid tumors and hematological malignancies. We believe MEDx is your ideal partner to meet your needs and help guide personalized treatment of patients.

218 Xinghu Street Suzhou Shi, Jiangsu Sheng ChinaMEDx, a leader of complete solution providers in companion diagnostics (CDx), offers comprehensive translational medicine support in the development of new drugs and CDx assays in oncology, and it provides clinical testing for precision medicine as well. It owns 20+ molecular diagnostic testing kits, approved by Notified Body (CE-IVD) and China NMPA, which are now available for global market. Those kits are all used to predict cancer treatment responses in both solid tumors and hematological malignancies. We believe MEDx is your ideal partner to meet your needs and help guide personalized treatment of patients.

498 GuoShouJing Road Building One, Suite 1411, 1412-1416 Zhangjiang High Technologies Park Pudong New District Shanghai Shanghai, China 201203Merge Healthcare specializes in clinical systems and offers cloud-based solutions for imaging and data analytics.

BlockA, Lane158 ,Gu'en Road, Pudong New District, Shanghai shanghai, shanghai, 200120 ChinaMilecell Biological Science & Technology Co. Ltd is a high-tech enterprise dedicated to the pharmaceutical industry, integrating research and development, production and sales. Since its establishment in 2014, The company has focused on the research and development and preparation of national brand Cell models. By creating The Primary Cell Solution - TPCS independent research and development brand, the company has carried out import substitution work to break the monopoly of developed countries in the United States and Europe on cell technology and the Chinese market. TPCS® aims to become a new quality productivity in the domestic biomedical field and empower the domestic innovative drug research and development industry.

R406,Huanan Building, No.1988 Dongfang Road,Pudong,Shanghai, ChinaMintchem specializes in production and distribution of inorganic fluoride materials, sulphate salts, bariums salts, and chloride salts of inorganic chemical product.

Shanghai, Shanghai ChinaMocell Biotech provides peptide synthesis, catalogue peptides, and reagents.

Room 8513, No.518, Zhuyuan Road, Minhang District Shanghai, ChinaMocell Biotech provides peptide synthesis, catalogue peptides, and reagents.

Room 202, Building 6, No.1000 Jinhai Road, Pudong District, Shanghai, China 201206 Pudong District, Shanghai, 201206 ChinaMP Biomedicals is dedicated to giving scientists and researchers innovative, quality tools and superior service to aid them in their quest for ground-breaking discovery and turning the hope for life-changing solutions into a reality. The company manufactures and sells more than 55,000 products and is one of the only companies in the industry to offer a comprehensive line of life science, fine chemical and diagnostic products. MP Biomedicals is a world-wide corporation, with ISO-certified and FDA-approved manufacturing and distribution facilities throughout the globe and headquartered in Southern California. A vast network of global distributors and satellite facilities and offices throughout Europe, Asia, Australia and the Americas assures customers top quality products delivered when and where needed. No matter how dynamic the evolution of the life science and biotechnology markets, we remain committed to supporting our customers in their efforts to make new discoveries. From basic research, through scale-up, to full-scale production and diagnostic testing, MP Biomedicals serves every industry need – from specialized areas of research to supplying large scale quantities of fine chemicals. Our customers partner with us because they want a long-time player and reliable colleague in the fields of life science research and diagnostics. MP Biomedicals will never rest in our odyssey to remain at the forefront of discovery in the ever-changing biomedical industry.

Shanghai, Shanghai ChinaMTT Pharma & Bio-technology is specialized in development, manufacture and sales of novel products, APIs and fine chemicals.

Shanghai ChinaNAIKAI specializes in importing and exporting the raw materials of Health Products, Pharmaceutical & Chemicals, Cosmetics and Food Additives.

Shanghai ChinaNAMSA is a Medical Research Organization (MRO), accelerating product development through integrated laboratory, clinical and consulting services. Driven by our regulatory expertise, NAMSA’s MRO® Approach plays an important role in translational research, applying a unique combination of disciplines—consulting, preclinical, toxicology, microbiology, chemistry, clinical and quality—to move client’s products through the development process, and continue to provide support through commercialization to post-market requirements, anywhere in the world.

Guo Shou-jing Road, Free Trade Zone Test No. 199 Shanghai, 201 203 ChinaNorth Shanghai Yi Biotechnology Co., Ltd. (Shanghai New Drug Safety Evaluation and National Research Center) was established in 1993 , is established under the national "Nine Five" key construction projects financed 5 national GLP one of the centers, formerly known as the Shanghai pharmaceutical industry Research Institute of Pharmacology and toxicology, pharmacology and toxicology research in 40 years. As China's first and most comprehensive preclinical safety evaluation research institutes, centers in 2003 became the first in China by the CFDA 's GLP certification body, then centers have adopted the international animal experiments Assessment and Accreditation Council ( AAALAC ) fully certified by OECD member Government of the Netherlands GLP fully certified by the US FDA 's GLP inspection by the College of American pathologists CAP certification, product testing by the Shanghai quality and Technical Supervision qualified certification bodies (CMAF certification), China national accreditation Board qualification certification ( CNAS certification).

Wuzhong District Bio Bay Suzhou, Jiangsu, 215123 ChinaNEXEL Co., Ltd. was established in 2012 as a spin-off from Korea University in Seoul, South Korea, specializing in induced pluripotent stem cell (iPSC) technology. Our philosophy is to “Make a Better Place” by supporting innovative research around the world through high-quality iPSC-derived somatic cell products and preclinical safety assessment services by utilizing our high-quality iPSC cell products. Nexel currently commercializes iPSC-derived ventricular cardiomyocytes, neurons and hepatocytes. In order to carry out more in-depth innovative research, we are in the process of launching 3D organoid models, including cardiac organoids and heart organoids. NEXEL, Co., Ltd. aims to grow as a global leader in the bio-industry. This is embodied by its enthusiastic and passionate employees and a corporate culture that supports creative innovation.. Based on state-of-the-art technology, we plan to manufacture higher quality products and improve the research environment of our valuable customers and collaborators. We also aim to directly improve the quality of life of patients affected by disease. We are investing our resources in novel protein-based therapies for previously untreatable indications. At NEXEL, we truly believe that through our work, we will leave the world a better place than the one we found it.

1388 North Shaan Xi Road Putuo District Shanghai, 200060 ChinaNopras Technologies is a globally recognized management consulting firm which specializes in services to organizations in the pharmaceutical, biotechnology/biologics, medical device/diagnostics and other FDA regulated industries. Our service portfolio covers FDA and foreign regulations/guidelines and spans the full product development life cycle from clinical development through market scrutiny.

Building No.4, Lane 1690, Zhangheng Road, Zhangjiang Hi-Tech Park, Shanghai, 201203 ChinaNovasep provides chiral separations, custom synthesis, manufacturing, generics development, and purification scale-up.

Minhang District, Shanghai Gu Dai Road 3100, Lane 68, 2nd FloorConnaught 100 Biological (Novobio) for clinical research and provide technical services and related products, specialized biotechnology companies. With a strong technical force, we can provide design, build to detect one-stop service. We aim to use their core competencies to help researchers quickly and efficiently obtain high-quality data, and generate and accelerate biological conversion of medical findings, particularly in gene function, an animal vaccine development, gene therapy, protein expression of the transgene,,, target validation, biological protection and other aspects.100 Biological Connaught has a mature technology and scientific management system, all processes are strictly in accordance with SOP experimental operation, the company has all kinds of advanced equipment, and at the same time has a number of domestic research institutes to establish a good working relationship. Now the company has established a number of experimental platforms, including cloning construct, viral packaging, molecular detection, cell culture. Meanwhile, the company also has a strong R & D, through independent research, to develop efficient biology reagents and kits, and other products. We can provide customers with a comprehensive biology services, including: RNAi Services, Gene expression analysis and genomic analysis services, miRNA Service, cDNA library construction services, Mammalian cell lines, stably transfected Construction Services, Clone Build Service, Viral packaging services, Peptide Synthesis, Prokaryotic expression service and Antibody Service.

Shanghai Gu Dai Road 3100, Lane 68, 2nd Floor Minhang District ChinaConnaught 100 Biological (Novobio) for clinical research and provide technical services and related products, specialized biotechnology companies. With a strong technical force, we can provide design, build to detect one-stop service. We aim to use their core competencies to help researchers quickly and efficiently obtain high-quality data, and generate and accelerate biological conversion of medical findings, particularly in gene function, an animal vaccine development, gene therapy, protein expression of the transgene,,, target validation, biological protection and other aspects.100 Biological Connaught has a mature technology and scientific management system, all processes are strictly in accordance with SOP experimental operation, the company has all kinds of advanced equipment, and at the same time has a number of domestic research institutes to establish a good working relationship. Now the company has established a number of experimental platforms, including cloning construct, viral packaging, molecular detection, cell culture. Meanwhile, the company also has a strong R & D, through independent research, to develop efficient biology reagents and kits, and other products. We can provide customers with a comprehensive biology services, including: RNAi Services, Gene expression analysis and genomic analysis services, miRNA Service, cDNA library construction services, Mammalian cell lines, stably transfected Construction Services, Clone Build Service, Viral packaging services, Peptide Synthesis, Prokaryotic expression service and Antibody Service.

D09, Building 6, No. 351 Sizhuan Road (SjtuPark) Songjiang District Shanghai, 201601 ChinaWith our creativity and full dedication, providing the most valuable tools and solutions for protein research, in this golden age of biology. Founded in 2013, NovoPro Inc. is formed by a group of experienced scientists, technique experts trained in top research institutes worldwide. All the technical members have years of working experience in leading biological companies. As one of the most innovative companies in China, NovoPro prides itself on the mission of outstanding-quality research reagents, tools, and services to the worldwide biological research community at highly competitive prices. Core competencies: • High quality custom services: 100% accuracy for gene synthesis, >98% for custom peptide. The custom polyclonal antibody production will apply multiple antigens, multiple immunizations, together with the proprietary NovoFocusTM antigen design and NovoBoostTM adjuvant, ensure top successful rate of the antibody end-use. • Easy, affordable, enjoyable solutions: Protein sequence is all we need, NovoPro can provide one-stop solution for several tools of target protein study. Further, our helpful tech-support manager and competitive cost will make your research easier, more enjoyable. • Experiencing true customization: Any modification, point mutation or any ideas in your mind, our scientific experts will try hard to realize your requirements, so why not contact us now.

5F, Building 3, NO.629 Chenglong Road, Shanghai, China Zip-code:200233With our creativity and full dedication, providing the most valuable tools and solutions for protein research, in this golden age of biology. Founded in 2013, NovoPro Inc. is formed by a group of experienced scientists, technique experts trained in top research institutes worldwide. All the technical members have years of working experience in leading biological companies. As one of the most innovative companies in China, NovoPro prides itself on the mission of outstanding-quality research reagents, tools, and services to the worldwide biological research community at highly competitive prices. Core competencies: • High quality custom services: 100% accuracy for gene synthesis, >98% for custom peptide. The custom polyclonal antibody production will apply multiple antigens, multiple immunizations, together with the proprietary NovoFocusTM antigen design and NovoBoostTM adjuvant, ensure top successful rate of the antibody end-use. • Easy, affordable, enjoyable solutions: Protein sequence is all we need, NovoPro can provide one-stop solution for several tools of target protein study. Further, our helpful tech-support manager and competitive cost will make your research easier, more enjoyable. • Experiencing true customization: Any modification, point mutation or any ideas in your mind, our scientific experts will try hard to realize your requirements, so why not contact us now.

Room 501, Building 10, No. 760 Xinjun Ring Road Minhang District Shanghai, Shanghai, 201114 ChinaNovotech offers clinical research services such as bioequivalence, clinical monitoring, data management, regulatory affairs and lab services.

199 Goushoujing Road, Pudong, Shanghai 201203, ChinaNSCNDSER offers toxicology services, PK/TK studies, safety pharmacology studies, developmental and reproductive toxicology services, genetic toxicology services, pathology services and DMPK and ADMET services.

No. 908, Ziping Road, International Medical Park Shanghai, Shanghai, 201318 ChinaProviding client-centered and high-quality service as our commitment, we strive to become a world leading gene and cell therapy CRO/CDMO group.

2F No. 306 Libing Road, 201203, Shanghai, ChinaOmni Pharmaceutical provides specialty generic and branded pharmaceuticals .

569 South Xizang Rd. Spaces Base, S-03-Suite 245 Shanghai, 200011 ChinaAt OPEN Health, we connect visionary minds, pioneering science, and advanced technology to drive real impact. By uniting people, science, and technology, we activate new opportunities for biopharma innovation. Our expertise across medical affairs and market access unlocks faster, smarter routes to market. We are committed to improving patient outcomes worldwide. OPEN Health. The right combination to unlock possibilities. Medical Affairs Our highly skilled medical communications specialists bring data to life, engaging with the healthcare community to unlock behavior change. Patient Engagement We are experts in strategic patient innovation and engagement, building bespoke patient solutions, always through the lens of a patient. HEOR & Market Access We remain at the forefront of HEOR through the development and application of innovative solutions, to unlock better and faster access for patients. Consulting (Acsel Health) Combining deep industry expertise, scientific rigor, and actionable analysis, Acsel Health partners to guide life-changing innovations through their critical stages, from early development through market maturity. To learn more, visit www.openhealthgroup.com.

上海市浦东新区达尔文路88号11号楼1、3楼 Floor 3, building 11, No. 88 Darwin Road, Pudong New Area, Shanghai 上海Shanghai, 上海Shanghai, 200000 China上海澳能生物技术有限公司（OriBiotech）总部位于上海张江药谷，在北京、上海、广州、成都均设有实验室及办事机构。自公司创建以来，秉持着以信誉为立身之本，从细节处着眼的精神，始终专注于肿瘤免疫及原代细胞领域，拥有一系列基于原代免疫细胞的临床前药物开发，以及体内体外药效评价技术平台。 Shanghai OriBiotech Co., Ltd., headquartered in Zhangjiang Pharmaceutical Valley in Shanghai, has laboratories and offices in Beijing, Shanghai, Guangzhou, and Chengdu. Since its inception, the company has adhered to the principles of credibility as its foundation and a focus on details, consistently specializing in the fields of tumor immunology and primary cells. It boasts a series of preclinical drug development platforms based on primary immune cells, as well as in vivo and in vitro pharmacodynamics evaluation technology platforms. 公司主要提供健康人外周原代细胞、动员外周原代细胞、脐血原代细胞的分离及分选服务；免疫药效实验材料筛选服务；承接免疫学体内外药效评价项目。通过先进的研发生产技术及完善的质量管理体系，真正做到细胞生产及药效服务各环节的全过程控制，为国内各生物制药及细胞治疗企业、CRO、CMO、CDMO、科研院所、生物技术公司等众多合作伙伴，提供高质量的产品和标准化的服务，助力中国生命科学研究领域的发展。 The company primarily provides isolation and sorting services for healthy donor-derived peripheral primary cells, mobilized peripheral primary cells, and umbilical cord blood primary cells; screening services for immunopharmacodynamics experimental materials; and undertakes immunology in vivo and in vitro pharmacodynamics evaluation projects. Through advanced research and development production techniques and a comprehensive quality management system, OriBiotech achieves full-process control in all aspects of cell production and pharmacodynamics services. It provides high-quality products and standardized services to numerous partners, including domestic biopharmaceutical and cellular therapy enterprises, CROs, CMOs, CDMOs, scientific research institutes, and biotechnology companies, contributing to the development of life science research in China.

Floor 1, Building 11, No. 88 Darwin Road, Pudong New Area, Shanghai Shanghai, Shanghai, 201203 China上海澳能生物技术有限公司（OriBiotech）总部位于上海张江药谷，在北京、上海、广州、成都均设有实验室及办事机构。自公司创建以来，秉持着以信誉为立身之本，从细节处着眼的精神，始终专注于肿瘤免疫及原代细胞领域，拥有一系列基于原代免疫细胞的临床前药物开发，以及体内体外药效评价技术平台。 Shanghai OriBiotech Co., Ltd., headquartered in Zhangjiang Pharmaceutical Valley in Shanghai, has laboratories and offices in Beijing, Shanghai, Guangzhou, and Chengdu. Since its inception, the company has adhered to the principles of credibility as its foundation and a focus on details, consistently specializing in the fields of tumor immunology and primary cells. It boasts a series of preclinical drug development platforms based on primary immune cells, as well as in vivo and in vitro pharmacodynamics evaluation technology platforms. 公司主要提供健康人外周原代细胞、动员外周原代细胞、脐血原代细胞的分离及分选服务；免疫药效实验材料筛选服务；承接免疫学体内外药效评价项目。通过先进的研发生产技术及完善的质量管理体系，真正做到细胞生产及药效服务各环节的全过程控制，为国内各生物制药及细胞治疗企业、CRO、CMO、CDMO、科研院所、生物技术公司等众多合作伙伴，提供高质量的产品和标准化的服务，助力中国生命科学研究领域的发展。 The company primarily provides isolation and sorting services for healthy donor-derived peripheral primary cells, mobilized peripheral primary cells, and umbilical cord blood primary cells; screening services for immunopharmacodynamics experimental materials; and undertakes immunology in vivo and in vitro pharmacodynamics evaluation projects. Through advanced research and development production techniques and a comprehensive quality management system, OriBiotech achieves full-process control in all aspects of cell production and pharmacodynamics services. It provides high-quality products and standardized services to numerous partners, including domestic biopharmaceutical and cellular therapy enterprises, CROs, CMOs, CDMOs, scientific research institutes, and biotechnology companies, contributing to the development of life science research in China.

Floor 1 & 3, Building 11, No. 88 Darwin Road, Pudong New Area, Shanghai Shanghai, Shanghai, 201203 China上海澳能生物技术有限公司（OriBiotech）总部位于上海张江药谷，在北京、上海、广州、成都均设有实验室及办事机构。自公司创建以来，秉持着以信誉为立身之本，从细节处着眼的精神，始终专注于肿瘤免疫及原代细胞领域，拥有一系列基于原代免疫细胞的临床前药物开发，以及体内体外药效评价技术平台。 Shanghai OriBiotech Co., Ltd., headquartered in Zhangjiang Pharmaceutical Valley in Shanghai, has laboratories and offices in Beijing, Shanghai, Guangzhou, and Chengdu. Since its inception, the company has adhered to the principles of credibility as its foundation and a focus on details, consistently specializing in the fields of tumor immunology and primary cells. It boasts a series of preclinical drug development platforms based on primary immune cells, as well as in vivo and in vitro pharmacodynamics evaluation technology platforms. 公司主要提供健康人外周原代细胞、动员外周原代细胞、脐血原代细胞的分离及分选服务；免疫药效实验材料筛选服务；承接免疫学体内外药效评价项目。通过先进的研发生产技术及完善的质量管理体系，真正做到细胞生产及药效服务各环节的全过程控制，为国内各生物制药及细胞治疗企业、CRO、CMO、CDMO、科研院所、生物技术公司等众多合作伙伴，提供高质量的产品和标准化的服务，助力中国生命科学研究领域的发展。 The company primarily provides isolation and sorting services for healthy donor-derived peripheral primary cells, mobilized peripheral primary cells, and umbilical cord blood primary cells; screening services for immunopharmacodynamics experimental materials; and undertakes immunology in vivo and in vitro pharmacodynamics evaluation projects. Through advanced research and development production techniques and a comprehensive quality management system, OriBiotech achieves full-process control in all aspects of cell production and pharmacodynamics services. It provides high-quality products and standardized services to numerous partners, including domestic biopharmaceutical and cellular therapy enterprises, CROs, CMOs, CDMOs, scientific research institutes, and biotechnology companies, contributing to the development of life science research in China.

Floor 3, building 11, No. 88 Darwin Road, Pudong New Area, Shanghai Shanghai, Shanghai, 201203 China上海澳能生物技术有限公司（OriBiotech）总部位于上海张江药谷，在北京、上海、广州、成都均设有实验室及办事机构。自公司创建以来，秉持着以信誉为立身之本，从细节处着眼的精神，始终专注于肿瘤免疫及原代细胞领域，拥有一系列基于原代免疫细胞的临床前药物开发，以及体内体外药效评价技术平台。 Shanghai OriBiotech Co., Ltd., headquartered in Zhangjiang Pharmaceutical Valley in Shanghai, has laboratories and offices in Beijing, Shanghai, Guangzhou, and Chengdu. Since its inception, the company has adhered to the principles of credibility as its foundation and a focus on details, consistently specializing in the fields of tumor immunology and primary cells. It boasts a series of preclinical drug development platforms based on primary immune cells, as well as in vivo and in vitro pharmacodynamics evaluation technology platforms. 公司主要提供健康人外周原代细胞、动员外周原代细胞、脐血原代细胞的分离及分选服务；免疫药效实验材料筛选服务；承接免疫学体内外药效评价项目。通过先进的研发生产技术及完善的质量管理体系，真正做到细胞生产及药效服务各环节的全过程控制，为国内各生物制药及细胞治疗企业、CRO、CMO、CDMO、科研院所、生物技术公司等众多合作伙伴，提供高质量的产品和标准化的服务，助力中国生命科学研究领域的发展。 The company primarily provides isolation and sorting services for healthy donor-derived peripheral primary cells, mobilized peripheral primary cells, and umbilical cord blood primary cells; screening services for immunopharmacodynamics experimental materials; and undertakes immunology in vivo and in vitro pharmacodynamics evaluation projects. Through advanced research and development production techniques and a comprehensive quality management system, OriBiotech achieves full-process control in all aspects of cell production and pharmacodynamics services. It provides high-quality products and standardized services to numerous partners, including domestic biopharmaceutical and cellular therapy enterprises, CROs, CMOs, CDMOs, scientific research institutes, and biotechnology companies, contributing to the development of life science research in China.

上海市浦东新区达尔文路88号11号楼1、3楼 上海, 上海, 201203 China上海澳能生物技术有限公司（OriBiotech）总部位于上海张江药谷，在北京、上海、广州、成都均设有实验室及办事机构。自公司创建以来，秉持着以信誉为立身之本，从细节处着眼的精神，始终专注于肿瘤免疫及原代细胞领域，拥有一系列基于原代免疫细胞的临床前药物开发，以及体内体外药效评价技术平台。 Shanghai OriBiotech Co., Ltd., headquartered in Zhangjiang Pharmaceutical Valley in Shanghai, has laboratories and offices in Beijing, Shanghai, Guangzhou, and Chengdu. Since its inception, the company has adhered to the principles of credibility as its foundation and a focus on details, consistently specializing in the fields of tumor immunology and primary cells. It boasts a series of preclinical drug development platforms based on primary immune cells, as well as in vivo and in vitro pharmacodynamics evaluation technology platforms. 公司主要提供健康人外周原代细胞、动员外周原代细胞、脐血原代细胞的分离及分选服务；免疫药效实验材料筛选服务；承接免疫学体内外药效评价项目。通过先进的研发生产技术及完善的质量管理体系，真正做到细胞生产及药效服务各环节的全过程控制，为国内各生物制药及细胞治疗企业、CRO、CMO、CDMO、科研院所、生物技术公司等众多合作伙伴，提供高质量的产品和标准化的服务，助力中国生命科学研究领域的发展。 The company primarily provides isolation and sorting services for healthy donor-derived peripheral primary cells, mobilized peripheral primary cells, and umbilical cord blood primary cells; screening services for immunopharmacodynamics experimental materials; and undertakes immunology in vivo and in vitro pharmacodynamics evaluation projects. Through advanced research and development production techniques and a comprehensive quality management system, OriBiotech achieves full-process control in all aspects of cell production and pharmacodynamics services. It provides high-quality products and standardized services to numerous partners, including domestic biopharmaceutical and cellular therapy enterprises, CROs, CMOs, CDMOs, scientific research institutes, and biotechnology companies, contributing to the development of life science research in China.

1375 Huai Hai Zhong LuPCAS provides custom synthesis, intermediates, custom manufacturing, microelectrics, and protection additives.

Building 6, Lane 1999, Zhangheng Road, Pudong District, Shanghai Shanghai, SH, 201203 ChinaAt PeptiLand, we are dedicated to providing high-quality, comprehensive and tailored synthesis services for our global partners. Our services cover a full range of peptides (including linear peptides, cyclic peptides, peptide conjugates, modified peptides and other special structures) , as well as novel amino acids, which can accurately meet the diverse needs in different scenarios.

East T3-2 121 Longgui Road, Jinqiao Free Trade Zone Shanghai, Shanghai, 201201 ChinaPharmaLegacy provides preclinical in vivo pharmacology efficacy services as well a therapeutic antibody discovery service program. Our state-of-the-art platforms include • Pioneering work using CD34+ humanized mice that carry a human immune system, to test biologics for immuno-oncology therapeutic efficacy • An NHP platform for therapeutic biologics testing in a variety of immune diseases • An advanced antibody discovery platform based on single B cell antibody sequencing • An internationally recognized Bone/Orthopaedics platform to test both hard tissue disease therapeutic candidates and medical devices We have over 300 clinically predictive animal disease models to evaluate pharmacological effects of drug candidates in the areas of inflammation/auto-Immune diseases, lung injury, liver/metabolic diseases and oncology. Our NHP platform and CD34+ humanized mice models have helped dozens of clients with IND filings to both FDA and CFDA (China) for their therapeutic biologics candidates in a variety of immune disease and oncology. Our animal vivarium is fully accredited by AAALAC and houses species ranging from rodents, rabbits and other small animals to NHP.

Building 7, 388 Jialilue Road Zhangjiang High-Tech Park Shanghai, 201203 ChinaPharmaLegacy provides preclinical in vivo pharmacology efficacy services as well a therapeutic antibody discovery service program. Our state-of-the-art platforms include • Pioneering work using CD34+ humanized mice that carry a human immune system, to test biologics for immuno-oncology therapeutic efficacy • An NHP platform for therapeutic biologics testing in a variety of immune diseases • An advanced antibody discovery platform based on single B cell antibody sequencing • An internationally recognized Bone/Orthopaedics platform to test both hard tissue disease therapeutic candidates and medical devices We have over 300 clinically predictive animal disease models to evaluate pharmacological effects of drug candidates in the areas of inflammation/auto-Immune diseases, lung injury, liver/metabolic diseases and oncology. Our NHP platform and CD34+ humanized mice models have helped dozens of clients with IND filings to both FDA and CFDA (China) for their therapeutic biologics candidates in a variety of immune disease and oncology. Our animal vivarium is fully accredited by AAALAC and houses species ranging from rodents, rabbits and other small animals to NHP.

2nd Floor, Building 1B No. 528 RuiQing Road PuDong Shanghai 201201 P.R. of ChinaPharmaResources is a publicly listed CRO/CDMO company headquartered in Shanghai. We are a one-stop service provider of small molecules for new drug discovery, development and manufacturing. Currently we have around 1000 employees, focusing on medicinal chemistry, process development, DMPK, pharmaceutical researching and GMP manufacturing.

528 Ruiqing Road Building SA Pudong, Shanghai, 201201 ChinaPharmaResources is a publicly listed CRO/CDMO company headquartered in Shanghai. We are a one-stop service provider of small molecules for new drug discovery, development and manufacturing. Currently we have around 1000 employees, focusing on medicinal chemistry, process development, DMPK, pharmaceutical researching and GMP manufacturing.

Building 7, No. 509 Ren Qing Rd, Pudong, Shanghai Shanghai, Shanghai, 201201 ChinaPharmaResources is a publicly listed CRO/CDMO company headquartered in Shanghai. We are a one-stop service provider of small molecules for new drug discovery, development and manufacturing. Currently we have around 1000 employees, focusing on medicinal chemistry, process development, DMPK, pharmaceutical researching and GMP manufacturing.

Building 12, No.59, Kaiqing Road, Shanghai, China Shanghai, Shanghai, 201201 ChinaPharmaResources is a publicly listed CRO/CDMO company headquartered in Shanghai. We are a one-stop service provider of small molecules for new drug discovery, development and manufacturing. Currently we have around 1000 employees, focusing on medicinal chemistry, process development, DMPK, pharmaceutical researching and GMP manufacturing.

No. 800 Bin-Hai 4th Road Hangzhou Bay New Zone Ningbo, 315336 ChinaPharmaron (Stock Code: 300759.SZ/3759.HK) is a leading fully integrated pharmaceutical service provider platform supporting the life science industry. Established in 2004, our firm commitment to excellence is exemplified by the continuous investment in our highly skilled team and 20 state-of-the-art facilities, ensuring excellent quality throughout our operations. As an integrated service provider, Pharmaron seamlessly supports clients from Discovery to Market, offering a comprehensive suite of services for the entire drug discovery, preclinical, clinical development, and manufacturing continuum. Our commitment extends across diverse therapeutic modalities, encompassing small molecules, biologics, medical devices and cell and gene therapy products. Boasting a global presence with over 21,000 skilled professionals and operational hubs in China, the U.S., and the U.K., we have consistently delivered innovative solutions. Our partner’s success is our mission. Supporting the development and successful approval of medicines for the patients Key highlights of Pharmaron’s diverse service capabilities: • Synthetic, medicinal and analytical chemistry • in vitro and in vivo Biology • ADME/DMPK • In vivo Pharmacology • Drug safety assessment • Recombinant protein expression, purification and characterization • Custom antibody expression • Biophysical screening • Radiochemistry and isotopically labelled metabolism • Chemical & pharmaceutical development • Process Chemistry & GMP API synthesis • GMP Formulation preparation • Clinical Pharmacology • GMP API Manufacturing • Clinical Trials • GMP Drug product manufacturing • Clinical development, including applications of 14C microtracer AMS technology • Plasmid and AAV Manufacturing • Analytical Services • Cell and Gene Therapy preclinical services (IND package) • Biologics and Biosimilars Manufacturing • ADC • Ophthalmology preclinical development services (small molecule, CGT and medical device) • Clinical Trials

No. 638, Xiushan Road (E.) Haimen District Nantong City, Jiangsu, 226100 ChinaPHT International is a 32-year-old, woman-owned, minority business headquartered here in Charlotte. We specialize in the supply of fine chemicals and intermediates to industries including cosmetics, personal care, polymers, industrial applications, and pharmaceuticals. Our global supply capabilities include in-house production at our facilities in China, joint ventures in China and India, and partnerships with select manufacturers that provide advanced fine chemical technologies.

Room 1109, Oriental International Plaza No. 85, LouShan Guan Rd. Shanghai, China, 200336 ChinaPHT International is a 32-year-old, woman-owned, minority business headquartered here in Charlotte. We specialize in the supply of fine chemicals and intermediates to industries including cosmetics, personal care, polymers, industrial applications, and pharmaceuticals. Our global supply capabilities include in-house production at our facilities in China, joint ventures in China and India, and partnerships with select manufacturers that provide advanced fine chemical technologies.

288 Shiyuan Road Shanghai, Shanghai, 201612 ChinaPony Biomedical Technology (Shanghai) Co., Ltd (hereinafter referred to as Pony Medicine) now has two major business base in both Beijing and Shanghai equipped with over 40000 ㎡ laboratory. We are a comprehensive technical service platform integrating drug design, drug synthesis, synthesis process development, drug activity screening, preparation research, pharmacodynamic evaluation, pharmacokinetic evaluation, toxicological evaluation and new drug registration. And we’ve been qualified with CMA, CNAS, GMP and GLP, as well as widely recognized by national drug ministries and commissions at home and overseas. Nowadays, the core R&D personnel of the laboratory are all overseas doctors with many years’ research and development experience in large international pharmaceutical enterprises and CROs, and senior professionals in the domestic drugs, who are engaged in and have accumulated rich R&D and industrialization experience in multi-chiral-center drug synthesis, multi-step drug synthesis, slow and controlled release preparation technology, liposome technology, nano preparation technology, low limit substance detection, unknown substance detection, pharmacodynamics & pharmacokinetics, preclinical toxicological safety evaluation, etc. The research fields involve drugs on tumor, cardiovascular, cerebrovascular, hypertension, infection, digestive system, mental and nervous system, etc.

1698 Wangyuan Road, Building 11 Shanghai , Shanghai, 201499 ChinaPredicine is a global molecular insights company committed to advancing precision medicine in oncology and infectious disease diagnostics. Predicine is developing proprietary technologies for cell-free DNA and cell-free RNA liquid biopsy to enable minimally invasive molecular diagnoses for early cancer detection, treatment selection, therapy response, minimal residual disease monitoring, and disease progression. The Predicine portfolio includes blood, urine, and tissue based NGS assays designed for globally harmonized use in research, clinical investigation, and companion diagnostic (CDx) development. Through its business operations in Silicon Valley, Houston, Chicago and Shanghai, Predicine is partnering and collaborating with leading biopharma companies, institutions, and governments to support personalized healthcare on a global scale. Further information is available on the company websites, http://www.predicine.com. Stay in touch on LinkedIn or @Predicine on Twitter.

Room 601, CENTRAL TOWERS 567 Lan Gao Road Shanghai, 200333 Princeton Instruments (PI) designs and manufactures high-performance CCD, ICCD, EMCCD, emICCD, and InGaAs cameras; spectrographs; and optics-based solutions for the scientific research, industrial imaging, and OEM communities. We take pride in partnering with our customers to solve their most challenging problems in unique, innovative ways. PI operates as a unit of Roper Technologies, a diversified growth company and a constituent of the S&P 500, Fortune 1000, and Russell 1000 indices. Roper provides engineered products and solutions for global niche markets, including water, energy, transportation, medical, education, and SaaS-based information networks. Princeton Instruments has two U.S. manufacturing facilities, one located in New Jersey (Trenton) and one in Massachusetts (Acton). Our worldwide sales and service organizations in Germany, France, the United Kingdom, Japan, China, and Singapore provide sales support and discuss application requirements in addition to being your local contacts for order processing and service. Capabilities: Princeton Instruments possesses core technological capabilities in several key areas: Scientific Imaging: High-performance CCD, ICCD, EMCCD, emICCD, and InGaAs cameras for an expansive range of applications, including astronomy, BEC, combustion, PIV, single-molecule imaging, surface and materials analysis, PSP, and nanotechnology. Spectroscopy: A wide selection of state-of-the-art CCD cameras, spectrographs, monochromators, and integrated systems for Raman, LIBS, absorption, fluorescence, NIR/SWIR, and luminescence spectroscopy. X-ray Imaging: Advanced scientific-grade CCD cameras for x-ray applications such as EUV, lithography, XRS, plasma, diffraction, microscopy, and tomography. Optics & Coatings:

6055 Jinhai Highway , Building 35, Floor 8, Fengxian Shanghai, Shanghai, 201499 ChinaPrisys Biotechnologies Co., Ltd. is a leading biotech-CRO based in Shanghai, China. In addition to our superior Drug Efficacy & Safety services in Nonhuman Primates (NHP) and lower species, we are offering a novel translational research platform to the new drug R&D industry, with the following major features: • An integrated platform combining preclinical research, medical sciences, animal experiment technologies, animal breeding etc., for the one-of-a-kind solution for drug efficacy & safety assessment. • A rich library of novel NHP disease models, covering multiple fields such as immunology, metabolism, cardiovascular, respiratory, kidney, liver, neurology, ophthalmology, etc., • Advanced in vivo l imaging technologies, including PET/CT, MRI, DR, ultrasound, etc., with full capabilities of imaging sequences and analytical diagnosis • Clinical equivalent surgical operation with integrated radio-intervention (digital subcontracting angiography, DSA) capability. • Independent disease research department including technologies specialized for NHP pulmonary, cardiovascular, CNS-related, metabolic, infectious, ophthalmic diseases. • High standard animal welfare enrichment programs and systemic innovation, including active IACUC+OHSP, constant 3R practices, luxury housing & rich enrichment options for experimental animals, etc. Our track record of success in the past decade proved we are a reliable partner for drug translational R&D, during both preclinical & early-clinical stages. We have extensive experiences collaborating with oversea pharmaceutical and biotech researchers. Please don’t hesitate to contact us to learn more or get a cost-effective quotation for your study: Email: jane.liu@ prisysbiotech.com bd@prisysbiotech.com Phone: +86-21-5043-5616 Website: www.prisysbiotech.com

kangyuan road, No. 777 Xiangcheng Suzhou , Jiangsu, 215100 ChinaRaffles Pharmatech is a leading provider of advanced chemical development and manufacturing services. We specialise in delivering high-quality intermediates RSMs, APIs and custom chemicals to support the pharmaceutical and speciality chemicals industries from concept through to commercialisation. With state-of-the-art facilities and a commitment to innovation, Raffles Pharmatech partners with companies globally. Our expert team of ~300 dedicated staff, combined with our cutting-edge technology, ensures precision, reliability, and efficiency in every stage of chemical development and production. We take pride in our flexibility and customer-focused approach, making us a trusted partner in the industry. We operate three sites, two research centres and a cGMP manufacturing site, with modern equipment and a wide range of capabilities, and the capacity to supply hundreds of tons per annum. Specialities include chiral molecules, challenging heterocycles and cryogenic processing. Why Choose Raffles Pharmatech? - Proven Track Record – Trusted by global pharma and biotech companies for reliable delivery of complex projects (we can connect you with some of our customers who are happy to provide a reference about their experience in working with us). - End-to-End Support – From route scouting and process development to scale-up and commercial supply. - Speed & Flexibility – Agile operations that adapt quickly to project needs, ensuring on-time delivery. - Quality Assurance – cGMP-compliant manufacturing with robust QC/QA systems. - Innovation-Driven – Strong R&D teams tackling the most challenging chemistries. - Sustainability Focus – Commitment to safe operations and environmentally responsible practices. - Global Mindset – International customer base with seamless communication and project management.

2nd Floor, 1999 Jinxiu Rd E Shanghai, Pudong, 201206 ChinaScientist.com is the world’s largest marketplace for medical research. We help pharmaceutical scientists discover life-saving medicines in less time and at lower cost. Our mission is to make it possible to cure all human disease by 2050. By connecting scientists and enabling them to exchange ideas and transact seamlessly online, Scientist.com is speeding up and reducing the cost of medical research. We were founded in 2007, launched our first research outsourcing marketplace in 2008 and built our first enterprise marketplace for Pfizer in 2009. Today, we operate enterprise marketplaces for 24 of the world’s top 30 pharmaceutical companies, 100+ biotechnology companies and the US National Institutes of Health (NIH).

Room 229, Building 26, No. 1333 Xinlong Road Minhang District, Shanghai, 201101 ChinaScientist.com is the world’s largest marketplace for medical research. We help pharmaceutical scientists discover life-saving medicines in less time and at lower cost. Our mission is to make it possible to cure all human disease by 2050. By connecting scientists and enabling them to exchange ideas and transact seamlessly online, Scientist.com is speeding up and reducing the cost of medical research. We were founded in 2007, launched our first research outsourcing marketplace in 2008 and built our first enterprise marketplace for Pfizer in 2009. Today, we operate enterprise marketplaces for 24 of the world’s top 30 pharmaceutical companies, 100+ biotechnology companies and the US National Institutes of Health (NIH).

Rm. B609-611 SanNuoYa Mansion No. 1759 Jinshajiang Rd. Putuo District, Shanghai, P.R.C ChinaScientist.com is the world’s largest marketplace for medical research. We help pharmaceutical scientists discover life-saving medicines in less time and at lower cost. Our mission is to make it possible to cure all human disease by 2050. By connecting scientists and enabling them to exchange ideas and transact seamlessly online, Scientist.com is speeding up and reducing the cost of medical research. We were founded in 2007, launched our first research outsourcing marketplace in 2008 and built our first enterprise marketplace for Pfizer in 2009. Today, we operate enterprise marketplaces for 24 of the world’s top 30 pharmaceutical companies, 100+ biotechnology companies and the US National Institutes of Health (NIH).

Niudun Rd. No. 200 Pudong New District Shanghai, 201203 China

Suite 8B-C, No.1 Building Huanxian Plaza NO. 515 Yishan Road Shanghai 200235 ChinaRndchem offers custom synthesis, reference compound synthesis, quality control, building block libraries, and drug candidates.

Xinqiao Development ZoneRongda Pharm & Chem Co supplies API and intermediates and provides custom manufacturing services.

Shanghai, Shanghai ChinaRuiyi Medical Tech offers intermediates, custom synthesis, and raw material products and services.

266, HanKou Road, SailTower 18F, Huangpu District Shanghai 200001, ChinaRUNDO-CRONOVA offers clinical trial management, statistics services, regulatory affairs, and consulting.

No.182,South Yuelong Rd. DigitalTower 12F, Chongchuan District, Nantong 226004,ChinaRUNDO-CRONOVA offers clinical trial management, statistics services, regulatory affairs, and consulting.

上2nd Floor, Building 11, Lane 118, Furonghua Road, Pudong New Area, Shanghai 2nd Floor, Building 11, Lane 118, Furonghua Road, Pudong New Area, Shanghai PUDONGXINGQU, Shanghi, 201315 ChinaShanghai Sailybio  medical Co.,Ltd., formerly known as Shanghai Sailybio Biotechnology Co., Ltd., and Shanghai Xuanfeng Biotechnology Co., Ltd., is committed to promoting the development of the global pharmaceutical industry after strategic upgrading and adjustment in 2024. Since its establishment in 2015, we have always adhered to the mission of "continuously creating higher value for customers and employees", serving the field of innovative drug research and development, and striving to become a global competitive pharmaceutical enterprise service provider. The company has built more than 1,000 square meters of R&D laboratories, and has a biomedical R&D and clinical project management team with rich industry experience, which can provide industry customers with professional and regulatory requirements for primary cell preparation and separation, preclinical druggability evaluation, clinical project services, and reagent consumables services. With the continuous expansion of business and continuous innovation of technology, we have carried out strategic upgrading and adjustment in 2024 and officially changed our name to Shanghai Sailybio  medical Co.,Ltd., This strategic realignment not only marks the further expansion of our business areas, but also our commitment to provide customers with higher quality services. The company's history is as follows: In May 2015, Shanghai Sailybio Biotechnology Co., Ltd. was established. In May 2016, Shanghai Xuanfeng Biotechnology Co., Ltd. was established. In 2017, it provided human peripheral blood mononuclear cell isolation services in the industry. In 2019, it established a clinical service team to provide services such as clinical trial application, approval and management, and joined the Chinese Society of Cell Biology. In 2020, it obtained the record certificate of Shanghai Pathogenic Microbiology Laboratory and won the Shanghai High-tech Enterprise. In 2021, a technical service platform will be established to provide in vitro efficacy function verification services. In 2022, Shanghai Sailybio Biotechnology Co., Ltd. passed GB/T 19001-2016/ISO 9001:2015 quality system certification. 2024 Obtained laboratory animal license. In 2024, the company will be strategically upgraded and adjusted, and the company's business will be fully transferred to Shanghai Sailybio  medical Co.,Ltd. to continue to provide excellent services to everyone.

上海市浦东新区芙蓉花路118弄11幢2层 2nd Floor, Building 11, Lane 118, Furonghua Road, Pudong New Area, Shanghai 浦东新区, 上海, 201315 ChinaShanghai Sailybio  medical Co.,Ltd., formerly known as Shanghai Sailybio Biotechnology Co., Ltd., and Shanghai Xuanfeng Biotechnology Co., Ltd., is committed to promoting the development of the global pharmaceutical industry after strategic upgrading and adjustment in 2024. Since its establishment in 2015, we have always adhered to the mission of "continuously creating higher value for customers and employees", serving the field of innovative drug research and development, and striving to become a global competitive pharmaceutical enterprise service provider. The company has built more than 1,000 square meters of R&D laboratories, and has a biomedical R&D and clinical project management team with rich industry experience, which can provide industry customers with professional and regulatory requirements for primary cell preparation and separation, preclinical druggability evaluation, clinical project services, and reagent consumables services. With the continuous expansion of business and continuous innovation of technology, we have carried out strategic upgrading and adjustment in 2024 and officially changed our name to Shanghai Sailybio  medical Co.,Ltd., This strategic realignment not only marks the further expansion of our business areas, but also our commitment to provide customers with higher quality services. The company's history is as follows: In May 2015, Shanghai Sailybio Biotechnology Co., Ltd. was established. In May 2016, Shanghai Xuanfeng Biotechnology Co., Ltd. was established. In 2017, it provided human peripheral blood mononuclear cell isolation services in the industry. In 2019, it established a clinical service team to provide services such as clinical trial application, approval and management, and joined the Chinese Society of Cell Biology. In 2020, it obtained the record certificate of Shanghai Pathogenic Microbiology Laboratory and won the Shanghai High-tech Enterprise. In 2021, a technical service platform will be established to provide in vitro efficacy function verification services. In 2022, Shanghai Sailybio Biotechnology Co., Ltd. passed GB/T 19001-2016/ISO 9001:2015 quality system certification. 2024 Obtained laboratory animal license. In 2024, the company will be strategically upgraded and adjusted, and the company's business will be fully transferred to Shanghai Sailybio  medical Co.,Ltd. to continue to provide excellent services to everyone.

上海市浦东新区芙蓉花路118弄11幢2层 浦东新区, 上海, 201315 ChinaShanghai Sailybio  medical Co.,Ltd., formerly known as Shanghai Sailybio Biotechnology Co., Ltd., and Shanghai Xuanfeng Biotechnology Co., Ltd., is committed to promoting the development of the global pharmaceutical industry after strategic upgrading and adjustment in 2024. Since its establishment in 2015, we have always adhered to the mission of "continuously creating higher value for customers and employees", serving the field of innovative drug research and development, and striving to become a global competitive pharmaceutical enterprise service provider. The company has built more than 1,000 square meters of R&D laboratories, and has a biomedical R&D and clinical project management team with rich industry experience, which can provide industry customers with professional and regulatory requirements for primary cell preparation and separation, preclinical druggability evaluation, clinical project services, and reagent consumables services. With the continuous expansion of business and continuous innovation of technology, we have carried out strategic upgrading and adjustment in 2024 and officially changed our name to Shanghai Sailybio  medical Co.,Ltd., This strategic realignment not only marks the further expansion of our business areas, but also our commitment to provide customers with higher quality services. The company's history is as follows: In May 2015, Shanghai Sailybio Biotechnology Co., Ltd. was established. In May 2016, Shanghai Xuanfeng Biotechnology Co., Ltd. was established. In 2017, it provided human peripheral blood mononuclear cell isolation services in the industry. In 2019, it established a clinical service team to provide services such as clinical trial application, approval and management, and joined the Chinese Society of Cell Biology. In 2020, it obtained the record certificate of Shanghai Pathogenic Microbiology Laboratory and won the Shanghai High-tech Enterprise. In 2021, a technical service platform will be established to provide in vitro efficacy function verification services. In 2022, Shanghai Sailybio Biotechnology Co., Ltd. passed GB/T 19001-2016/ISO 9001:2015 quality system certification. 2024 Obtained laboratory animal license. In 2024, the company will be strategically upgraded and adjusted, and the company's business will be fully transferred to Shanghai Sailybio  medical Co.,Ltd. to continue to provide excellent services to everyone.

3rd Floor,Building 6B-C,No.188 Xinjunhuan Road,Minhang District Shanghai, 201114 ChinaSanyou Biopharmaceuticals is a world-leading high-tech biotechnology enterprise specialising in the R&D and services of innovative biologic drugs. Guided by the mission to make the R&D easy for innovative biologics, Sanyou Bio has developed the 4C business model, which integrates - Differentiated CRO (Contract Research Organization) - Integrated CDO (Contract Development Organization) - Innovative CPO (Contract Project Organization) - Characteristic CRS (Core Reagent Solution) Sanyou Bio operates an integrated, state-of- the art biologic drug R&D laboratory supported by a professional team where the majority hold advanced degrees (Ph.D. or Masters). The company has developed three cutting edge technology platforms: - Super-trillion phage display platform (core innovation), - Integration (streamlining drug discovery processes), and - Intelligence (data-driven R&D optimisation) These platforms include over 50 sub-platforms covering material preparation, biologics discovery, molecule optimisation, in vitro and in vivo efficacy studies, production cell line construction, upstream and downstream process development, preclinical R&D, industrialisation. As a leading provider of reagents and R&D services for innovative biologics, Sanyou Bio offers comprehensive drug discovery, development, and manufacturing solutions tailored to meet diverse customer needs. Comprehensive Services: Antibody Services: - Custom antibodies - Antibody production - Antibody purification . Antibody modification - Antibody engineering (e.g. humanisation) - Antibody discovery - Monoclonal - Polyclonal - Bi-specifics antibodies - Nanobody - Antibody drug conjugates Protein and Antigen Services: - Protein production - Protein expression - Antigen synthesis Gene and Molecular Engineering: - Phage display - Plasmid construction - Gene synthesis Cell Line Development: - Overexpression cell lines - Reporter cell lines - CHO expression system - HEK expression system - Minipool - Monoclonal cell line construction Recombinant and specialised products - ScFv - IgG - IgM - VHH - His tag For more information, please visit: https://www.sanyoubio.com

3rd Floor,Building 6B-C,No.188 Xinjunhuan Road Minhang District, 201114 ChinaSanyou Biopharmaceuticals is a world-leading high-tech biotechnology enterprise specialising in the R&D and services of innovative biologic drugs. Guided by the mission to make the R&D easy for innovative biologics, Sanyou Bio has developed the 4C business model, which integrates - Differentiated CRO (Contract Research Organization) - Integrated CDO (Contract Development Organization) - Innovative CPO (Contract Project Organization) - Characteristic CRS (Core Reagent Solution) Sanyou Bio operates an integrated, state-of- the art biologic drug R&D laboratory supported by a professional team where the majority hold advanced degrees (Ph.D. or Masters). The company has developed three cutting edge technology platforms: - Super-trillion phage display platform (core innovation), - Integration (streamlining drug discovery processes), and - Intelligence (data-driven R&D optimisation) These platforms include over 50 sub-platforms covering material preparation, biologics discovery, molecule optimisation, in vitro and in vivo efficacy studies, production cell line construction, upstream and downstream process development, preclinical R&D, industrialisation. As a leading provider of reagents and R&D services for innovative biologics, Sanyou Bio offers comprehensive drug discovery, development, and manufacturing solutions tailored to meet diverse customer needs. Comprehensive Services: Antibody Services: - Custom antibodies - Antibody production - Antibody purification . Antibody modification - Antibody engineering (e.g. humanisation) - Antibody discovery - Monoclonal - Polyclonal - Bi-specifics antibodies - Nanobody - Antibody drug conjugates Protein and Antigen Services: - Protein production - Protein expression - Antigen synthesis Gene and Molecular Engineering: - Phage display - Plasmid construction - Gene synthesis Cell Line Development: - Overexpression cell lines - Reporter cell lines - CHO expression system - HEK expression system - Minipool - Monoclonal cell line construction Recombinant and specialised products - ScFv - IgG - IgM - VHH - His tag For more information, please visit: https://www.sanyoubio.com

Floor 2, Building T3, No.559, Zhuyuan Road Minhang District Shanghai, 201112 ChinaSanyou Biopharmaceuticals is a world-leading high-tech biotechnology enterprise specialising in the R&D and services of innovative biologic drugs. Guided by the mission to make the R&D easy for innovative biologics, Sanyou Bio has developed the 4C business model, which integrates - Differentiated CRO (Contract Research Organization) - Integrated CDO (Contract Development Organization) - Innovative CPO (Contract Project Organization) - Characteristic CRS (Core Reagent Solution) Sanyou Bio operates an integrated, state-of- the art biologic drug R&D laboratory supported by a professional team where the majority hold advanced degrees (Ph.D. or Masters). The company has developed three cutting edge technology platforms: - Super-trillion phage display platform (core innovation), - Integration (streamlining drug discovery processes), and - Intelligence (data-driven R&D optimisation) These platforms include over 50 sub-platforms covering material preparation, biologics discovery, molecule optimisation, in vitro and in vivo efficacy studies, production cell line construction, upstream and downstream process development, preclinical R&D, industrialisation. As a leading provider of reagents and R&D services for innovative biologics, Sanyou Bio offers comprehensive drug discovery, development, and manufacturing solutions tailored to meet diverse customer needs. Comprehensive Services: Antibody Services: - Custom antibodies - Antibody production - Antibody purification . Antibody modification - Antibody engineering (e.g. humanisation) - Antibody discovery - Monoclonal - Polyclonal - Bi-specifics antibodies - Nanobody - Antibody drug conjugates Protein and Antigen Services: - Protein production - Protein expression - Antigen synthesis Gene and Molecular Engineering: - Phage display - Plasmid construction - Gene synthesis Cell Line Development: - Overexpression cell lines - Reporter cell lines - CHO expression system - HEK expression system - Minipool - Monoclonal cell line construction Recombinant and specialised products - ScFv - IgG - IgM - VHH - His tag For more information, please visit: https://www.sanyoubio.com

11#-502, Lane 299, Bisheng Rd., Zhangjiang High-Tech Park Shanghai, 201204 ChinaSeebio Biotech provides a variety of custom services, including literature research, route design, process development and optimization, intermediate synthesis, pilot test and scale-up production, contract manufacture of special chemicals, and other technical services and supplies biochemical, diagnostic, and molecular biology reagents.

240# Hedan Road, Waigaoqiao Free Trade Zone, Shanghai, China Shanghai, Shanghai, 200131 ChinaSequanta Technologies is a leading multi-omics research and clinical service provider in China, focusing on genomics, proteomics and related services to support pharmaceutical clients in biomarker discovery and clinical trials. Sequanta provides diversified genomics and proteomics assays validated by research standard and CAP standard, which include genotyping and gene expression qPCR assays, NGS assays and protein biomarker detection assays. The featured assays include Foundation One CDx, Illumina TSO500 assay for tissue and ctDNA, Single cell solutions, Olink Flex, Target 48/96 and Explore 384/3072 assays, whole genome and whole exome sequencing, meta-genome , mRNA and smRNA sequencing, , etc. Customized panels are also available based on specific project needs.

2277 Longyang Road, Unit 305 Yongda International Plaza Pudong Shanghai, CHINA 201204

1st Building, No.299, Kangwei Road Pudong District Shanghai, 201315 ChinaSGS helps pharmaceutical, biopharmaceutical, and medical device companies by providing services along the entire drug development pathway. As a global contract research organization, our global Health Science team provides integrated solutions from preclinical activities to Phase I-IV clinical trials, bioanalytical, pharmaceutical development, biologics characterization, biosafety, and quality control testing of small and large molecules, raw materials, containers and finished products. In an ever-changing world, with technological change reaching breakneck speed, SGS helps navigate the sometimes complex process to successfully deliver high quality, safe and medical devices to market. SGS boasts a wealth of global health science expertise. We will support you every step of the way as you deliver first-class, fully compliant biopharmaceutical, pharmaceutical and medical device products. Our expert staff is trained to the highest standards and has an in-depth knowledge of their fields and your business needs.

3rd Building, No.889 Yishan Road, Xuhui District Shanghai, 200233 ChinaSGS helps pharmaceutical, biopharmaceutical, and medical device companies by providing services along the entire drug development pathway. As a global contract research organization, our global Health Science team provides integrated solutions from preclinical activities to Phase I-IV clinical trials, bioanalytical, pharmaceutical development, biologics characterization, biosafety, and quality control testing of small and large molecules, raw materials, containers and finished products. In an ever-changing world, with technological change reaching breakneck speed, SGS helps navigate the sometimes complex process to successfully deliver high quality, safe and medical devices to market. SGS boasts a wealth of global health science expertise. We will support you every step of the way as you deliver first-class, fully compliant biopharmaceutical, pharmaceutical and medical device products. Our expert staff is trained to the highest standards and has an in-depth knowledge of their fields and your business needs.

Buiding 8 439 Chunxiao Road Zhangjiang, Pudong Shanghai 201203 ChinaShanghai Ambrosia provides drug assay development services, focusing on cancer and immune system diseases.

Shanghai Pudong New Area, Jinke Road 3577 model organism floor (Lab)Founded in September 2000, is the first specialized in the development and application of transgenic and gene knockout technology companies, we are committed to provide customers with professional and efficient service model organism technology, and strive to build a national brand, to become influential in the world force of life science products and service providers. The company is the national "863" program biotechnology animal models of disease R & D base, high-tech enterprises in Shanghai, Shanghai Engineering Research Center for animal models, professional and technical services Shanghai model organisms internet. Shanghai South model organisms located in Shanghai Pudong Zhangjiang Hi-Tech Park. Companies adhere to the professional and technical personnel as the core, model organisms key technology as the leading development ideas, gathered a group of academic attainments deep, skilled scientific and technical personnel; have advanced equipment and facilities that can accommodate more than 150,000 mice the SPF grade animal room; from the establishment of cloning, transgenic or gene knockout plasmid into mouse embryonic stem cell manipulation, microinjection, genetics and breeding, genotyping, strains breeding, embryo cryopreservation, a phenotypic analysis testing series of genetically engineered mouse models of R & D, to achieve the target gene from transgenic or gene knockout mouse model phenotyping pipeline and then R & D model. The company's quality laboratory animals, animal welfare, biological attitude and level of safety management has been highly praised AAALAC Committee, in 2012 completely by AAALAC certification, and successfully passed the review. Since its establishment, it has established a total of more than 1500 kinds of genetically engineered mouse models; at home and abroad well-known universities, research institutes, hospitals, pharmaceutical companies to provide an efficient model organism professional and technical services . Domestic users covering 29 provinces and regions, overseas customers covering Asia, Europe, America and Australia.

Shanghai Pudong New Area Harley Road, Lane 898, Building 6, Room 312 (office) Shangahi ChinaFounded in September 2000, is the first specialized in the development and application of transgenic and gene knockout technology companies, we are committed to provide customers with professional and efficient service model organism technology, and strive to build a national brand, to become influential in the world force of life science products and service providers. The company is the national "863" program biotechnology animal models of disease R & D base, high-tech enterprises in Shanghai, Shanghai Engineering Research Center for animal models, professional and technical services Shanghai model organisms internet. Shanghai South model organisms located in Shanghai Pudong Zhangjiang Hi-Tech Park. Companies adhere to the professional and technical personnel as the core, model organisms key technology as the leading development ideas, gathered a group of academic attainments deep, skilled scientific and technical personnel; have advanced equipment and facilities that can accommodate more than 150,000 mice the SPF grade animal room; from the establishment of cloning, transgenic or gene knockout plasmid into mouse embryonic stem cell manipulation, microinjection, genetics and breeding, genotyping, strains breeding, embryo cryopreservation, a phenotypic analysis testing series of genetically engineered mouse models of R & D, to achieve the target gene from transgenic or gene knockout mouse model phenotyping pipeline and then R & D model. The company's quality laboratory animals, animal welfare, biological attitude and level of safety management has been highly praised AAALAC Committee, in 2012 completely by AAALAC certification, and successfully passed the review. Since its establishment, it has established a total of more than 1500 kinds of genetically engineered mouse models; at home and abroad well-known universities, research institutes, hospitals, pharmaceutical companies to provide an efficient model organism professional and technical services . Domestic users covering 29 provinces and regions, overseas customers covering Asia, Europe, America and Australia.

Shanghai, Shanghai ChinaShanghai Boyle Chemical Co. offers custom synthesis and supplies APIs and intermediates.

Rm 702A, B Block, Feng Lin International Center, No.388, Feng Lin Rd., Xuhui District Shanghai, shanghai, 200032 ChinaShanghai Centennial Scientific Ltd. is a premium market access and health economics consulting company in China established by top specialists including health economists, outcomes researchers, statisticians, and clinicians. - Extensive hospital and government KOLs network across China to enable a high-quality data collection, result dissemination, and real world application -Dedicated access to an EMR database (SuValue®) composed of 207+ hospitals nation wide covering over 101 million patient population - Provides high-quality after-project services including training and presentations to payers and KOLs at national clinical and reimbursement conference. -Leading expertise in health economics evidence generation where our interactive models have been presented/used by national and province level payers and KOLs -Numerous successful examples that our Interactive HE studies / models have supported 40+ products listing in NRDL and PRDL in China

Room 2310, Building E, PUFA Square, NO.1715, North Zhongshan Road Shanghai, Putuo 200061 ChinaShanghai CINMORE Chemical Co., Ltd supplies food ingredients and absorbents.

5F,20 Apartment,No.528,Rui Qing road, East ZhangJiang Technical Industrial Zone Shanghai, Pudong 201201 ChinaShanghai Claison Bio-tech Co., Ltd. is dedicated to discover, develop and market advanced biotechnologies. With the mission of “care for the life in science”, Claison focuses on the research and development of high-tech methods in cancer biotherapy. Our target is to accelerate the application of those technologies in cancer biotherapy and become the leader in this field.

No. 301 Wudian Road Shanghai, Pudong ChinaShanghai Clean Chemical Technology (SCCT) supplies fine chemicals such as ketones, carboxylic acids, esters, hydrocarbons, and alcohols

Shanghai, ChinaShanghai Crystal Day Biotech specializes in research and development as well as sale of ELISA kits and other reagents including antibodies and cell culture products.

F2, #5 building, 576 Libing Road Shanghai , 201203 ChinaShanghai De Novo Pharmatech Co., Ltd is a new drug discovery company focused on the research and development of novel small molecular drugs on the unmet diseases. The company was established in 2010, and located in Zhangjiang High-Tech Park, Pudong New Area Shanghai. With the help of the unique development environment and combined with the self advantages in pharmaceutical chemistry, analysis, formulation, biology, clinic and other aspects, the company is committed to the research and development of novel small molecular drugs. At present, there are nearly ten new molecular targeted drug and immuno-oncology drug candidates at different stages of development, the therapeutic areas including: cancer, anti-infective and metabolic disease.

Shanghai, Shanghai ChinaShanghai Eliv Pharmaceutical is a high-tech company which own proprietaryintellectual property rights with experience in intermediate to API production, analytical method development and impurity research.

Suite 602, 1011 Halley Road, Zhangjiang Hi-Tech Park, Shanghai 201203, ChinaShanghai GenePharma provides RNAi and vector-based RNAi construction services.

No.199 Dong Ping Street, Suzhou Industry Park, Suzhou 215125, ChinaShanghai GenePharma provides RNAi and vector-based RNAi construction services.

Shanghai, Shanghai ChinaShanghai GenePharma provides RNAi and vector-based RNAi construction services.

Shanghai, Shanghai ChinaShanghai genomePilot Technology offers microarray analysis, next generation sequencing, and bioinformatics services.

Suite 802, Building Kaili, 432 West Huaihai RD Shanghai, Shanghai, 200030 ChinaShanghai GenomSeqCare Biotechnology Co. Ltd is specialized in real world evidence (RWE) research support. It provides end to end digital solutions to RWE studies including data collection, data management, data integration and data analysis. RWE Box is their data platform for patient centric research.

No. 1150, Guiqiao Road, Pudong New Area Shanghai 201206 ChinaShanghai Hua Xin offers recombinant human products for treating cancer.

Building A18, 100 Dongting Lake Road, Linjiang Town, Haimen District, Jiangsu, 226100 ChinaInnoStar, established in 2010, is a leading contract research organization (CRO) dedicated to excellence in nonclinical and translational research. We deliver high-quality services, earn trust through our proven track record, drive value through technical innovation, and ensure efficiency through streamlined management. Our comprehensive services include Screening and discovery services, Nonclinical pharmacodynamics, Nonclinical pharmacokinetics, Nonclinical safety evaluation, Clinical sample bioanalysis, Biomarkers and translational research. InnoStar was proudly listed on the STAR Market of the Shanghai Stock Exchange on September 3, 2024 (Stock Code: 688710).

Shanghai, ChinaInnoStar, established in 2010, is a leading contract research organization (CRO) dedicated to excellence in nonclinical and translational research. We deliver high-quality services, earn trust through our proven track record, drive value through technical innovation, and ensure efficiency through streamlined management. Our comprehensive services include Screening and discovery services, Nonclinical pharmacodynamics, Nonclinical pharmacokinetics, Nonclinical safety evaluation, Clinical sample bioanalysis, Biomarkers and translational research. InnoStar was proudly listed on the STAR Market of the Shanghai Stock Exchange on September 3, 2024 (Stock Code: 688710).

Shanghai ChinaInnoStar, established in 2010, is a leading contract research organization (CRO) dedicated to excellence in nonclinical and translational research. We deliver high-quality services, earn trust through our proven track record, drive value through technical innovation, and ensure efficiency through streamlined management. Our comprehensive services include Screening and discovery services, Nonclinical pharmacodynamics, Nonclinical pharmacokinetics, Nonclinical safety evaluation, Clinical sample bioanalysis, Biomarkers and translational research. InnoStar was proudly listed on the STAR Market of the Shanghai Stock Exchange on September 3, 2024 (Stock Code: 688710).

439 Chunxiao Rd., Building No. 1Shanghai Innovative Research Center offers transcriptomics, proteomics, detection services, pharmodynamic research, and screening services.

555 Zu Chong Zhi Road , Zhang Jiang Hi-Tech Park, Pudong Shanghai 201203 ChinaSIMM's scientists elucidate the structural basis of bioactive substances, discover new drug targets and drug mechanisms of action and comprehensively evaluate drug candidate safety.

Shanghai, Shanghai ChinaSIMM's scientists elucidate the structural basis of bioactive substances, discover new drug targets and drug mechanisms of action and comprehensively evaluate drug candidate safety.

Shanghai, Shanghai ChinaShanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences (CAS) focuses on providing a comprehensive solution in drug discovery and development. By combining basic and applied research efforts and through cross-fostering between chemistry and biology, scientists at SIMM carry out studies toward the elucidation of the structural basis of bioactive substances, discovery of new targets or mechanisms of action, comprehensive pre-clinical evaluation of drug candidates, and promotion of commercialization, thereby playing an indispensable role in building China’s drug innovation capabilities.

Yue Yang Lu, , Shanghai Shi , CNShanghai Laboratory Animal Center, CAS (SLACCAS) serves also as the National Rodent Laboratory Animal Center, Shanghai Branch and the National Laboratory Rabbit Center. It was established in 1965 and joined SIBS in 2000. In 2001, SLACCAS was relocated to Jiuting, Songjiang District of Shanghai. SLACCAS is mainly engaged in preserving laboratory animal resources, supplying laboratory animals, monitoring animal qualities, conducting animal experimentations, developing animal resources, introducing and implementing comparative medical research on animal models and genetic engineering animals, as well as fostering technological and managerial professionals in the field of laboratory animals and providing technical services. SLACCAS follows the international standard for laboratory animal care, production and experimentation, and keeps a close tie with major internationally renowned laboratory animal centers. To provide better support for the life science research, SLACCAS is committed to become one of the best facilities for laboratory animal production as well as personnel training. In 2003, Shanghai SLAC laboratory Animal Co., Ltd. (SLAC) was established to commercialize laboratory animal production and supply. The establishment of SLAC has greatly increased the annual laboratory animal production. It also made significant progresses in many aspects, such as strain/stock, production scale, management, quality control, and technology innovation. At present SLACCAS has 128 staffs, of whom 10 are senior staff members, 23 intermediate level technicians. Total professional personnel are 45%. In recent 5 years, SLACCAS has undertaken over 20 national or local government-sponsored research projects with the total grants of 20 million Yuan RMB, received 4 awards for scientific and technological advancement, 12 patents and 3 other intellectual property rights. The current animal stock in SLACCAS has 150 laboratory animal strains. SLACCAS also produces 20 different kinds of animal feeds for special experiments. Each year, SLACCAS produces about 1.5 million mice accounting for 15% of the domestic market for laboratory animals with a sales volume of nearly 30 million Yuan RMB.

320 Yue Yang Road Shanghai, 200031 ChinaShanghai Laboratory Animal Center, CAS (SLACCAS) serves also as the National Rodent Laboratory Animal Center, Shanghai Branch and the National Laboratory Rabbit Center. It was established in 1965 and joined SIBS in 2000. In 2001, SLACCAS was relocated to Jiuting, Songjiang District of Shanghai. SLACCAS is mainly engaged in preserving laboratory animal resources, supplying laboratory animals, monitoring animal qualities, conducting animal experimentations, developing animal resources, introducing and implementing comparative medical research on animal models and genetic engineering animals, as well as fostering technological and managerial professionals in the field of laboratory animals and providing technical services. SLACCAS follows the international standard for laboratory animal care, production and experimentation, and keeps a close tie with major internationally renowned laboratory animal centers. To provide better support for the life science research, SLACCAS is committed to become one of the best facilities for laboratory animal production as well as personnel training. In 2003, Shanghai SLAC laboratory Animal Co., Ltd. (SLAC) was established to commercialize laboratory animal production and supply. The establishment of SLAC has greatly increased the annual laboratory animal production. It also made significant progresses in many aspects, such as strain/stock, production scale, management, quality control, and technology innovation. At present SLACCAS has 128 staffs, of whom 10 are senior staff members, 23 intermediate level technicians. Total professional personnel are 45%. In recent 5 years, SLACCAS has undertaken over 20 national or local government-sponsored research projects with the total grants of 20 million Yuan RMB, received 4 awards for scientific and technological advancement, 12 patents and 3 other intellectual property rights. The current animal stock in SLACCAS has 150 laboratory animal strains. SLACCAS also produces 20 different kinds of animal feeds for special experiments. Each year, SLACCAS produces about 1.5 million mice accounting for 15% of the domestic market for laboratory animals with a sales volume of nearly 30 million Yuan RMB.

800 Dongchuan Road, Shanghai, 200240 ChinaShanghai Jiao Tong University formerly the Nang Yang Public School was founded in 1896 and is one of the oldest universities in China.

Room 106, Building B, No. 8, Lane 1305, Huajing RoadShanghai Jinglan Chemical offers intermediate and API manufacturing services.

10F, Building A1, Xu Pu Road 2555, Zhangjiang Science City, Pudong New Area, Shanghai Shanghai , Shanghai , 200000 ChinaShanghai Kylinlab Biopartner Co., Ltd. specializes as a Contract Research Organization (CRO), driving forward research within the central nervous system (CNS). Our vision：Our vision is to explore the central nervous system (CNS) and establish ourselves as a leading international service company specializing in innovative solutions for brain health and intelligence. Our Mission：We are dedicated to conquering challenges, upholding integrity, fostering innovation, and enriching an open R&D and technology platform. Our goal is to advance the clinical translation of CNS drugs, bringing us closer to realizing the dream of developing effective treatments and benefiting more patients. Our Values：Prioritizing R&D Priority, Customers First, Emphasizing Technology Emphasis, Quality Focus We offer comprehensive CNS drug development services: - Target screening - Pharmacokinetic studies - Efficacy assessments - CNS safety pharmacology - Neurological mechanisms research - High-quality IND applications Since our establishment, we have successfully managed specialized experiments and IND applications for respected pharmaceutical companies. This work has helped us build a systematic and consistent CNS drug evaluation quality system. We continue to drive significant progress in neurological drug development as a reliable, innovative partner.

Shanghai, Shanghai ChinaShanghai LeadChem offers custom synthesis, pyridine derivatives, and synthetic perfumes.

789 Shennan Road, Xinzhuang Industry Park, Minhang District, Shanghai 201108 ChinaShanghai LeadChem offers custom synthesis, pyridine derivatives, and synthetic perfumes.

3F, BLDG 77-78, 887 Zuchongzhi RD, Zhangjiang Hi-Tech Park, Pudong New District Shanghai, 201203 ChinaLIDE is an award winning oncology contract research organization with 14 years of delivering preclinical drug evaluation services to over 200+ clients worldwide. LIDE offers traditional CRO services and has a collection of more than 2100 patient derived xenograft (PDX) models covering 50+ cancer types, of which 200+ are special drug resistant and/or genetically altered. LIDE's proprietary MiniPDX and IO-FIVE tools offer an evolved approach to drug r&d that maximizes budget efficiency and minimizes time to validation. LIDE differentiates itself from other CROs by continually conducting self-funded internal research of its immense tumor bio bank, and working with KOLs in the academic space to vigorously promote the development and application of translational medical research. We also adopt the highest international operational standards. The company owns AAALAC accredited SPF level Animal Centers, safety level 2 laboratories and world-class, state of the art equipment.

3F, BLDG 77-78, 887 Zuchongzhi RD Zhangjiang Hi-Tech Park, Pudong New District Shanghai, 201203 ChinaLIDE is an award winning oncology contract research organization with 14 years of delivering preclinical drug evaluation services to over 200+ clients worldwide. LIDE offers traditional CRO services and has a collection of more than 2100 patient derived xenograft (PDX) models covering 50+ cancer types, of which 200+ are special drug resistant and/or genetically altered. LIDE's proprietary MiniPDX and IO-FIVE tools offer an evolved approach to drug r&d that maximizes budget efficiency and minimizes time to validation. LIDE differentiates itself from other CROs by continually conducting self-funded internal research of its immense tumor bio bank, and working with KOLs in the academic space to vigorously promote the development and application of translational medical research. We also adopt the highest international operational standards. The company owns AAALAC accredited SPF level Animal Centers, safety level 2 laboratories and world-class, state of the art equipment.

F201,Buiding10,No.115,Lane1276,Nanle RoadShanghai Linc-Bio Science offers antibody products and ELISA kits in addition to custom antibody and cytobiology services.

Kangxin Gong Road, Pudong New Area, Shanghai International Medical Park Lane, Building 3, 3399, Shanghai, ChinaShanghai Megiddo Biological Pharmaceutical Co., Ltd. from the initial first-generation sequencing service started, gradually extended to high-throughput sequencing, bioinformatics service bioinformatics cloud computing, medical laboratory and bio-medicine. Under the current five subsidiaries: United States and Kyrgyzstan science and technology, information technology Sanger, Megiddo Medical Control, more than Chinese biomedical, Megiddo Institute. Where the United States and Kyrgyzstan are setting up experimental base in Shanghai, Beijing and Guangzhou, sales network throughout the country. Megiddo organism has first-class sequencing platform (HiSeq2500, HiSeq 4000, MiSeq, ABI 3730XL, ABI 7500) and advanced MS platforms (Q-Exactive, Triple TOF 5600, Obitrap Fusion, QTRAP 5500), specializes in genome sequencing, transcriptome sequencing, metagenomic sequencing, single-cell sequencing, sequencing of the target area, exon sequencing, high-throughput genome sequencing technology services and proteomics, metabolomics and other technical services, but also provides multi-omics solutions that meet various research demand. Megiddo biological building high-performance computing clusters (HPC), the Dell rack-mounted servers, blade servers and lustre parallel file system. Computing capacity of up 29.4Tflops, total memory size is 10TB, high-performance storage capacity of 2PB. For the storage, processing and subsequent analysis of massive biological data to provide a stable, efficient hardware support.

Kangxin Gong Road, Pudong New Area, Shanghai International Medical Park Lane, Building 3, 3399 Shanghai ChinaShanghai Megiddo Biological Pharmaceutical Co., Ltd. from the initial first-generation sequencing service started, gradually extended to high-throughput sequencing, bioinformatics service bioinformatics cloud computing, medical laboratory and bio-medicine. Under the current five subsidiaries: United States and Kyrgyzstan science and technology, information technology Sanger, Megiddo Medical Control, more than Chinese biomedical, Megiddo Institute. Where the United States and Kyrgyzstan are setting up experimental base in Shanghai, Beijing and Guangzhou, sales network throughout the country. Megiddo organism has first-class sequencing platform (HiSeq2500, HiSeq 4000, MiSeq, ABI 3730XL, ABI 7500) and advanced MS platforms (Q-Exactive, Triple TOF 5600, Obitrap Fusion, QTRAP 5500), specializes in genome sequencing, transcriptome sequencing, metagenomic sequencing, single-cell sequencing, sequencing of the target area, exon sequencing, high-throughput genome sequencing technology services and proteomics, metabolomics and other technical services, but also provides multi-omics solutions that meet various research demand. Megiddo biological building high-performance computing clusters (HPC), the Dell rack-mounted servers, blade servers and lustre parallel file system. Computing capacity of up 29.4Tflops, total memory size is 10TB, high-performance storage capacity of 2PB. For the storage, processing and subsequent analysis of massive biological data to provide a stable, efficient hardware support.

Shanghai, Shanghai ChinaShanghai Mankong Biotechnology specializes in manufacturing of bulk APIs, fine chemicals and plant extracts.

178号 Ban Xia Lu Shanghai Shi ChinaEstablished in 2021 in Texas, USA, GenoBioTX is committed to advancing life science research and drug discovery through cutting-edge model organisms, gene editing, and life-decoding technologies. As a subsidiary of Shanghai Model Organisms Center, we uphold the same high standards and credentials in delivering high-quality animal models and research services. Our Expertise: We specialize in developing genetically modified animal models, including: Humanized Mouse Models (e.g., immune checkpoint gene humanized models for antibody drug efficacy studies), Knockout, Knock-in, Transgenic, and Conditional Knockout Models Our Services: Customized Mouse Model Generation – Tailored genetic modifications to meet specific research needs CDX (Cell-Derived Xenograft) and PDX (Patient-Derived Xenograft) Mouse Models Phenotyping & Genotyping Services – Comprehensive analysis of genetic models PK/PD Study Services – Pharmacokinetics and pharmacodynamics research support Animal Breeding & Genotyping – Reliable colony management for long-term studies By leveraging our expertise, GenoBioTX aims to empower researchers with innovative tools for preclinical research and therapeutic development.

F3, Building 2, No. 178 Banxia Road, Pudong New Area Shanghai, 201308 ChinaEstablished in 2021 in Texas, USA, GenoBioTX is committed to advancing life science research and drug discovery through cutting-edge model organisms, gene editing, and life-decoding technologies. As a subsidiary of Shanghai Model Organisms Center, we uphold the same high standards and credentials in delivering high-quality animal models and research services. Our Expertise: We specialize in developing genetically modified animal models, including: Humanized Mouse Models (e.g., immune checkpoint gene humanized models for antibody drug efficacy studies), Knockout, Knock-in, Transgenic, and Conditional Knockout Models Our Services: Customized Mouse Model Generation – Tailored genetic modifications to meet specific research needs CDX (Cell-Derived Xenograft) and PDX (Patient-Derived Xenograft) Mouse Models Phenotyping & Genotyping Services – Comprehensive analysis of genetic models PK/PD Study Services – Pharmacokinetics and pharmacodynamics research support Animal Breeding & Genotyping – Reliable colony management for long-term studies By leveraging our expertise, GenoBioTX aims to empower researchers with innovative tools for preclinical research and therapeutic development.

Huan Ke Lu Shanghai Shi ChinaManufacturer of fluoro-aromatic chemicals and is specialized in Halogenation, Cyanation, Nitration, Hydroxylation, Amination and Carboxylation on the benzene and pyridine.

Room 408, No. 515 Huanke Road, Pudong, Shanghai, China Shanghai, 201203 ChinaManufacturer of fluoro-aromatic chemicals and is specialized in Halogenation, Cyanation, Nitration, Hydroxylation, Amination and Carboxylation on the benzene and pyridine.

NO.151,Libing Rd.,Zhangjiang Hi-Tech Park,Pudong New Area Shanghai 201203 ChinaShanghai Outdo Biotech offers tissue processing, tissue microarrays, and gene chips.

Shanghai, Shanghai ChinaShanghai Outdo Biotech offers tissue processing, tissue microarrays, and gene chips.

No151, Libing Rd Zhangjiang Hi-Tech Park, Pudong Shanghai, 201203 ChinaShanghai Outdo Biotech Co.Ltd. (Outdo Biotech) is a leading company in human/animal Tissue Microarrays (TMA) and “Clinical-Type” Gene Chip (CTGC) in China. Our shareholders are Shanghai Biochip Co., Ltd. & National Engineering Center for Biochip at Shanghai, Shanghai Cancer Institute and Eastern Liver and Bladder Hospital of Second Military Medical University. TMA is a mean of combining tens to hundreds of specimens of tissue, paraffin embedded or frozen, onto a single slide for analysis at once. Our construction of TMAs is flexible and helps meet the needs of our customers. A TMA slide is processed like an ordinary tissue section, and then used for histochemical, immuno-histochemical staining, in-situ hybridization and FISH. Combined with highly automated image analysis system, TMA is a high-throughput molecular profiling tool for parallel analysis of biological and molecular characteristics for specimens of pathological tissues. TMA technology also provides a platform for the efficient locating and evaluating of protein, RNA, DNA molecules in various tissues and is particularly useful for functional genomic studies. TMA is commonly used to confirm the results of expression Microarrays as well as in the development of diagnostic and prognostics markers for clinical applications. TMA makes use of vast amount of archived paraffin embedded tissue and makes them accessible for medical and academic research. TMA is playing an ever increasing role in translational medicine, bridging the gap of discovery at the research bench to clinical utility implementation in patient care. Our company now has three sets of newly developed high throughput tissue microarray products available such as Cat100, Cat.200 and Cat.500, including liver carcinoma, gastric carcinoma, lung carcinoma, esophagus carcinoma, kidney carcinoma, breast carcinoma, pancreas carcinoma and so on.We can design tissue microarrays according to the needs of customers with the tissue specimens provided by our tissue bank or the customers. We also has developed two CTGC products including HBV YMDD Mutation Detection Gene Array Kit for detection of patients with Lamivudine resistance and Interleukin-1B Mutation Detection Gene Array Kit for detection of hosts with H. pylori infection susceptibility to gastric cancer.

Shanghai Panqi Biochem Tech Co., Ltd.Shanghai Panqi Biochem Tech offers chiral analysis, NMR, optical rotation, custom synthesis, chromatography, and chemical compounds.

200 Tai Cang Rd. Shanghai 200020 ChinaShanghai Pharmaceutical provides custom manufacturing services.

4F 780 Cailun RoadShanghai Pharma Engine offers statistical analysis, validation, chromatography, spectrometry, regulatory affairs, and consulting.

Shanghai, Shanghai, 201318 China Shanghai Phoenix Pharmaceutical Technology Co., Ltd start up by a group of experienced research organic chemists from pharmaceutical industry in 2015 based in Shanghai, China. Phoenix Pharm focus on Inhibitor, Labeled compound, Impurity and Peptide synthesis; Cutting-edge API in-licensing and registration in China; Intermediate importing & exporting. Our mission is to provide superior quality products and services to pharmaceutical industries worldwide.

1278，Keyuan Rd,Shanghai ChinaShanghai Research Center for Model Organisms passed the complete verification of AAALAC the Experimental Animals International Verification Institution, which signals that Shanghai Research Center for Model Organisms has reached the world advanced level of protecting animals in a scientific and humane way in its researches on bioscience and medicine. AAALAC is an authorized international institution of evaluation and verification on feeding and employing of experimental animals.

1278 Keyuan Rd Shanghai ChinaShanghai Research Center for Model Organisms passed the complete verification of AAALAC the Experimental Animals International Verification Institution, which signals that Shanghai Research Center for Model Organisms has reached the world advanced level of protecting animals in a scientific and humane way in its researches on bioscience and medicine. AAALAC is an authorized international institution of evaluation and verification on feeding and employing of experimental animals.

Shanghai, Shanghai ChinaShanghai Rich Chemicals supplies fine chemicals.

Room 602, 83#, No. 3999 Xiupu Road, Shanghai, ChinaShanghai Rich Chemicals supplies fine chemicals.

Room 305, Building D, 1088 Kangqiao East Road, Pudong New District, Shanghai Shanghai, Pudong New District, 201315 ChinaSchbio Biotechnology Co., Ltd. is a biotechnology company that provides high-quality R&D outsourcing services for drug discovery. The company focuses on providing a service platform for antibodies and small molecules in the field of tumor and autoimmune diseases, from antibody prophase sequence discovery based on phage library screening to in vitro efficacy based on cell functional validation. At present, the company has set up a 400㎡ cell laboratory in Taizhou, which meets the standard of P2 laboratory, and a function verification platform based on PBMC cell, which can complete a series of platform function verification experiments related to ADCC, MLR, SEB/CMV recall, Macrophage differentiation and phagy

Shanghai, Shanghai ChinaShanghai Sensichip Infotech offers microRNA analysis, next generation sequencing, and microarray services.

Bldg 2, 237 Xitai Rd.Shanghai Sinch offers custom synthesis, custom manufacturing, and chemical compounds.

Shanghai, Shanghai ChinaShanghai Sinch offers custom synthesis, custom manufacturing, and chemical compounds.

2140 Xie Tu Road Shanghai, 200032 ChinaThe Shanghai Institute of Planned Parenthood Research (SIPPR) was founded in 1978 in light of national family planning policy and the long-term development strategy for science and technology. The year 1979 saw the establishment of the WHO Collaborating Center for Research in Human Reproductive Health in SIPPR. Ever since 1983, SIPPR has been consecutively designated as one of the major collaborating centers of WHO/HRP in area of Reproductive Health. The institute aims at being leading domestic center; making progress in scientific researches in order to carry out the national policy; controlling population and improving the quality of population. SIPPR also keeps an open eye on the outside world and has been developing in cooperation with international organizations and agencies in order to make contributions to the global human reproductive health. SIPPR is now standing as one of the principal members of Shanghai Life Science Research Center, a national resource institute for fertility regulating studies, and one of the largest WHO collaborating centers among Asia Pacific region. With continuous support from the Government, WHO, and UNFPA, SIPPR has developed into a comprehensive research center on the national level and international collaborating resource for human reproductive health. Till now SIPPR has successfully conducted many national key projects and international research programs. In SIPPR there are the Departments of Pharmaceutical Development, Pharmacology & Toxicology, Reproductive Epidemiology and Social Science, Reproductive Biology and Hospital. The research covers a wide variety ranging from developing contraceptive drugs and devices, quality monitoring, basic science in reproductive health, epidemiology and social science, clinical pharmacology and trails, reproductive regulating pharmacology and toxicology test and other related researches. By means of editing and publishing bilingual (Chinese and English) journals--“Reproduction & Contraception”, the latest information of reproductive health is being widely disseminated among the circle and the mass. SIPPR has a Special Hospital of Reproductive Health.

2140 Xie Tu Road,Shanghai,P.R.China 200032The Shanghai Institute of Planned Parenthood Research (SIPPR) was founded in 1978 in light of national family planning policy and the long-term development strategy for science and technology. The year 1979 saw the establishment of the WHO Collaborating Center for Research in Human Reproductive Health in SIPPR. Ever since 1983, SIPPR has been consecutively designated as one of the major collaborating centers of WHO/HRP in area of Reproductive Health. The institute aims at being leading domestic center; making progress in scientific researches in order to carry out the national policy; controlling population and improving the quality of population. SIPPR also keeps an open eye on the outside world and has been developing in cooperation with international organizations and agencies in order to make contributions to the global human reproductive health. SIPPR is now standing as one of the principal members of Shanghai Life Science Research Center, a national resource institute for fertility regulating studies, and one of the largest WHO collaborating centers among Asia Pacific region. With continuous support from the Government, WHO, and UNFPA, SIPPR has developed into a comprehensive research center on the national level and international collaborating resource for human reproductive health. Till now SIPPR has successfully conducted many national key projects and international research programs. In SIPPR there are the Departments of Pharmaceutical Development, Pharmacology & Toxicology, Reproductive Epidemiology and Social Science, Reproductive Biology and Hospital. The research covers a wide variety ranging from developing contraceptive drugs and devices, quality monitoring, basic science in reproductive health, epidemiology and social science, clinical pharmacology and trails, reproductive regulating pharmacology and toxicology test and other related researches. By means of editing and publishing bilingual (Chinese and English) journals--“Reproduction & Contraception”, the latest information of reproductive health is being widely disseminated among the circle and the mass. SIPPR has a Special Hospital of Reproductive Health.

6th Floor, Building 11A, 528# Ruiqing Rd., Heqing town Shanghai, Pudong 200423 ChinaShanghai Synmedia Chemical Co. (SSCC) is a High-tech Enterprise who engages in the consultation, R&D, Production of the medical intermediate and fine chemical.

Room 205, 22 Boxia Road, Pudong Software Park, Pudong New Area, Shanghai Room 501-502, No.232, Liang Jing Road Pudong Software Park Pudong New Area, Shanghai China SHANGHAI, SHANGHAI, 200120 ChinaSynyi AI is a leading domestic medical intelligence company, specializing in the management, mining and application of medical data. The company is committed to building data-driven artificial intelligence applications for clinical medicine, medical management, patient services, and medical research to accelerate the development of smart medical systems. As a core supplier of the “National Team” for health and medical big data – CLP Data, through the establishment of a large-scale refined data governance, modeling and intelligent analysis platform, the comprehensive management of medical data and the maximization of value utilization are realized.

232 Liang Jing Lu Shanghai Shi, 201203 ChinaSynyi AI is a leading domestic medical intelligence company, specializing in the management, mining and application of medical data. The company is committed to building data-driven artificial intelligence applications for clinical medicine, medical management, patient services, and medical research to accelerate the development of smart medical systems. As a core supplier of the “National Team” for health and medical big data – CLP Data, through the establishment of a large-scale refined data governance, modeling and intelligent analysis platform, the comprehensive management of medical data and the maximization of value utilization are realized.

4258#, Jindu RoadShanghai Techwell Biopharmaceutical specializes in research and development of biochemical bulks, fermentation bulks, and chemosynthesis API in addition to GMP manufacturing services.

518 Ziyue RD Shanghai, Minhang District ChinaShanghai Veterinary Research Institute (SHVRI), formerly Shanghai Institute of Domestic Animal Parasitology, the Chinese Academy of Agricultural Sciences (CAAS), was founded in 1964. As one of the four national institutes of veterinary research, SHVRI is the only one located at the south to the Yangtz River. Currently, SHVRI has 131 full-time employees, including 90 scientific researchers, led by 18 professor-ranked principle investigators. In the spring, 2006, SHVRI also serves as the branch of the China Animal Health and Epidemiology Center and is in charge of animal diseases surveillance in the southern china. SHVRI focuses on basic, applied and bio-technological research in the field of veterinary medicine. In addition, it has been endeavored for translational works of veterinary scientific and technological achievements and industrial development. In accordance with the Chinese government’s strategic directives and the principle of knowledge innovation, SHVRI will become one of national bases for innovative research in animal medicine. With full passion and endeavor, all the faculties of SHVRI are keeping pace with the era, working hard on innovative researches, dedicating themselves to the cause of building SHVRI into a first-class veterinary medicine innovation center with top-class talented researchers, equipments and instruments, administration, achievements, and reputation.

Room 607, Building 2, Kangxin Road 3377, Pudong new area Shanghai, Shanghai, 201318 ChinaAbout GeneMedi Found in 2010, GeneMedi is a BioTech company with strong expertise in viral and non-viral vectors mediated gene expression, gene transfer, gene editing and gene therapy. GeneMedi help scientists from academic to industry in vectors optimazation, scalable production, process development and technology transfer. GeneMedi offers Pre-made and custom-made recombiant protein for drug discovery and diagnostic ingredients. Our Responsbility 1. High quality and scalable production in adeno-associated virus (AAV) vector, lentivirus vector and adenovirus vector. 2. Optimized and verified viral vector systems (AAV, lentivirus and adenovirus). 3. AAV capsid evolution and novel AAV generation& AAV cassette optimization: Create less immunogenic AAV vectors with improved transduction and expression properties. 4. Pre-made and custom-made Recombinant proteins, Enzymes and antigens for drug discovery and diagnostics ingredients, high quality, bulk in stock. About Promise-ORF viral CDNA library Genemedi has collected the larger number of human, mouse and rat protein-coding ORF cDNA clones in multiple types of viral vector systems (AAV, lentivirus, adenovirus). Our viral ORF/CDNA clones are suitable for a variety of viral packaging, functional assays, protein expression and easy purification in many cell types as well as cell-free transcription and translation coupling systems, and large scale functional genomics and proteomics studies. Both viral plasmids and viral particles are available in Promise-ORFTM viral CDNA library.

No.1 Building. 466 Yin Du Shanghai, 201108 ChinaShanghai Yaxin Biotechnology Co. manufactures and supplies recombinant enzymes expressed with E. coli.

# 351 Guoshoujing Rd., Building 2, Floor 4Shanghai Youseen New Med. Explorita provides natural drug development, chromatography, spectrometry, spray drying, and chinese medicine.

749 Guanghua Rd., Zhuanqiao Town, , Minxing District, Shanghai , 201108 ChinaFounded in 1987, Shanghai Ziyuan Pharmaceutical Co.,Ltd. is the first pharmaceutical materials manufacturing factory in Shanghai held by Shanghai No. 1 Biochem. & Pharma.CO.,Ltd.. Our company owns independent manufacturing license for drugs. Registration and production place is located in 749 Guanghua Rd., Zhuanqiao town of Minhang district in Shanghai. Production system has received certificate of GMP certification of State Food and Drug Administration and C-GMP certification of US FDA. Scope of production and business:Dobutamine hydrochloride , ethylenediamine diaceturate, Calcium Dibutyacyladenosine Cyclosphate, Diisopropylamine Dichloroacetate etc.. Dobutamine hydrochloride was certificated by US FDA in 1994 and received reexamination of US FDA in 1996. And in 2003 and 2008 it passed the reexamination of US FDA again. Fosphenytoin Sodium was certificated by US FDA in 2005 and reexamined in 2008 with no 483. Besides, our company's new drug: Chlorothiazide and Naftifine Hydrochloride , was registered in US and exported to US.

749 Guang Hua Lu Zhuanqiao town Shanghai Shi ChinaFounded in 1987, Shanghai Ziyuan Pharmaceutical Co.,Ltd. is the first pharmaceutical materials manufacturing factory in Shanghai held by Shanghai No. 1 Biochem. & Pharma.CO.,Ltd.. Our company owns independent manufacturing license for drugs. Registration and production place is located in 749 Guanghua Rd., Zhuanqiao town of Minhang district in Shanghai. Production system has received certificate of GMP certification of State Food and Drug Administration and C-GMP certification of US FDA. Scope of production and business:Dobutamine hydrochloride , ethylenediamine diaceturate, Calcium Dibutyacyladenosine Cyclosphate, Diisopropylamine Dichloroacetate etc.. Dobutamine hydrochloride was certificated by US FDA in 1994 and received reexamination of US FDA in 1996. And in 2003 and 2008 it passed the reexamination of US FDA again. Fosphenytoin Sodium was certificated by US FDA in 2005 and reexamined in 2008 with no 483. Besides, our company's new drug: Chlorothiazide and Naftifine Hydrochloride , was registered in US and exported to US.

Room 2008, Rong-Xin Building, No1851，Sichuan North Road , Hongkou Distric Shanghai 200081 ChinaShenjiu Medpharm offers regulatory consulting, biostatistics, patent transfer, clinical research, and principal investigator recruitment.

Floor 2, Building A 328#, Wuhe Road Shanghai, 201109 ChinaShineGene Bio-Technologies offers gene and peptide synthesis, PCR, probe design, labeling, and antibody production.

Building 1,No.720 Cailun Rd,Shanghai Zhangjiang Hi-Tech Park Shanghai, 201203 ChinaSIDANSAI Biotechnology is a high-tech company mainly focusing on the development of novel technologies and new products on stem cell and molecular biology. Specialties include TALEN technology, human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) technical platforms.

5th Floor, Building 20, Lane 500, Furonghua Road, Pudong Shanghai, 200000 ChinaMethylation based gene testing

99 Haike Rd, Building 3, 1st Floor Zhangjiang Shanghai, Shanghai, 201210 ChinaSinotherapeutics provides expert drug product CRO/CDMO service for NCE, covering conventional, complex and enabling formulations, all to be carried out cost-effectively and timely.

No. 163, Zhuhai Rd., Binjiang Street, Haimen District Nantong, Jiangsu, 226100 ChinaSinotherapeutics provides expert drug product CRO/CDMO service for NCE, covering conventional, complex and enabling formulations, all to be carried out cost-effectively and timely.

3rd Floor, Unit 2 159 Tianzhou Road Shanghai 200233, ChinaSongwon is the second largest manufacturer of polymer stabilizers in the world. Our vision is to be Salient in Additives and become the supplier of choice for polymer additives through our continued commitment to providing better quality, better service and better value to our customers. We are firmly focused on delivering growth by anticipating the needs and desires of our customers and by aspiring to be a leading example in additives technology development.

Suzhou World Trade Center Suzhou, Jiangsu ChinaIn the fields of Intellectual Property, Technology, and Market Research, Stellarix is expertized in research and analytical depth combined with non-traditional and standard consulting methodologies to obtain the best outcomes. While operating in numerous domains, Pharmaceutical and Biotechnology domains remain crucial, as this industry continues to face unparalleled challenges, such as increasing regulatory scrutiny, increased transparency expectations, emphasis on innovative technologies, increasing cost, lack of compliance to IT infrastructure and technologies. It is one of the rapidly evolving industry, from selling of products to delivering value through better patient health and wellbeing. Stellarix caters to all the challenges by identifying technology gaps of changing industry trends, IP analysis for your novel technology or violation of your existing one, to in-depth chemical or structure search in your interest area. Successively, we help you stand still at every stage of your journey.

6F, 163, Jiangchang 3rd road, Zhabei district, Shanghai 200436 ChinaSumika Chemical Analysis Service (SCAS) provides regulatory services, REACH consulting, chemical registration, and MSDS services.

806room, 76, Jiangchang 3rd road, Zhabei district, Shanghai 200436 ChinaSumika Chemical Analysis Service (SCAS) provides regulatory services, REACH consulting, chemical registration, and MSDS services.

Building 19, Biomedical Industrial Park, No. 21 Chaoqian Road, Suzhou Industrial Park, Suzhou, Jiang Su, China Suzhou, Jiangsu, 215000 ChinaAbogen Biosciences is a fuly intearated cinicatstage new powerhouse in the evolving field of RNA therapeuics. Drven by the mission to revolutionize the future of health and ife, we are committed to pioneering mRNA medicines through innovation, integration and insight. Founded in 2019, we have been rapidy rising to prominence in biotechnology powered by our proprietary clinically valdated mRNA-LNP platform that combines advanced Al technologies, automalion and scalable manufacturing. With deep experise in mRNA modifications and delivery, we are pushing the boundaries of immuno-oncology, autoimmune disease therapies and infectious disease vaccines.

No. 485 Panxu Road,Suzhou,Jiangsu ,ChinaSuzhou Howsine Biological Technology offers custom synthesis and API products and services.

4th Floor, Building C3 LifeBay, Wuzhong District Suzhou, Jiangsu, 215124 ChinaKanwhish is a China-based CRO specializing in high-quality bioanalytical services to support global drug development. With deep scientific expertise and a strong commitment to regulatory compliance (GLP, GCLP, ICH M10), we provide comprehensive solutions for pharmacokinetics, immunogenicity, and biomarker analysis across preclinical and clinical stages. Our team of seasoned scientists, state-of-the-art platforms (including LC-MS/MS, ELISA, MSD, qPCR, and flow cytometry), and proven experience in global regulatory submissions make us the partner of choice for biotech and pharma companies worldwide. Partner with Kanwhish — where scientific rigor meets responsive service.

905, Building 6, No.88 Xianshi Road, Changshu High-tech Industrial Development Zone Suzhou, Jiangsu, 215500 ChinaReadCrystal Biotechnology is a CRO specializing in structural analysis services, offering high-quality services for innovative pharmaceutical companies and life science researchers in the drug discovery field. The company has established a service platform with X-ray crystallography, Cryo-EM SPA, and MicroED as core structural analysis technologies. This platform provides services in protein expression and purification, structural biology, biophysical characterization, and drug screening, accelerating the processes for clients in the early stages of drug discovery. In addition, MicroED technology is our core technology and can be used to resolve crystals as small as 100nm. It can be applied to the research of biological macromolecular crystals (proteins/RNA), drugs, chemistry and materials (MOF/COF/organic molecules/inorganic minerals, etc.).

Room 301,Block A, Boji Science & Technology Park No 2 of Taishan Road Suzhou New District, Jiangsu, 215129 ChinaSuzhou Rovathin Foreign Trade Co. is specialized in the design, synthesis, sales and outsourcing of organic compounds for the pharmaceutical, drug discovery, agrochemical and biotechnology industries.

328, Building A2 Nanobiotechnology Park 218 Xinghu Road Suzhou Industrial Park Suzhou, Jiangsu, 215000 ChinaSingle B Cell antibody discovery platform and technologies service

Building 5,, Zone 2, No. 98 Zhaoxi Road, Shaxi Town Taicang, Jiangsu, 215411 ChinaTruwayBio is dedicated to providing flexible and cost-effective preclinical drug development services for pharmaceutical innovators. Our comprehensive offerings include In Vitro Biology, in vitro ADME, in vivo PK, cancer efficacy models, immune disease animal models and Non-GLP toxicology studies, supported by state-of-the-art in vivo platforms for mice, rats, canines, and non-human primates. We operate on a simple yet powerful philosophy: Become your extended R&D lab. Through our customer-centric approach and risk-free commitment model (no upfront payments), we ensure every study delivers maximum scientific value. while prioritizing uncompromised data quality, agile service customization and optimal cost efficiency, trust TruwayBio to transform your preclinical research into a strategic advantage – where every study advances both your pipeline and your competitive edge.

Suzhou City, Jiangsu Province ChinaSuzhou Xishan Zhongke Laboratory Animal Co., Ltd.

, Suzhou, Jiangsu , CNSuzhou Xishan Zhongke Laboratory Animal Co., Ltd.

Suzhou, Jiangsu ChinaSuzhou Zelgen Biosciences offers cell line generation, protein expression, peptide synthesis, and antibody production services.

No. 209 Chenfeng RoadSuzhou Zelgen Biosciences offers cell line generation, protein expression, peptide synthesis, and antibody production services.

320 Lv Lin Lu Shanghai Shi ChinaSynPeptide Co Ltd is a leading provider of innovative peptide-based services and research tools

Shanghai, Shanghai ChinaSyncozymes offers chiral compounds, biocatalysis, drug scaffold synthesis, protein engineering, lyophilization, and screening.

Shanghai, Shanghai ChinaSynCores provides chemistry synthesis services.

No. 128 Die Qiao Road, HengMian Town Shanghai, Pudong 201319 ChinaSyncoZymes offers custom synthesis, process development, biocatalyst screening, and supply of enzymes, chiral chemicals, scaffolds, and enzymatic kits.

Shanghai ChinaSyncoZymes offers custom synthesis, process development, biocatalyst screening, and supply of enzymes, chiral chemicals, scaffolds, and enzymatic kits.

528 Ruiqing Rd. Heqing, Pudong, Shanghai 201201Synkinase offers kinase inhibitors, building blocks, and custom synthesis services.

320 Lvlin Road Shanghai Shi China

C-3, 735 Ziping Road Zhoupu, Pudong New Area Shanghai, Shanghai, 201318 ChinaAs a pre-clinical contract research organisation focusing on small molecule drug discovery , SYNthesis offer a range of flexible collaborative relationships to our partners. Operating under a Fee for service (single compound or small library) or a Full Time Equivalent (Medicinal chemistry programs, Hit to lead and Lead Op) business model. SYNthesis has executed multiple research projects across many drug targets. We have a solid record of successful delivery with multiple clinical candidates from work conducted in our laboratories.

425 Changyang St Suzhou Industrial Park Suzhou, Jiangsu, 215000 ChinaAs a pre-clinical contract research organisation focusing on small molecule drug discovery , SYNthesis offer a range of flexible collaborative relationships to our partners. Operating under a Fee for service (single compound or small library) or a Full Time Equivalent (Medicinal chemistry programs, Hit to lead and Lead Op) business model. SYNthesis has executed multiple research projects across many drug targets. We have a solid record of successful delivery with multiple clinical candidates from work conducted in our laboratories.

13th Floor, Building 1, 111 Wusongjiang Avenue, Wuzhong District, Suzhou, China Suzhou, Jinagsu, 215000 ChinaTaipuMai (Suzhou) Pharmaceutical Technology Co., Ltd. is engaged in preclinical pharmacology and efficacy studies of drugs, pharmaceutical R&D services, research on medical materials and biological products, as well as technology development, transfer, and consulting services in the biopharmaceutical field. TaipuMai Pharma is a differentiated enabling platform enterprise focused on the development of animal disease models, preclinical efficacy studies integrated with pharmacokinetics and exploratory toxicology, as well as in vitro functional assays. The company serves as a cornerstone for improving clinical translation efficiency and plays a key role in supporting the advancement of new drug candidates into clinical trials. The company is equipped with barrier-grade small animal facilities (for housing mice, rats, guinea pigs, etc.), general-grade large animal housing, and supporting functional laboratories. Its animal facilities meet both domestic and international standards and are accredited by AAALAC.

Unit 417, 4th floor, Lippo Cntre, Tower Two, No. 89 Queensway, Admiralty, Hongkong 5th floor, Tower One, 1227 Zhangheng Rd, Pudong, Shanghai,China shanghai, shanghai, 201203 ChinaTandemAI is focused on lowering the barrier to entry to the most advanced tools in drug discovery. We designed our fully integrated pre-clinical drug discovery platform to empower researchers to discover therapeutic candidates faster and more efficiently by democratizing access to the most innovative tools in drug discovery. We hope to dramatically improve the success rate of pre-clinical therapeutic candidates and, ultimately, help improve the lives of people waiting for new treatment options.

5th floor, Tower One, 1227 Zhangheng Rd, Pudong, Shanghai,China shanghai, shanghai, 201203 ChinaTandemAI is focused on lowering the barrier to entry to the most advanced tools in drug discovery. We designed our fully integrated pre-clinical drug discovery platform to empower researchers to discover therapeutic candidates faster and more efficiently by democratizing access to the most innovative tools in drug discovery. We hope to dramatically improve the success rate of pre-clinical therapeutic candidates and, ultimately, help improve the lives of people waiting for new treatment options.

5th floor, Tower One, 1227 Zhangheng Rd, Pudong shanghai, shanghai, 201203 ChinaTandemAI is focused on lowering the barrier to entry to the most advanced tools in drug discovery. We designed our fully integrated pre-clinical drug discovery platform to empower researchers to discover therapeutic candidates faster and more efficiently by democratizing access to the most innovative tools in drug discovery. We hope to dramatically improve the success rate of pre-clinical therapeutic candidates and, ultimately, help improve the lives of people waiting for new treatment options.

Shanghai, Shanghai ChinaTargetDrug focuses on research and development, clinical trials and drug screening services.

4th floor, No.1, Lane 997, Qiu Jiang Road, Zha Bei Distric Shanghai 200071 ChinaTenGen Biomed provides pharmacology, gene engineering, protein modification, and drug screening for early stage drug and vaccine development.

Room A101, No.100, Lane 2891, South Qilianshan Road Shanghai 200331 ChinaFounded in 1989, Thorlabs has its headquarters in Newton, NJ. This location is also home to our mechanics, optics, fiber, advanced systems technology, and advanced applications teams as well as one of our three distribution warehouses. On-site manufacturing allows us to customize our products quickly and efficiently to meet specialized customer requests. Our technical support team, call center, marketing, and web development teams make their homes in Newton as well, and are dedicated to providing comprehensive customer support and services.

Suite 813-815, 999 West Zhongshan Road, Shanghai, China, 200051Tigermed (Stock code: 300347.SZ/3347.HK) is a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry. With a broad portfolio of services and a promise of quality, from preclinical development to clinical trial to commercialization, we are collaborating with over 2,800 customers and committed to moving their development journey efficiently and cost-effectively. Tigermed currently represents a worldwide network of more than 180 locations with over 9700 employees across Asia Pacific, Europe, North America, Latin America and Africa. We are devoted to building an integrated platform that enables the boundless possibilities for the healthcare industry, embracing challenges to fulfill our commitment to serving unmet patients’ needs, and ultimately saving lives.

Building #4 No.255 Rongteng RoadTosoh offers ceramic materials, fine chemicals, fluoro compounds, organic intermediates, and polymer products and services.

Room 2618, International Trade Center, No. 2201 Yan-An West Road, Shanghai, China 200336Tosoh offers ceramic materials, fine chemicals, fluoro compounds, organic intermediates, and polymer products and services.

120 Changyang Street, Industrial Park Suzhou, Jiangsu, 215024 ChinaTOT BIOPHARM Co., Ltd. is a one-stop biologics CRO and CDMO supplier, with focus on global antibody-drug conjugates manufacturing services, dedicated to becoming the industry leading and trusted biopharmaceutical best partner for global clients. With extensive practical experience, mature technical platforms and robust quality system, TOT BIOPHARM has developed diversified strategic partnerships with domestic and international pharmaceutical companies to provide one-stop CDMO solutions for drug development and manufacturing, which help customers to accelerate the development and manufacturing of biologics, especially antibody-drug conjugates (ADCs), empowering to achieve high-quality development for the industry. TOT BIOPHARM has established a large-scale commercial GMP production base for biological drugs which has equipped with multiple complete upstream and downstream production lines, with a total manufacturing capacity exceeding 20,000 L. The company has established an integrated platform for antibody-drug conjugates (ADCs), which can complete key production processes such as antibodies, linker and drug substance to be completed in one place, reducing transfer costs and regulatory risks. Currently, TOT BIOPHARM has established a quality management system in line with commercial manufacturing, which has successfully supported the commercial production of several marketed products. TOT BIOPHARM has a mature, stable core team and good reputation for professional, which can provide customers with excellent professional services.

728 Yan-an Road (West), Huamin Empire Plaza, Suite 7B,Shanghai 200050, ChinaTrademax offers intermediates, API, herbal extracts, and custom synthesis services.

Shanghai, Shanghai ChinaTRUST&WE supplies fine chemicals and offers custom synthesis and manufacturing services.

425 Changyang Street, Suzhou Industrial Park Suzhou, Jiangsu, 215000 ChinaEstablished in 2008, Viva Biotech (01873.HK) provides one-stop services ranging from early-stage Structure-Based Drug R&D to commercial manufacturing to global biopharmaceutical innovators. We offer leading early-stage to late-phase drug discovery expertise by integrating our dedicated team of experts, cutting-edge technology platforms, and state-of-the-art equipment in X-ray crystallization, Cryo-EM, DEL, ASMS, SPR, HDX, AIDD/CADD, and much more. Our business covers all aspects of therapeutic strategies and drug modalities, including small molecules and biologics across the pharma and biotech spectrum. The experienced chemistry team, led by senior medicinal chemists and drug discovery biologists, provides services for drug design, medicinal chemistry (hit to lead and lead optimization), custom synthesis, chemical analysis and purification, kilogram scale-up, peptide synthesis and corresponding bioassays. With our subsidiary, Langhua Pharma, we offer our worldwide pharmaceutical and biotech partners a one-stop integrated CMC (Chemical, Manufacturing, and Control) service from preclinical to commercial manufacturing. Additionally, Viva embedded an equity for service (EFS) model to high potential startups to address unmet medical needs.

No.735, Ziping Road Pudong New Area Shanghai, Shanghai, 201318 ChinaEstablished in 2008, Viva Biotech (01873.HK) provides one-stop services ranging from early-stage Structure-Based Drug R&D to commercial manufacturing to global biopharmaceutical innovators. We offer leading early-stage to late-phase drug discovery expertise by integrating our dedicated team of experts, cutting-edge technology platforms, and state-of-the-art equipment in X-ray crystallization, Cryo-EM, DEL, ASMS, SPR, HDX, AIDD/CADD, and much more. Our business covers all aspects of therapeutic strategies and drug modalities, including small molecules and biologics across the pharma and biotech spectrum. The experienced chemistry team, led by senior medicinal chemists and drug discovery biologists, provides services for drug design, medicinal chemistry (hit to lead and lead optimization), custom synthesis, chemical analysis and purification, kilogram scale-up, peptide synthesis and corresponding bioassays. With our subsidiary, Langhua Pharma, we offer our worldwide pharmaceutical and biotech partners a one-stop integrated CMC (Chemical, Manufacturing, and Control) service from preclinical to commercial manufacturing. Additionally, Viva embedded an equity for service (EFS) model to high potential startups to address unmet medical needs.

No. 334, Aidisheng Rd, Zhangjiang Hi-tech Park 上海市, 上海市, 201203 ChinaEstablished in 2008, Viva Biotech (01873.HK) provides one-stop services ranging from early-stage Structure-Based Drug R&D to commercial manufacturing to global biopharmaceutical innovators. We offer leading early-stage to late-phase drug discovery expertise by integrating our dedicated team of experts, cutting-edge technology platforms, and state-of-the-art equipment in X-ray crystallization, Cryo-EM, DEL, ASMS, SPR, HDX, AIDD/CADD, and much more. Our business covers all aspects of therapeutic strategies and drug modalities, including small molecules and biologics across the pharma and biotech spectrum. The experienced chemistry team, led by senior medicinal chemists and drug discovery biologists, provides services for drug design, medicinal chemistry (hit to lead and lead optimization), custom synthesis, chemical analysis and purification, kilogram scale-up, peptide synthesis and corresponding bioassays. With our subsidiary, Langhua Pharma, we offer our worldwide pharmaceutical and biotech partners a one-stop integrated CMC (Chemical, Manufacturing, and Control) service from preclinical to commercial manufacturing. Additionally, Viva embedded an equity for service (EFS) model to high potential startups to address unmet medical needs.

218 Xing Hu Jie, A3-404VRL Laboratories offers diagnostic assay, viral assay, microbiology, and antibody services.

Part A Mingtai Building 351 Guoshoujing Road Zhangjiang Hi-tech Park Shanghai 201203 ChinaWacker offers contract manufacturing, biologic analysis, and quality control/assurance services.

NO 409, Ziyue Road, Zizhu Scientific Park, Minhang District, Shanghai, ChinaWatson International Ltd is a chemical trading company as well as the business department of FCAD Group. FCAD helps clients from different fields to develop their required fine chemicals or formulations. From pharmaceutical materials to diagnostic reagents, cruing agent to construction chemicals, photographic formulations to electronic intermediates, cosmetics ingredients to flavors, FCAD tries to achieve high quality by the most economic route. Today, FCAD's several R&D companies have become leaders of involved chemical branches which ensures of strong technical support to Watson's custom synthesis service. For example, Apnoke Scientific has been a well-known company in amino acid and peptide area; While Ulcho Biochemical Ltd is a specified company in complicated Carbohydrate and Nucleotide and Ionic Liquid synthesis. FCAD helps clients from different fields to develop their required fine chemicals or formulations. From pharmaceutical materials to diagnostic reagents, cruing agent to construction chemicals, photographic formulations to electronic intermediates, cosmetics ingredients to flavors, FCAD and the subsidiaries try to achieve high quality by the most economic route. Our clients include GE, P&G, Siemens, Sony, Pfizer, Merck, AstraZeneca, Sigma-Aldrich, TCI and so on.

Room 1518, Asia Pacific Plaza, NO 18, Zhaofeng Road, Kunshan, ChinaWatson International Ltd is a chemical trading company as well as the business department of FCAD Group. FCAD helps clients from different fields to develop their required fine chemicals or formulations. From pharmaceutical materials to diagnostic reagents, cruing agent to construction chemicals, photographic formulations to electronic intermediates, cosmetics ingredients to flavors, FCAD tries to achieve high quality by the most economic route. Today, FCAD's several R&D companies have become leaders of involved chemical branches which ensures of strong technical support to Watson's custom synthesis service. For example, Apnoke Scientific has been a well-known company in amino acid and peptide area; While Ulcho Biochemical Ltd is a specified company in complicated Carbohydrate and Nucleotide and Ionic Liquid synthesis. FCAD helps clients from different fields to develop their required fine chemicals or formulations. From pharmaceutical materials to diagnostic reagents, cruing agent to construction chemicals, photographic formulations to electronic intermediates, cosmetics ingredients to flavors, FCAD and the subsidiaries try to achieve high quality by the most economic route. Our clients include GE, P&G, Siemens, Sony, Pfizer, Merck, AstraZeneca, Sigma-Aldrich, TCI and so on.

85 Liangle Road, Laogang Town, Pudong New District shanghai, 201302 ChinaThe company is an international supply chain enterprise specializing in the life sciences and chemical sectors, serving clients worldwide. It is dedicated to providing comprehensive solutions, upstream raw materials, products, and services for innovative drug R&D, in vitro diagnostics (IVD), and fundamental life science research. Its clientele includes leading pharmaceutical companies, biotechnology firms, and research institutions across more than 20 countries and regions, making it a trusted partner for both customers and suppliers in the global life science research and application industry.

Add::Room 401, Building 14, Sanjie Fang,Harbour City Plaza, 33 Shuiyun Road, Pudong New Area, Shanghai shanghai, 201306 ChinaThe company is an international supply chain enterprise specializing in the life sciences and chemical sectors, serving clients worldwide. It is dedicated to providing comprehensive solutions, upstream raw materials, products, and services for innovative drug R&D, in vitro diagnostics (IVD), and fundamental life science research. Its clientele includes leading pharmaceutical companies, biotechnology firms, and research institutions across more than 20 countries and regions, making it a trusted partner for both customers and suppliers in the global life science research and application industry.

Unit B102, 326 Edison RD Shanghai, 201203 ChinaWelch Materials develops and manufactures Chromatography consumables including HPLC columns, Solid Phase Extraction (SPE) columns, GC columns, sample vials, syringe filters, and chromatographic media.

Room#1036, No.2 Building, No.699 South Huashi Road, Qidong Economic Development Zone, Qidong, Suzhou, 000000 ChinaAs a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and life sciences industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, advanced therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions.

吴中区吴中大道1318号 苏州, 江苏, 215104 ChinaAs a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and life sciences industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, advanced therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions.

131 Kaiqing Road, Pudong Shanghai, 201201 ChinaAs a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and life sciences industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, advanced therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions.

Fute Road 288 Waigaoqiao free trade zone Shanghai, shanghai, 200131 ChinaAs a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and life sciences industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, advanced therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions.

1318 Wuzhong Avenue,As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and life sciences industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, advanced therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions.

699 Huashi Nan Road, Qidong, Nantong, Jiangsu Province, 226299, China Nantong, Jiangsu, 226299 ChinaAs a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and life sciences industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, advanced therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions.

9 Yuegong RoadAs a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and life sciences industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, advanced therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions.

1336 Wuzhong Avenue, Xinzhiyuan Building B, Wuzhong District Suzhou, Jiangsu, 215104 ChinaWuXi Biologics’ industry-leading research protein generation group offers custom-tailored services for recombinant protein and antibody production in mammalian cells. By using patented state-of-the-art technologies, we deliver high quality products and services to the biopharmaceutical and diagnostic companies. Over 5,000+ proteins delivered per year Unique highly-automated, high-throughput system Multiple production platforms: E. coli, insect, yeast, CHO, NS0, HEK-293 Wide variety of mAbs, ADCs, proteins, enzymes, kinases etc. Extensive formulation and analytical support services High capacity and high quality from mg to 100+ grams in weeks

101-201Room, C37 Building, No.218 Xing Hu Road, Suzhou Industrial Park Suzhou, Jiangsu, 215000 ChinaWuXi Biologics’ industry-leading research protein generation group offers custom-tailored services for recombinant protein and antibody production in mammalian cells. By using patented state-of-the-art technologies, we deliver high quality products and services to the biopharmaceutical and diagnostic companies. Over 5,000+ proteins delivered per year Unique highly-automated, high-throughput system Multiple production platforms: E. coli, insect, yeast, CHO, NS0, HEK-293 Wide variety of mAbs, ADCs, proteins, enzymes, kinases etc. Extensive formulation and analytical support services High capacity and high quality from mg to 100+ grams in weeks

Room 368, Section 302, No. 211 North Fute Road Pilot Free Trade Zone Shanghai, 200131 ChinaWuXi Biologics’ industry-leading research protein generation group offers custom-tailored services for recombinant protein and antibody production in mammalian cells. By using patented state-of-the-art technologies, we deliver high quality products and services to the biopharmaceutical and diagnostic companies. Over 5,000+ proteins delivered per year Unique highly-automated, high-throughput system Multiple production platforms: E. coli, insect, yeast, CHO, NS0, HEK-293 Wide variety of mAbs, ADCs, proteins, enzymes, kinases etc. Extensive formulation and analytical support services High capacity and high quality from mg to 100+ grams in weeks

Factory Building 2, Lane 31, Yiwei Road, China（Shanghai) Pilot Free Trade Zone Shanghai, 200131 ChinaWuXi Biologics’ industry-leading research protein generation group offers custom-tailored services for recombinant protein and antibody production in mammalian cells. By using patented state-of-the-art technologies, we deliver high quality products and services to the biopharmaceutical and diagnostic companies. Over 5,000+ proteins delivered per year Unique highly-automated, high-throughput system Multiple production platforms: E. coli, insect, yeast, CHO, NS0, HEK-293 Wide variety of mAbs, ADCs, proteins, enzymes, kinases etc. Extensive formulation and analytical support services High capacity and high quality from mg to 100+ grams in weeks

288 Fute Zhong Rd Waigaoqiao Free Trade Zone, Shanghai , 200131 ChinaWuXi NextCODE is a global genomic information company using sequence data to improve health and deliver precision medicine for people around the world. With offices in Shanghai; Kendall Square in Cambridge, Massachusetts; and Reykjavik, Iceland, we offer unique and comprehensive capabilities for generating, organizing, mining, sharing and applying genomic data. This platform serves our partner companies, research institutions, health systems, hospitals, scientists and clinicians around the world to develop means of better understanding, diagnosing, treating and preventing disease. We are using it to advance our own growing range of sequence-based diagnostics and wellness products in China.

288 Fute Zhong Rd Waigaoqiao Free Trade Zone Shanghai 200131, ChinaWuXi NextCODE is a global genomic information company using sequence data to improve health and deliver precision medicine for people around the world. With offices in Shanghai; Kendall Square in Cambridge, Massachusetts; and Reykjavik, Iceland, we offer unique and comprehensive capabilities for generating, organizing, mining, sharing and applying genomic data. This platform serves our partner companies, research institutions, health systems, hospitals, scientists and clinicians around the world to develop means of better understanding, diagnosing, treating and preventing disease. We are using it to advance our own growing range of sequence-based diagnostics and wellness products in China.

Building 1, 207 Huanqiao Road, Pudong New Area Shanghai, 201315, China Shanghai, Shanghai, 201315 ChinaXtalPi ("QuantumPharm Inc.", stock code: 2228.HK) is a quantum physics-based, AI-powered drug R&D company dedicated to revolutionizing drug discovery and development by significantly improving the speed, scale and success rate of therapeutic innovations. With operations in both China and the U.S., we leverage advanced capabilities and resources in each market to meet the diverse needs of our customers and collaborators across the pharmaceutical and biotechnology industries. Our cutting-edge cloud integrated platform is meticulously designed to optimize quantum physics based algorithms, in silico modeling, and computational chemistry using experimental data generated from our state-of-the-art automated wet lab. This approach enhances the efficiency and productivity of laboratory workflows, allowing for accelerated candidate selection and lead optimization in small molecule discovery, along with robust crystal structure prediction and polymorph screening in solid state chemistry. We are strategically positioned at the forefront of a transformative shift in pharmaceuticals, where the convergence of AI, computational chemistry and automation is increasingly critical for the success of novel therapeutics and targeted therapies.

4299 Jindu Road, Building 3, 3rd Floor Shanghai 201108 ChinaZannan Pharma offers API intermediates and custom synthesis services.

7th Block, NO.237 Xitai Road,Shanghai, ChinaZealing Chemicals offers API intermediates and custom synthesis services.

Shanghai, Shanghai ChinaZealing Chemicals offers API intermediates and custom synthesis services.

No. 328 2nd Floor C Bi Bo Road, Zhangjiang, Hi-tech Park Shanghai 201203 ChinaZensun provides antibody production, gene expression, and purification services in the screening of anti-tumor and cardiovascular drugs.

Shanghai, Shanghai ChinaZensun provides antibody production, gene expression, and purification services in the screening of anti-tumor and cardiovascular drugs.

Room C, East 15F, No.688 East Beijing Road, Shanghai, China, 200001Huahai Pharmaceuticals manufactures APIs and intermediates and provides formulation services.

Shanghai, Shanghai ChinaZhou Fang Pharm Chemical offers API, raw materials, bulk pharmaceuticals, and intermediate products.

1st Floor, Gate B, No.20 Building, No.528 Ruiqing Road, Zhangjiang, High-tech Industrial East District, Shanghai 201203 ChinaZJ Biotech offers real time polymerase chain reaction (RT-PCR) kits in addition to Western and Southern blotting services.

Shanghai, Shanghai ChinaZJ Biotech offers real time polymerase chain reaction (RT-PCR) kits in addition to Western and Southern blotting services.